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INTRODUCTION 
Parkinson's disease (PD) is a progressive disabling neurological disorder 
resulting from degeneration of dopamine-containing cells in the substantia 
nigra [21]. A specific degeneration of nigral and other pigmented 
brainstem nuclei, with a characteristic inclusion, the Lewy body, in 
remaining nerve cells, is found at autopsy [72]. Tremor at rest, rigidity, 
bradykinesia, and loss of postural reflexes are the main symptoms of the 
clinical syndrome [59,60,99]. Postmortem studies also indicate that motor 
signs only develop when 80% of the cells in the substantia nigra are lost 
[127]. Among the many instruments to evaluate the clinical picture, the 
Unified Parkinson's Disease Rating Scale [58,107], being a reliable and 
valid scale [125,163,199], is the most widely used today. 
It was not until the last two decades that cognitive dysfunction in PD 
became a topic of great interest. In his original description of the 'shaking 
palsy', James Parkinson stated that "senses and intellects are uninjured" 
[144]. Later, some clinicians, such as Trousseau [196] and Charcot [28] 
mentioned symptoms of cognitive decline, but they observed this only in 
patients in the terminal phase of the disease. In view of recent studies in 
which it is suggested that cognitive dysfunction of PD is characterized by 
bradyphrenia [50,161,168], or subcortical dementia [15,30,43-45,93,97], the 
French neurologist Lamy [106] did an interesting observation: "En dépit de 
leur inertie et de leur indifférence apparentes, les malades sont 
parfaitement présents à ce qui se passe autour d'eux; leur mémoire est 
bonne; et l'on ne peut relever qu'un certaine lenteur dans les idées, une 
tendance très explicable à la tristesse", an observation which suggests a 
specific mental deficit in absence of a general cognitive decline. 
Before 1980, studies dealing with cognitive dysfunction in PD were 
mostly restricted to the question as to whether or not dementia is part of 
the symptom complex of PD or not. In a review from that period [7] it is 
concluded that this percentage rises to between 40 and 50, and that both 
neuropsychological and neuropathological data indicate that the majority 
of demented PD patients show findings indistinguishable from Alzheimer's 
disease, a finding not related to age. Later studies did not confirm this 
high percentage [2,11,14,56,57,71,74,102,121,128,155,176,179,180,194]. Only 
some incidental reports supported the notion of specific deficits 
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[90,157,186]. As far as the basal ganglia were concerned, the current 
opinion was that the function of this area is restricted to motor control: 
"the overwhelming clinical impression (of PD patients) is of a group of 
patients devastated by motor incapacity, but with preserved cognitive 
function" [122]. 
The discrepancy between the assumed exclusive motor function of the 
basal ganglia and the evidence of cognitive impairments in PD raised the 
question whether and to which extent the cognitive impairments are 
related to disease characteristics of PD. A vast amount of studies showed 
the impact of the severity of motor symptoms [36,94,123,209], in particular 
of rigidity and bradykinesia, in contrast to that of tremor [86,115,-
126,137,156,162,165,209]. Whereas duration of disease turned out to be of 
minor importance, age at onset of disease proved to be an important 
determinant of diminishing intellectual functioning: a late onset increases 
the risk of cognitive decline [5,26,54,87,138,141,159]. Also depression 
proved to be a major predictor of cognitive impairments [4,29,36,-
101,177,178,195,205,207]. The introduction of levodopa marked a new 
orientation of research towards pharmacotherapeutic aspects of cognitive 
function in PD. Numerous studies have dealt with the cognitive effects of 
levodopa therapy, which are assumed to vary from non-existent to slightly 
positive [1,8,19,20,37,48,75,88,92,95,108,109,133,134,142,149,150,153,-
158,207]. The same holds true for selegiline (deprenyl) [89,154]. In 
contrast, anticholinergic therapy was shown to have negative effects on 
cognitive function, especially on memory performance [2,37,49,51,53,-
104,114,131,160,171,185,198]. 
In the middle of the seventies, Bowen [9,10] published the first studies 
involving a broad spectrum of neuropsychological tests. Specific 
impairments in short-term memory, concept formation and shifting set 
were found in absence of general intellectual deterioration. In 1983, Lees 
and Smith [111] confirmed these results in untreated patients. These 
authors suggested that these impairments could be attributed to 
destruction of the ascending dopaminergic mesocorticolimbic pathway. This 
suggestion was followed by many reports which hypothesized that the 
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cognitive impairments in PD reflected dysfunction of the frontal lobe 
[2,188-192,201,203]. These studies focused on cognitive functions which are 
generally assumed to be dependent on the integrity of the frontal lobe. 
These functions are often summarized under the heading 'executive 
functions', being defined as the "capacities that enable a person to engage 
successfully in independent, purposive, self-serving behavior" [116]. They 
include, but are not limited to, a large variety of abilities, such as focused 
and sustained attention, fluency and flexibility of thought in the generation 
of solutions to novel problems, and the planning and regulating of adaptive 
goal-directed activity [192]. Consequently, the range of tests assumed to 
assess executive functions is wide and heterogeneous. Many studies have 
been undertaken to test the 'frontal' hypothesis of cognitive impairments in 
PD. Some studies confirmed this hypothesis [61,112], some found only 
partial or no evidence to do so [24,25,55,78,79,140,142,202]. The more 
these studies focused on a detailed analysis of the pattern of performance, 
the more discriminative differences in cognitive performance between PD 
patients and frontal patients were found. 
Cools et al. [34,35] started from a different view point. On the basis of 
animal studies [32,33,197], they developed the concept of an impaired 
shifting aptitude in PD, being the capacity to reorganize behavior 
according to the requirements of the task without any cue or guidance. 
They operationalized shifting aptitude in a number of tests assessing 
shifting behavior in three distinct modalities: the verbal, conceptual and 
motor modality. They found that the performance of PD patients was 
significantly poorer than that of control subjects (CS) on all these tests. 
More in detail, they established that the impairment of PD patients did 
not manifest itself at the level of task acquisition, but at the level of shift 
performance. They also found that differences in motor shift performance 
between PD patients and CS disappeared when the motor shift 
performance of the PD patients was corrected for cognitive shift 
performance [200]. Their findings suggested that one and the same 
cognitive function is impaired in PD, which showes up in different 
modalities. 
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The present thesis is a continuation of the above mentioned study of Cools 
et al. In that study, it was emphasized that PD patients are only impaired 
in the arbitrary reorganization of behavior, and not in the reorganization of 
behavior that is directed by currently available information. In other words, 
PD patients are impaired in the internal generation of problem solving 
strategies. When external information is provided as to how a problem can 
be solved, PD patients perform as well as CS. The last decade, many 
studies dealing with the internal versus external regulation of problem 
solving in PD confirmed globally the validity of this distinction in PD [16-
18,70,105,110]. However, the internal-external paradigm also applies to 
frontal dysfunction [117,118,129,146,147], irrespective of differences in 
performance between frontal patients and PD patients. In line with the 
above mentioned, only detailed analysis of patterns of performance can 
clarify which are the characteristic impairments of PD patients in this 
respect. 
In this thesis, we focus on the differential impact of these two types of 
problem solving in PD patients. In the first part, we investigate shifting 
and memory performance of PD patients as far as self-generated problem 
solving is required. Poor performance on tests of cognitive shifting is a 
recurrent finding in PD [6,17,22,24,35,76,113,187], but the real nature of 
this deficit is not clear: it is thought as an impairment in concept formation 
[9,36], or maintaining set [66,188], or shifting set [111,188], or dealing with 
multiple sets simultaneously [208]. In the first chapter, we examine whether 
or not the pattern of performance of PD patients on tests of cognitive 
shifting reflects an impaired self-generated problem solving, 
operationalized in a differential phase-wise performance of card-sorting 
tests. This operationalization enables us to test also the hypothesis of 
Owen et al. [142] that poor card-sorting performance of PD patients 
reflects learned irrelevance i.e. the inability to shift to a dimension which 
was previously irrelevant, being an alternative interpretation of poor 
performance of tests of cognitive shifting. 
The second and third chapter deal with memory performance in PD. 
Poor memory performance [3,12,38,39,47,62,98,136,174,201] - especially 
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recall in contrast to recognition [13,63,65,84,182,201] - is a frequently 
established finding in PD. The question arises whether or not the poor 
memory performance in PD is a relatively isolated cognitive impairment, or 
is also coupled to an impaired self-generated problem solving. For this 
purpose, we present some verbal memory tasks and investigate whether or 
not PD patients respond differentially to cues which provide external 
guidance and to cues which require internal processing i.e. self-generated 
problem solving. 
Chapter 4 is about the complex relationship between cognitive 
impairments and disease characteristics. Hitherto, studies which intended 
to establish to which extent the cognitive impairments in PD are related to 
disease characteristics, especially to the core symptoms of motor 
dysfunction, provided controversial results [36,119,137]. This might be due 
to the fact that a wide, and therefore rather aspecific variety of tests, 
mainly providing global sum scores, were included in these studies, a 
procedure which may mask finer, but more specific deficits in PD. Our 
objective is to investigate whether or not performance of tasks which 
require self-generated problem solving is associated with any of the disease 
characteristics of PD, and to what extent. This might indicate whether or 
not an impaired self-generated problem solving is also a part of the core 
symptoms in PD. 
We conclude the first part of this thesis with a pharmacotherapeutical 
subject. For practical-therapeutical reasons, most studies in the effects of 
pharmacotherapy on cognitive function in PD aimed at the identification 
of positive or negative side-effects of pharmacotherapy whatsoever, which 
implicates again the inclusion of a large variety of tests without evidence of 
specificity. In Chapter 5, a study on the effect of a current 
pharmacotherapy in PD on self-generated problem solving is reported. 
The second part of the present thesis addresses the question whether or 
not an impaired self-generated problem solving is specific to PD. A lot of 
studies on specificity compared PD patients with patients suffering from 
Alzheimer's disease [23,41,42,44,67-69,82,84,85,97,100,120,135,145,148,151, 
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152,169,172,173,181,182,183,195,207] in order to establish whether or not 
there are consistent differences in cognitive performance between 
degenerative diseases of cortical and subcortical origin. On the other hand, 
many other studies compared PD patients with patients suffering from 
other subcortical disorders, such as Huntington's disease [64,82,100,-
151,152,169], and more in particular from diseases incorporating a 
parkinsonian syndrome, such as progressive supranuclear palsy 
[52,148,151,169] and multisystem atrophy [167,193] in order to establish 
whether or not there are consistent similarities in cognitive performance 
between disorders, which have a subcortical substrate in common. 
Hitherto, the results of both types of studies are rather disappointing: a 
consistent pattern of test performance, which is specific to subcortical or 
even parkinsonian syndromes, and which also discriminates between these 
syndromes and cortical syndromes, is still lacking. What is more, patients 
with a variety of health problems, such as excessive drinking [184], mood 
disorders and with a long history of hospitalization [83] also showed poor 
performance on the same tests as PD patients. Consequently, the question 
arises whether or not self-generated problem solving, being not an 
automatic, but an effort-demanding handling of problems [204], might be 
one of the first functions vulnerable to any serious and chronic disease. 
In order to test the specificity of an impaired self-generated problem 
solving to disorders with striatal involvement, we choose a slightly different 
approach. If an impaired self-generated problem solving is specific to these 
disorders, it follows that it should be manifest in patients with disorders or 
with pharmacotherapy which affects striatal function and that it cannot be 
established in patients with disorders or pharmacotherapy which does not 
so. We selected three groups of patients in which striatal function is 
differentially affected by a disorder or pharmacotherapy: 
1. A group of patients with early adult or adult onset myotonic dystrophy 
(MyD). MyD is a disease of which the clinical picture is often described 
in terms of a subcortical dementia syndrome [81,96,143], but without 
evidence of a subcortical substrate [27,46,130]. Accordingly, we predict 
that MyD patients do not show an impaired self-generated problem 
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solving, in spite of pervasive symptoms of the subcortical syndrome 
(Chapter 6). 
2. A group of high-functioning adolescents suffering from autism. Autism -
formerly denominated as childhood schizophrenia [103,170] - is a 
serious disorder which is akin to schizophrenia [170] being a disease in 
which striatal dysfunction is frequently established [77,166,175]. As far 
as autism is concerned, some studies found evidence of disturbed 
dopaminergic mechanisms [31,73,80,91,124,164,206], which are known to 
direct the function of the striatum, some did not [132,139]. On the basis 
of these findings, we expect to find that an impaired self-generated 
problem solving fits the clinical picture of only a part of these patients 
(Chapter 7). 
3. A group of patients with torticollis spasmodicus before and after 
administration of a drug which disrupts striatal functioning. Torticollis 
spasmodicus is a disorder without evidence of striatal dysfunctioning. If 
an impaired self-generated problem solving is coupled to striatal 
dysfunctioning, it will become manifest only after administration of the 
drug (Chapter 8). 
The thesis concludes with a summary and general discussion. 
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Summary 
In the present study the hypothesis was tested that learned irrelevance 
underlies the frequently observed poor performance of Parkinson's disease 
(PD) patients on card sorting tests. If learned irrelevance accounts for the 
poor performance of PD patients on card sorting tests, PD patients and 
control subjects (CS) will not differ in the acquisition phase, in which basic 
concept formation is assessed, but they will differ in the subsequent 
shifting phases. We presented three distinct card sorting tests with an 
identical format to 51 PD patients and 24 normal controls. The groups did 
not differ with respect to intelligence, memory, or attention. PD patients 
showed a slightly better performance in the acquisition phase. In the first 
shifting phase, the performance of PD patients was significantly poorer 
than that of CS after correction for basic concept formation. In the second 
shifting phase this difference disappeared. It is concluded that learned 
irrelevance does not account for the poor performance of PD patients in 
card sorting tests. The results are discussed in terms of self-generation of 
problem solving strategies. 
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Introduction 
During the last decade neuropsychological studies have provided evidence 
that patients with Parkinson's disease (PD) show certain cognitive deficits, 
which have been grouped under headings such as an "impaired executive 
function" or a "frontal lobe syndrome" [5,12,27]. Impaired executive 
function can be assessed by a range of tests [29]. Among these tests, card 
sorting is a prominent one. Impaired performance of PD patients on card 
sorting tests, especially the Wisconsin Card Sorting Test (WCST), is a 
frequently recurring finding in neuropsychological studies on PD. Although 
this test was originally developed to assess mental flexibility in normal 
subjects [16], it gained later the reputation to detect frontal lobe dysfuncti-
on [22,23]. Several forms and scoring procedures have been proposed to 
increase the discriminative power of the test [17,25]. However, there is no 
consensus as far as the underlying deficit of poor performance is concer-
ned. Various cognitive dysfunctions have been suggested as representing 
the basic impairment, such as an impairment of shifting set [20,27], main-
taining set [14,27], and concept formation [3,9]. 
Recently, Owen et al. [26] have suggested that deficits in set-shifting 
tests, including the WCST, may originate from the disruption of two 
distinct forms of attentional set-shifting ability: perseveration and learned 
irrelevance. Perseveration occurs when a subject is unable to shift from a 
previously relevant dimension; it reflects an increased tendency to respond 
to a dimension which previous positive feedback indicated as the relevant 
one. Learned irrelevance occurs when a subject is unable to shift to a 
previously irrelevant dimension; it is due to an active inhibition of respon-
ding to a dimension which previous negative feedback indicated as an 
irrelevant one. In a highly sophisticated experiment, based on the intra-
and extradimensional shift paradigm of Downes et al. [11], Owen and 
colleagues presented two independent set-shifting tasks in which the 
relative contribution of perseveration and learned irrelevance was assessed 
in a pre- and post-shift condition, to PD patients and to patients with 
frontal lobe damage. They found evidence that perseveration is characte-
ristic for frontal patients, and that learned irrelevance is characteristic for 
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PD patients. In the present study, we tested the hypothesis whether 
learned irrelevance can also account for the performance of PD patients 
on card sorting tests. We presented three card sorting tasks of the WCST 
format. After the acquisition phase, in which basis concept formation was 
assessed, there were two unannounced shifts to a category, which had been 
irrelevant in the preceding phase. In a previous study [8], we had already 
found evidence that differences in card sorting performance between PD 
patients and control subjects (CS) become obvious only in the second 
phase, after correction for base-line performance in the first phase. If 
learned irrelevance affects the performance of PD patients on card sorting 
tests, the performance of PD patients will be poorer than that of CS each 
time the subject has to shift to a category which was irrelevant in the 
preceding phase. Unlike most studies which used the overall measures 
derived from the current manual [17], the hypothesis of Owen and collea­
gues takes into account that the WCST is essentially a test to be perfor­
med in consecutive phases which may not appeal to identical abilities. 
Therefore, the present study deals with the phase-wise analysis of three 
homologous card sorting tests. 
Method 
Subjects 
The PD group consisted of 71 consecutive patients from the outpatients' 
Department of Neurology at the University of Nijmegen. The diagnosis of 
idiopathic PD was based on the presence of tremor, rigidity, and bradyki-
nesia. The symptoms were evaluated by one neurologist (M. H.) a week 
before psychological testing. The score of the Unified Parkinson's Disease 
Rating Scale (UPDRS) was used as a measure of severity of PD. Patients 
with non-PD symptoms, EEG and CT scan abnormalities, cerebrovascular 
disease and dementia according to DSM ΠΙ-R criteria had been excluded. 
Medication was neither changed nor stopped during the investigation. In a 
recent study [30] we have found evidence that anticholinergic therapy 
deteriorates performance of PD patients on card sorting tests. 
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male/female 
Table 1. 
Age 
Age at onset of disease 
Duration of disease 
UPDRS sum score 
Demographical and clinical characteristics. 
PD patients (n= 
31/20 
mean sd 
53.9 (10.2) 
50.7 (10.2) 
3.3 (2.4) 
9.7 (3.5) 
=51) CS (n=24) 
11/13 
mean sd 
52.7 (8.5) 
(p=0.33) 
For this reason patients on anticholinergic therapy (n=14) were also 
excluded. The control group (CS), which consisted of 32 subjects, had no 
central neurological symptoms. Most control subjects were spouses of the 
PD patients, who participated in this study. Since shifting performance can 
only be assessed correctly in subjects who are able to achieve the acquisi-
tion phase [9], all subjects who were unable to achieve the acquisition 
phase of any card sorting test were excluded. Eventually, 51 PD patients 
and 24 CS participated in the present study. Thirty-one PD patients were 
male and twenty female. The mean age was 53.9 years (sd=10.2). Forty-
one patients were new, the others were on levodopa therapy. Eleven CS 
were male and thirteen were female. Most of them were spouses of PD 
patients who participated in this study. Their mean age was 52.7 years 
(sd=8.5). There were no significant differences between PD patients and 
CS with respect to male/female ratio, or to age. All participants gave 
informed consent. Table 1 shows the relevant demographic data and the 
disease profile of the PD group. 
Since comparison of consecutive phases presupposes that the subject 
achieves at least the first phase, subjects who were unable to achieve the 
acquisition were excluded from analysis. From the original pool of 71 PD 
patients, again 6 patients were excluded besides the 14 patients on anticho-
linergic therapy. That is 28% in total. From the original group of 32 CS, 8 
CS were excluded, which equals 25%. 
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Tests 
Reference Tests 
In order to assess intelligence, memory and attention we included a series 
of reference tests in our battery. We selected four subtests from the Dutch 
adaptation of the WAIS-R to exclude biasing differences in intelligence 
between both groups, and to exclude general mental deterioration: vocabu­
lary and similarities, measuring verbal intelligence, picture completion and 
block design, measuring visuoperceptual intelligence [10]. Memory was 
assessed by means of the Dutch adaptation of the Rey Auditory Verbal 
Learning Test [21]. A list of 15 semantically unrelated words was presented 
orally five times. The subject was asked to state the memorized words after 
each presentation. The number of correct words after five presentations 
was the score of memory performance. Attention was assessed with the 
Stroop Color-Word Test [18]. Only Part В (speed of color bar identificati­
on) and Part С (speed of color vs word identification) were utilized. The 
score was obtained by subtracting the number of seconds the subject 
needed to read the simple Part В from those needed to read the complex 
Part С 
Criterion Tests 
We presented three card sorting tests: the Wisconsin Card Sorting Test 
(WCST) and a verbal and spatial variation. Assessment of card sorting by 
means of a number of tests with identical format, but with heterogeneous 
material, prevents us from basing our conclusions on the unique variance 
of one single test. When both variations of the WCST were developed, we 
adopted the traditional dichotomy of verbal and visuoperceptual intelligen­
ce in order to increase the heterogeneity of the sorting criteria. In each 
test the subject began to sort on basis of trial and error according to a 
category that was known only to the experimenter. A false response was 
corrected by the experimenter. To minimize the impact of memory, the 
correct (or corrected) matchings were laid down just below the appropriate 
stimulus cards. After a fixed number of correct responses the experimenter 
changed the category twice without informing the subject. The first phase, 
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in which basic concept formation is assessed, is labelled as "acquisition 
phase", whereas the second and third phase are labelled as "shifting 
phases". Since we presented three card sorting tests, we decided not to 
repeat the tests. Thus, each test consisted of an acquisition phase and two 
shining phases. 
We presented the WCST in the original form. The simplified form of 
Nelson [25], which was developed for detecting frontal lobe lesions, was 
not suitable for the aim of the present study, since the subjects are expli-
citly instructed after the acquisition that the sorting rule has been changed, 
which makes the task of the subject not only more simple, but also quite 
different [4,15]. The verbal variation of the WCST was the animals sorting 
test (AST). This test consists of three series of 24 cards each. On each 
card the name of an animal species is printed. Initially, subjects had to 
match 'bird vs mammal'. After seven correct responses the experimenter 
changed the sorting category to 'herbivore versus carnivore' and, finally, to 
'native versus exotic'. If a subject still failed to make a correct assignment 
after 17 trials, the experimenter proceeded with the next series. The spatial 
sorting test (SST) consists of two stimulus cards and three series of 20 
response cards, each depicting two figures that are assembled from a line 
and a triangle in a varying spatial relationship (see Figure 1). Three 
patterns out of the total of conceivable spatial relations are selected as 
criteria in assigning the cards to one of the two sample cards identical vs 
reversal, top position vs middle position, line crossing an angular point vs 
coinciding with the vertical side. The instructions given to the subjects are 
analogous to those for animal sorting. 
As already indicated, the Heaton manual only provides overall measures, 
and these measures can hardly, or not at all, be transformed into measures 
which enable us to compare performance per phase. Besides, the definition 
of perseverative errors, being the most powerful discriminative measure of 
the test, is not identical in the acquisition phase and in the shifting phases; 
nevertheless, these unequal quantities have to be added up to one perseve-
rative error score in order to increase the diagnostic discriminative power 
of the test according to the manual [17]. 
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Figure I. Spatial Sorting Test: stimulus cards. 
This makes perseverative errors unfit for a comparison of performance in 
distinct phases. In previous studies [1,30], we have found that the number 
of trials which a subject needs before he makes the fixed number of 
correct assignments in succession is an appropriate score to measure 
performance. The total number of trials in all phases together correlated 
strongly with the total number of categories, being a conventional measure. 
In each phase, only one category can be scored, which makes this measure 
unfit to assess performance within each single phase. Therefore, we used 
the number of trials per phase which a subject needs before he reaches the 
fixed number of correct assignments successively (WCST: 10; AST: 7; SST: 
7). We are fully aware that the modifications in the administration and 
scoring of the traditional WCST, which enabled us to assess card-sorting 
performance per phase, make a comparison of our results with those of 
other studies rather precarious. 
Data analysis 
Card sorting performance was assessed and standardized per phase, and 
the sum of scores was calculated per phase, resulting in an overall score 
for acquisition, the first shift and the second shift. Finally, the difference 
scores between the first shift and the acquisition and between the second 
and the first shift were calculated. 
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Table 2. Test performance. 
PD patients (n=51) CS (n=24) ρ 
WAIS V-IQ 
WAIS P-IQ 
RAVLT 
Stroop C-B 
Sum categories 
SS acquisition 
SS first shift 
SS second shift 
CSS first shift 
CSS second shift 
mean 
112.1 
114.3 
40.7 
43.5 
7.6 
5.2 
31.7 
38.8 
26.5 
33.7 
sd 
(13.6) 
(15.0) 
(9.1) 
(23.6) 
(1.4) 
(5.4) 
(23.6) 
(23.9) 
(23.0) 
(23.5) 
mean 
117.1 
117.3 
44.3 
40.4 
8.0 
6.0 
21.6 
36.6 
15.6 
29.6 
sd 
(14.8) 
(16.7) 
(10.4) 
(15.8) 
(1.1) 
(6.8) 
(18.1) 
(26.5) 
(17.6) 
(28.6) 
ns 
ns 
ns 
ns 
ns 
ns 
<0.07 
ns 
<0.05 
RVALT = Rey Auditory Verbal Learning Test 
Stroop C-B = Stroop Color Word Test card С minus card В 
SS = standardized sum of trials transformed into percentage of the 
maximum number of trials 
CSS first shift = SS first shift conected for acquisition performance 
CSS second shift = SS second shift corrected for acquisition performance 
Differences between the groups were evaluated using Student's t-test or -
where appropriate - the chi-square test. Although the sex imbalance (F/M 
ratio 118% in CS vs 65% in PD) was not significant, we also analyzed the 
results including a correction for cofactor sex (linear model), only to find 
that sex was not related to test performance, and that the results were 
almost identical, whether or not sex was included in the analysis. Thus, for 
the sake of simplicity, we choose to present the results of the t-test only, 
this being the most straightforward method. The significance level was set 
at 0.05 (two-sided). 
As shown in Table 2, the groups did not differ in intelligence, memory 
and attention. With respect to card sorting performance, PD patients and 
CS achieved almost the same number of categories. Thus, there was no 
difference in overall performance. The standardized sum scores of the 
acquisition of both groups did not differ significantly. Actually, PD patients 
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performed slightly better than CS in the acquisition phase. However, the 
standardized sum scores of PD patients and CS in the first shifting phase 
was on the verge of significance (p<0.07). The performance of PD patients 
was much poorer than that of CS and reached significance after correction 
for base-line performance in the acquisition phase. In contrast, the stand-
ardized sum scores of the groups in the second shifting phase were no 
longer any different. The two groups performed fairly identically in the 
second shifting phase, also after correction for base-line performance in 
the acquisition phase. 
Discussion 
In the present study we tested the hypothesis that learned irrelevance 
accounts for the poor performance of PD patients on card sorting tests. 
We compared the performance of PD patients and CS in three consecutive 
phases of card sorting tests. PD patients and CS did not differ with respect 
to age, intelligence, or attention. Data of education levels are not available, 
but we do not think that this invalidates our study, because almost all 
controls were spouses of the PD patients, and because the data concerning 
the level of general intelligence in Table 2 indicate that there are no 
significant differences in general intelligence between PD patients and CS. 
We presented three card sorting tests with identical instructions but 
heterogeneous materials, the format being that of the original form of the 
WCST. For reasons indicated in the section Method, the simplified form of 
the WCST [25] was not suitable for the present study. Therefore, the 
outcome of the present study cannot be compared with that of studies 
using the Nelson version of the WCST. 
In contrast to the studies of Taylor, Saint-Cyr, and Lang [27] and of 
Cooper, Sagar, Jordan, Harvey, and Sullivan [9], we found no evidence 
that PD patients were impaired in concept formation. Actually, the perfor-
mance of our PD patients in the acquisition phase was even slightly better 
than that of CS. There are several explanations for this discrepancy. First, 
we excluded patients who did not achieve the acquisition phase, whereas 
Taylor and colleagues, and Cooper and colleagues have provided no infor-
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mation in this respect. Although exclusion of those patients in our study 
may have led to a relatively high performance on the acquisition phase, it 
is unlikely that this underlies the difference. For, the percentage of PD 
patients who had to be excluded on basis of this criterion (11%; n=6) was 
smaller than that of CS who had to be excluded (25%, η=8), suggesting 
that PD patient showed even a slightly better concept formation. A second 
explanation for the noted discrepancy may be the fact that we excluded 
PD patients on anticholinergic therapy. Recently, we have found that this 
therapy selectively impairs card sorting performance [30], a finding which 
was recently confirmed by Farina et al. [13]. Given the results of the 
present study, we reanalysed the data of that study in order to establish to 
what extent anticholinergic therapy affected each distinct phase: It turned 
out that eight out of the eleven PD patients on anticholinergic therapy 
were unable to achieve the acquisition phase. Thus, inclusion of PD 
patients on anticholinergic therapy, as Taylor and colleagues have done, 
can bias the performance in the acquisition phase, being a measure for 
concept formation. A third explanation for the noted discrepancy may be 
the fact that our PD patients had no cognitive deterioration in terms of 
their performance on the various subtests of the WAIS, whereas the PD 
patients in the study of Cooper and colleagues performed significantly 
more poorly than CS on the WAIS subtests digit span backwards and 
picture arrangement. Although the PD patients in the study of Cooper and 
colleagues did not show abnormal scores on the National Adult Reading 
Test (NART) and on the WAIS subtest vocabulary and, accordingly, have 
been claimed to have no shortcomings in premorbid or current intelligence, 
the noted deficits may have contributed to their impaired performance on 
the acquisition phase. 
With respect to cognitive shifting, most studies base their conclusions on 
the number of categories achieved. If PD patients achieved significantly 
fewer categories than CS, one has concluded, that they are impaired in 
cognitive shifting [2,3,7,27]. However, if there was no significant difference 
in this respect, it is concluded that PD patients were not impaired in 
cognitive shifting [9,24]. In the present study, we found that PD patients 
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were impaired in cognitive shifting in spite of the fact that they achieved 
approximately the same number of categories as CS (7.6 versus 8.0). 
Apparently, the number of categories is a score which is not subtle enough 
for detecting the actual impairment. The present study shows that PD 
patients who achieved as many categories as CS needed significantly more 
trials to shift from the acquisition phase to the next phase. Thus, PD 
patients were impaired in cognitive shifting. This result is not biased by the 
fact that some PD patients on levodopa therapy participated in the present 
study. The studies by Downes et al. [11], Lange et al. [19] and Owen et al. 
[26] have indicated that set-shifting in PD may be ameliorated rather than 
deteriorated by levodopa therapy. Thus, our PD patients showed poor 
cognitive shifting in spite of levodopa therapy. 
Our results are not consistent with the hypothesis of Owen et al. [26] 
that the poor performance of PD patients on card sorting tests is due to 
learned irrelevance. If PD patients suffered from learned irrelevance, they 
should show poor performance each time they had to shift to a previously 
irrelevant category. However, our PD patients only showed a poor perfor-
mance in the first shifting phase. In the second shifting phase, PD patients 
and CS needed approximately the same number of trials to shift to a 
category, which was not only irrelevant in the acquisition phase, but also 
irrelevant in the first shifting phase, i.e. to a twofold irrelevant category. 
Thus, PD patients were not inhibited by learned irrelevancy in the second 
shifting phase. Therefore, the question arises whether or not the differen-
ces in the first shifting phase are due to learned irrelevance. According to 
the concept of learned irrelevance, a subject learns which category is 
irrelevant when he makes a wrong assignment and gets the feedback 
'incorrect'. Inversely, the subject does not learn that a certain category is 
irrelevant, when he does not make an assignment to that category. Howe-
ver, many subjects in the present study started with the correct category 
and achieved the acquisition without any failure, i.e. without learning 
explicitly which categories were irrelevant. For example, nearly all subjects 
(44 PD and 21 CS) started with the correct category in the acquisition of 
the AST, i.e. they did not learn that other categories were irrelevant. 
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Nevertheless, PD patients needed more trials than CS in the first shining 
phase of the AST (6.1 vs 3.6). Therefore, a complementary explanation is 
needed. Many neuropsychological studies in PD have established that PD 
patients are impaired in problem solving which requires processing internal 
information. In contrast, PD patients are not impaired in problem solving 
that is guided by external cues. In a previous study based on this paradigm 
[6], we have found that PD patients organize information to be recalled to 
a significantly lower degree than CS do. CS spontaneously generated 
categories in which this information could be stored, without any instructi-
on to do so, a finding quite in line with the results of a study of Taylor, 
Saint-Cyr and Lang [28]. In contrast, PD patients adhered to the externally 
imposed sequence on which the information to be recalled was presented. 
A corresponding finding was reported by Downes et al. [11], who found 
that CS used significantly more semantically related word clusters in an 
alternating fluency task than PD patients. Transposing these findings to 
the present study, it is plausible that CS spontaneously group the cards to 
be sorted into categories already in the acquisition phase, irrespective of 
the relevancy of these categories. In the acquisition phase, PD patients 
focus on the explicit instruction and feedback of the experimenter, which 
explains their slightly better performance. Since PD patients and CS 
performed equally well in the acquisition, they do not differ as far as 
responding to feedback, i.e. grouping according to relevancy, is concerned. 
In the first shifting phase, CS benefit from their spontaneous organization 
during the acquisition, because they already dispose of alternative catego-
ries. The incompatible feedback of the first shifting phase forces the PD 
patients to start the generation of alternative categories, which requires 
proportionally more trials. Owing to this generative information processing 
in the first shifting phase, PD patients, just like CS, dispose of alternative 
categories in the second shifting phase. For this reason, the degree of 
complexity in the second shifting phase is similar for both groups. Accor-
dingly, both groups do not differ in the number of trials in the second 
shifting phase. 
In sum, the present study provides evidence that PD patients, who are 
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not impaired in concept formation, suffer from an impaired ability to shift 
from the acquisition phase to the first shifting phase, but have an intact 
ability to shift from the first shifting phase to the next shifting phase in 
three distinct card sorting tests with identical format. It is concluded that a 
reduced self-generation of problem solving strategies, but not learned 
irrelevance, underlies the observed deficit. Since the patients who partici­
pated in this study were relatively young and mildly disabled, our study 
does not exclude that learned irrelevance may affect card-sorting perfor­
mance of PD patients in a later stage of the disease. 
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Summary 
Parkinson's Disease patients (PD) do not differ from control subjects (CS) 
when they have to execute a problem solving task in which external cues 
for solving the problem are given. However, when PD have to solve a 
problem by means of an internally generated strategy, they show a serious 
decrease in performance. We hypothesised that this distinction may also 
apply to the way PD and CS organize recall. In order to test our 
hypothesis the California Verbal Learning Test (CVLT) was administered 
to 59 PD and 30 CS. The test consists of five learning trials using a 16-
word target list, composed of four items from each of four semantic 
categories. The fact that the word list was built on this implicit 
organization was not divulged in advance. The sequence in which the 
words were read is fixed; each subsequent word belongs to a category 
being different from the category to which the preceding word belongs. 
The organization in recall according to the semantic categories is 
considered to be the result of an unprompted, internally generated 
strategy. Recall according to the sequence in which the words are read by 
the experimenter, is viewed as an externally offered strategy. The results 
prove to be in line with our hypothesis: unlike CS who appeared to rely 
mainly and increasingly on an internally generated semantic organization, 
PD showed evidence of gradually adhering more to the externally imposed 
serial sequence. 
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Introduction 
One of the features which supposedly distinguish task performance of 
patients with Parkinson's Disease (PD) from that of control subjects (CS) 
is the presence or absence of external cues, i.e. cues provided by a stimulus 
or the experimenter. PD patients are found to perform less well than CS 
on tasks which require internal (self-directed) planning. But when external 
control is provided, no substantial difference in task performance is 
revealed. Even the performance on highly challenging tasks has been 
shown to be not impaired in PD patients where rules are explicit and 
strongly prompted by the experimenter. The differential performance of 
PD patients on internally and externally guided tasks holds for procedures 
in the field of problem solving, attention and motor planning 
[1,4,6,7,20,34,42]. 
In the growing amount of literature on memory problems in PD, a fairly 
consistent finding is that PD patients show impaired recall, but unimpaired 
recognition [2,5,13,14,15,18,27,28,35]. Although there is consensus 
concerning the existence of such distinct memory performances, there is 
still debate about the crucial parameters of memory deficits in PD. It is 
suggested that the apparent impairment of patients with PD on internally 
cued tasks may be responsible for the difference in performance on recall 
and recognition tasks, as a recognition paradigm includes external cues, 
whereas in a recall paradigm the subjects have to include internal 
strategies to retrieve the information [3]. 
In this study we intend to check the differential influence of external vs 
internal control on recall performance using the California Verbal 
Learning Test (CVLT) developed by Delis et al. [10]. In addition to 
measuring the amount of information that a subject is able to remember, 
the CVLT offers a multi-factor framework for quantifying the ways in 
which a subject learns word lists. The CVLT word list is composed in such 
a way that it can be organized semantically, i.e. according to the categories 
of which the list is composed, or serially, by relying on the sequence in 
which the words are read by the experimenter. The semantic organization 
in recall is the result of an internally generated strategy: the subjects are 
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not told that the material-to-be-remembered can be categorized. Self-
generated guidelines are required in order to take advantage of the 
opportunities for categorization. In contrast, the serial organization in 
recall is, by definition, the result of echoing an explicit and externally 
offered structure: the sequence in which the words are read. 
When, indeed, the presence or absence of external control has validity 
in predicting cognitive deficits in PD, PD patients should organize recall in 
the CVLT less semantically and more serially than CS. Since it is precisely 
the repetitive presentation of recall trials that helps the subjects to 
organize recall in a task-oriented way [38], the expectation is that PD 
patients shall perform in successive trials decreasingly in a semantic and 
increasingly in a serial manner. 
Methods 
Subjects 
We studied 59 patients (37 men and 22 women) with idiopathic 
Parkinson's Disease who regularly visited the neurological outpatient clinic. 
The diagnosis of PD was based on the presence of at least two of the 
following symptoms: tremor, rigidity, bradykinesia and on the absence of 
non-Parkinsonian signs and symptoms (see Table 1 for duration and 
severity of PD). Severity of PD was rated by means of the motor 
examination part of the UPDRS (14 variables with 0-4 scores; total range 
of motor scores 0-56). According to the low average UPDRS score 
(mean=15.9) in combination with the small deviation (SEM=0.8) it turned 
out that our PD patient group showed only mild/moderate physical 
symptoms. All but 17 patients were taking antiparkinsonian medication 
daily: 7 patients were taking orphenadrine-HCl (mean 140 mg ± 60 mg), 
33 patients levodopa plus decarboxylase inhibitor (mean 440 mg ± 210 
mg), 3 patients bromocriptine (mean 10 mg ± 4.08 mg), 13 patients 
amantadine (200 mg) and 29 patients selegiline (10 mg). 27 patients were 
taking more than one type of anti-parkinsonian medication. Each PD 
patient was neurologically examined (M.H.) to diagnose PD as well as to 
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rule out other etiologies of cerebral dysfunction. Subjects with a history of 
stroke, head injury, psychiatric illness according to DSM-III-R criteria, 
neurosurgical operation or taking other drugs acting on the Central 
Nervous System (CNS) were excluded, as were patients with clinical 
evidence of dementia based on the Mini Mental State Examination 
(MMSE) [16]. 
The control group consisted of 30 subjects (9 men and 21 women), 
mainly patients' spouses. Subjects with CNS disease, psychiatric illness 
according to DSM-III-R criteria, head injury, clinical evidence of dementia 
based on the MMSE, or taking centrally active drugs were excluded from 
the study. 
Informed consent was obtained from all subjects. 
Procedure 
In order to compare the groups and to control for intelligence, attention 
and depression, the following neuropsychological reference tests were 
employed: four subtests from the Dutch adaptation of the WAIS-R, 
namely Vocabulary and Similarities measuring verbal intelligence, and 
Picture Completion and Block Design measuring visuoperceptual 
intelligence. Attention was assessed by means of the Stroop Color-Word 
Test; the testscore was obtained by subtracting the reading time of subtest 
В from that of subtest С [22]. Depression was measured by the Zung 
Depression Scale [47]. 
The Dutch adaptation of the California Verbal Learning Test (CVLT, 
carried out by Dekker et al. [11]) was administered to measure the 
following crucial parameters: levels of total recall and recognition on all 
trials, semantic and serial organization, and learning rate across trials [10]. 
The CVLT consists of five learning trials of a 16-word target shopping list 
('Monday shopping list'), composed of four items from each of four 
different semantic categories (fruit, tools, spices, clothing). The sequence 
in which the words were read is fixed; each subsequent word belongs to a 
category being different from the category to which the preceding word 
belongs. After each learning trial free recall was measured. An 
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interference list of 16 words (Tuesday shopping list') was then presented 
for one trial. After a 20-minute delay during which nonverbal testing 
occurred, recognition of the first list was assessed using a verbal 
presentation of a list containing the target words (all 16 first list items) and 
28 distractor words in a yes-no recognition paradigm. All items are names 
of objects that could be on a shopping list. 
The following relevant CVLT indices were included in this study: the 
number of words recalled per trial and across trials 1-5, number of 
recognition hits, semantic and serial clustering ratio per trial and across 
trials 1-5. The semantic ratio was the ratio of words from the same 
category recalled together over semantic clustering expected by chance 
given the number of words and categories recalled. The serial ratio was the 
ratio of words recalled in the same order as they were presented over 
serial clustering expected by chance given the number of words recalled. In 
order to calculate the clustering ratios the observed correct clustering 
score was divided by the expected correct clustering score (which indicates 
the chance value of clustering given the total number of words). A ratio of 
1 indicated a chance clustering performance, and a ratio greater or less 
than 1 indicated above or below chance clustering performance, 
respectively. Formulas for clustering scores were based on the study of 
Shuell [37], see also CVLT Research Edition, p. 18 [10]. 
Test protocols were scored using the IBM-PC California Verbal 
Learning Test scoring programme [17]. 
Statistical methods 
In order to correct for the covariates age, IQ, attention, depression and 
medication, analysis of covariance was carried out in the following way. All 
parameters were log transformed in order to reduce skewness. To 
investigate which covariables (and their interactions) did indeed need 
adjustment for, all subset model selection procedures (R2) were applied 
before carrying out the ANCOVA. 
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Table 1. Subject variables. 
Age (yrs) 
Duration of PD 
(yrs) 
UPDRS 
Total IQ * 
Stroop C-B (sec.) 
Zung Depression 
PD 
(n=59) 
55.4 (1.5) 
5.2 (0.4) 
15.9 (0.8) 
119.0 (2.0) 
38.3 (1.8) 
41.5 (1.2) 
CS 
(n=30) 
53.9 (2.1) 
-
-
125.0 (2.1) 
39.4 (2.3) 
34.3 (1.4) 
Ρ 
ns 
-
-
<.05 
ns 
<.01 
Results are expressed as the means (±SEM) of the subject variables. 
PD refers to patients with Parkinson's disease and CS to control subjects. 
The UPDRS refers to the motor examination part. 
* Total IQ L· estimated on basis of WAIS Vocabulary, Similarities, Picture 
Completion and Block Design. 
To check the robustness of the procedure, residuals were studied and the 
data were reanalyzed with the most influential observations downweighted. 
As this produced no (relevant) change in the outcome, only the results of 
the unweighted analysis are given. Results with P-values less than 0.05 
(two-sided) are considered significant. 
Results 
Reference variables 
PD patients and CS were highly comparable as far as age and attention 
were concerned, but total IQ and Zung Depression differed significantly 
between the groups: PD patients displayed lower IQ and higher scores on 
the depression scale than CS (Table 1). 
Number of words recalled per trial and across trials 1-5 
Results per trial are shown in Figure 1. 
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Figure 1. Recall scores. Mean recall (±SEM) of the CVLT words in PD patients 
(interrupted lines) and CS (continuous lines), lite number of words 
recalled are shown on the y-axis. 
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Figure 2. Semantic ratios. Mean semantic ratios (±SEM) in PD patients (interrupted 
lines) and CS (continuous lines). Vie semantic ratios are shown on the y-
axis. 
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Figure 3. Serial ratios. Mean serial ratios (±SEM) in PD patients (interrupted lines) 
and CS (continuous lines). The serial ratios are shown on the y-axis. 
PD patients recalled fewer words than CS (PD versus CS: ß=-0.20, 
p<0.05). Sex (ß=0.34, p<0.001), total IQ (ß=0.41, p<0.001) and age (ß=-
0.20, p<0.05) were significant covariates (R2=0.41). This indicates that CS 
performed better than PD patients, and that women, subjects with higher 
IQ, and younger subjects performed better. When sex, total IQ and age 
were taken as covariates, the difference between PD and CS remained 
significant. 
No factors could be found influencing learning across trials 1-5. 
Number of recognition hits 
The mean number of words recognized was 14.6 (SEM=0.2) by PD 
patients, 15.3 (SEM=0.2) by CS. There was no significant group difference, 
and total IQ was the only significant predictor of recognition performance 
(ß=0.38; p<0.01; R2=0.16). 
Semantic clustering ratio per trial and across trials 1-5 
Results per trial are shown in Figure 2. Group (PD versus CS: β=-0.21; 
p<0.03) and total IQ (ß=0.29; p<0.01) were significant variables of 
semantic learning (R2=0.20). CS clustered words increasingly more in a 
semantic way than PD patients. The same holds for subjects with higher 
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total IQ scores: they clustered words increasingly more semantically than 
subjects with lower total IQ scores. When total IQ was used as a covariate, 
the difference between PD and CS remained significant. 
Serial clustering ratio per trial and across trials 1-5 
Results per trial are shown in Figure 3. After removing the influence of 
sex (ß=-0.22; p<0.05), which emerged as the sole significant covariate, 
Group (PD versus CS: ß=0.20; ρ=0.06) was just on the verge of 
significance (R2=0.12). Men clustered words increasingly more serially 
than women. The same holds for PD patients (men and women): they 
clustered words increasingly more serially than CS. 
Medication, Zung Depression scores and age 
These factors did not emerge as significant covariates of learning 
performance in any analysis. 
Correlation between recall and semantic/serial scores 
A partial correlation analysis (adjusted for Group, sex, and IQ) was 
performed in order to assess the relationship between recall and clustering 
strategies. It holds for both groups that the number of words recalled was 
significantly correlated with semantic clustering ratio (r=0.59; p<0.01): the 
more the subjects organized recall semantically, the more words they were 
able to recall. The opposite holds for recall and serial clustering (r=-0.34; 
p<0.01): the more the subjects organized recall serially, the fewer words 
they were able to recall. 
Discussion 
Various authors have postulated a distinction between internally and 
externally guided tasks as a basis for explaining cognitive impairment in 
PD patients. PD patients supposedly have a reduced ability to generate 
strategies when they are not prompted or guided by currently available 
information. Successful task performance in PD patients may depend on 
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the degree to which internal, i.e. self-generated guidelines are required 
[4,6,42]. The purpose of this study was to check by experiment whether the 
distinction between external and internal control has any validity in 
predicting recall deficits in PD patients. 
The results indicate that PD patients had a deficient recall (Figure 1), 
whereas their recognition performance was similar to that of CS. This 
pattern of memory performance in our group of PD patients was in line 
with previous reports on recall and recognition [8,12,39,40,42,45,46]. Our 
findings support the validity concerning the differential influence of 
external vs internal control: during recall no external help was available, 
the subjects had to include internal strategies for the retrieval of 
information, while recognition was externally guided [3]. 
In the present study, the finding of greatest significance appears to be 
the striking difference in the pattern of learning strategies between PD 
patients and CS: CS organized recall increasingly in an internally 
generated, i.e. semantic manner; PD patients did not (Figure 2). 
Furthermore, in spite of the same serial order of the stimulus words in the 
successive trials, CS showed a decreasing tendency to organize recall in a 
serial, i.e. externally guided way; only the PD group demonstrated a 
progressive increase over trials in serial strategy (Figure 3). Precisely these 
results support the differential impact of external vs internal guidance. 
The results on semantic clustering ratio across trials 1-5 are in full 
accordance with the results of Taylor et al. [43], at least as far as 
immediate free recall is concerned. Tweedy et al. [45], however, argue that 
"the tendency for free recall to be organized by semantic category is 
virtually the same" for both PD patients and CS. This was concluded on 
the basis of only one free recall trial. Had the analysis of the semantic 
ratios been restricted to the first trial in our study, indeed, no differences 
would have emerged between both groups (Figure 2). However, in order to 
identify the strategy of organization more than one recall trial is needed. It 
is precisely the repetitive presentation of recall trials that helps the 
subjects to organize recall in a task-oriented way [38]. 
The increasing serial clustering ratios over trials in PD patients does not 
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mean a loss of their capacity to use a semantic clustering strategy. Actually, 
all the semantic ratios were greater than 1, indicating above chance 
clustering performance (Figure 2). Although at a reduced level compared 
with CS, PD patients were able to organize the stimulus material in a 
semantical way. PD patients have indeed been found to manifest 
phenomena such as proactive interference build-up and release [36] which 
depend upon semantic organization. 
In most investigations of multitrial free recall, the term strategy or 
organization has been employed only for the condition of internal control. 
However, the CVLT manual uses the term 'serial learning strategy', being 
a condition of external control. We consider that we have good arguments 
for adopting this term. With regard to the increase in the overall recall 
performance, no differences were found between the two groups (Figure 
1). Improvement over trials can not appear without strategy or 
organization [44]. PD patients utilized little semantic clustering. If serial 
clustering would not be a learning strategy, no improvement would have 
occurred in PD on the successive trials. 
Delis et al. [9] have found that semantic cluster scores loaded positively 
on a 'General Verbal Learning factor': they concluded that semantic 
clustering is a more effective learning strategy than serial clustering. We, 
too, found that semantic and serial organization are correlated positively 
and negatively, respectively, with the total number of words recalled. 
Owen et al. [30,31] have demonstrated that significant learning and 
memory impairments were found, particularly in PD patients with more 
severe clinical symptoms. Our PD group did not include patients in the 
more advanced stages of the disease; consequently, our data could not be 
staged as a function of clinical severity. Our study shows that even in the 
mild/moderate stages of PD learning and memory problems can be 
revealed. 
The results of our study may be biased by the effects of medication: a 
majority of the patients was treated with a combination of levodopa and 
selegiline. This supposition is not, however, confirmed by investigation: 
with the exception of a study by Poewe et al. [32], no deleterious effect in 
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memory performance has been revealed as a function of dopaminomimetic 
therapy [26,27]. In contrast, some studies have shown that levodopa 
treatment facilitates memory performance [21,29]. Up to now, no negative 
effects of selegiline on cognition have been reported [19,33]. There is an 
ongoing discussion about the effects of orphenadrine-HCl [23,24,25,41]. In 
the light of the aforementioned studies, medication was incorporated as an 
additional variable in the analyses, but did not emerge as a significant 
factor in any of them (data not shown). 
In the Introduction it was stressed that deficits of PD patients in the 
field of problem solving, attention and motor planning are supposed to be 
a consequence of a disturbance in a basic executive function: a diminished 
capacity to generate strategies if not guided or prompted by currently 
available information. Apparently, our experimental analysis of memory 
deficits in PD renders substantial support to this concept. Memory and 
learning problems of PD patients should be added to the chain of deficits 
which result from this executive dysfunction. 
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Summary 
The present study is a continuation of a previous study in memory 
performance which showed that PD patients moved increasingly on explicit 
cues which prompt the external strategy of serial clustering, in comparison 
to CS, who profited increasingly from implicit cues which prompt the 
internal and more effective strategy of semantic clustering. In this study, 
we investigated whether the recall of PD patients can be affected by 
adding or removing explicit cues. We manipulated the California Verbal 
Learning Test in two ways: 
First, we told the subjects under study in advance from which categories 
the items to be recalled were derived, thus making the implicit cue to 
cluster semantically explicit (explicit condition). 
Next, we permuted the sequence of the items in each trial, thus 
preventing the subjects from adhering to the serial order, i.e. to explicit 
cues (permuted condition). We included the data of our previous study 
(mixed condition) in the analysis of memory and learning performance in 
the three conditions. Learning of PD patients as reflected in the semantic 
ratio proved to be more affected by the cueing conditions than that of CS. 
Total performance and the serial ratios did not show a significant 
interaction between group and cueing condition. The results are discussed 
in terms of external and internal generation of problem solving strategies. 
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Introduction 
In many studies [2,5,15,22,23], it is established that patients with 
Parkinson's disease (PD) perform in problem solving tasks as well as 
control subjects (CS), when cues are available. The performance of PD 
patients seriously decreases when cues are absent. However, it is unclear 
whether or not a response of PD patients is dependent on certain qualities 
of a cue. 
In a recent study [3], we made the distinction between explicit and 
implicit cues. We investigated whether PD patients responded 
differentially to explicit or implicit cues in a memory task. Responding to 
explicit cues means that the subject utilizes the information of the cue just 
as it is, i.e. as an external guideline. Responding to implicit cues means 
that the subject processes the information internally in such a way that 
surplus information is derived from the cue before utilizing it. We selected 
the California Verbal Learning Test [7], a test in which items of four se-
mantic categories have to be learned in five consecutive trials. Since the 
semantic organization of the items was not divulged in advance, it is an 
implicit cue requiring internal processing, which results in semantic 
clustering. Recall in terms of spontaneous grouping of the items in 
semantic categories implicates an internal, self-directed strategy. Adhering 
to the sequence in which the words are read by the experimenter reflects 
responding to explicit cues, being a external strategy. We found that PD 
patients gradually adhered to the externally imposed serial strategy, in 
contrast to CS, who increasingly recalled items in semantic clusters, being 
the result of an internally generated strategy. These findings showed that 
PD patients increasingly responded to explicit cues, i.e. moved on to the 
externally prompted strategy in a verbal memory task. 
In the present study we continued our research in this field. First, we 
investigated whether PD patients can be activated to cluster semantically, 
when the implicit cue to do so is made explicit, thus making internal 
processing of implicit information redundant. To this end, we presented 
the CVLT to PD patients and CS, but we told the subjects under study in 
advance from which semantic categories the items were derived, thus 
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making the implicit semantic organization of the items explicit. We refer to 
this manipulation of the CVLT format as the explicit condition, in contrast 
to the mixed condition of our previous study, in which explicit and implicit 
cues were simultaneously presented. If the performance of PD patients 
equals that of CS, and if the profiles of the semantic ratios of PD patients 
and CS across the trials are similar, it indicates that - just like CS - PD are 
able to utilize semantic cues in a recalling task, when these are explicitly 
presented. 
Next, we examined whether PD patients resort to semantic clustering, 
when explicit cues which prompt external strategies, are removed, and 
consequently only the implicit cue to internal processing is left. Sagar et al. 
[19] found evidence that PD patients showed similar built-up and release 
of proactive interference (PI) on the basis of implicit semantic categories 
as CS. These authors correctly point out that such a normal PI built-up 
and release presuppose the ability to use implicit semantic information 
spontaneously. That is fully in line with the results of our previous study 
which showed that PD patients were able to use the implicit cues of the 
test items which indicates the internal strategy of semantic clustering, 
although at a reduced level compared with CS. Actually, in the first trial 
the PD patients showed even a slightly higher semantic ratio than CS. In 
the subsequent trials the semantic ratio of the PD patients remained 
constant, whereas that of CS substantially increased. These findings suggest 
that the presence of explicit cues prevents PD patients from profiting from 
the more effective, but internal strategy, being semantic clustering. We 
presented the CVLT to PD patients and CS, but this time we permuted 
the sequence of the items in each trial. In this 'permuted condition' 
subjects are prevented from adhering to the serial order, i.e. to explicit 
cues, which were present in both the mixed and the explicit condition. If 
the semantic ratio of PD patients across the trials increases in the same 
way as that of CS, it is plausible that in absence of strong and explicit cues 
PD resort to the only cue which is left, and which implicitly prompts 
semantic clustering. Moreover, if the total performance of PD patients 
equals that of CS in the permuted condition, PD patients benefit from the 
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more effective strategy of clustering to the same extent as CS. However, if 
their total performance is poorer, it is plausible that PD patients are 
impaired in profiting from implicit cues, even when explicit cues are 
removed. 
Since both experiments are the continuation of our previous study in 
memory performance in PD, the data of that study will be included in the 
analyses of the present data. 
Materials and methods 
Subjects 
Fifty four PD patients (42 men and 12 women) and 11 CS (4 men and 7 
women) participated in the study of the explicit condition. Among them, 23 
were untreated. Thirty PD patients were on levodopa and 6 on 
anticholinergic therapy, 5 of them on both therapies. 
The patient group of the permuted condition consisted of 17 patients 
(10 men and 7 women) and 27 CS (8 men and 19 women). Seven PD 
patients were untreated. Ten patients were on levodopa and one also on 
anticholinergic therapy. All gave informed consent. The diagnosis of 
idiopathic PD was based on the presence of at least two of the following 
symptoms: tremor, rigidity, bradykinesia and postural disturbances. The 
symptoms were evaluated by a neurologist (M. H.) a week before psycholo­
gical testing. Patients with non-PD symptoms, EEG and CT scan 
abnormalities, cerebrovascular disease, psychiatric illness according to 
DSM III-R criteria, or clinical evidence of dementia based on the MMSE 
[10] were excluded. Severity of PD was rated by means of the motor 
examination part of the Unified Parkinson's Disease Rating Scale [8]. 
As far as CS are concerned, most of them were patients' spouses, which 
explains the large number of female CS. Subjects with CNS disease, 
psychiatric illness according to DSM ΠΙ-R criteria, head injury, clinical 
evidence of dementia based on the MMSE or taking centrally active drugs 
were excluded from the study. 
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Methods 
In order to compare the groups and to control for intelligence, attention 
and depression, we used the same reference tests as in the previous study: 
four tests of the Dutch adaptation of the WAIS-R, the Stroop Color Word 
Test [13] and the Zung Depression Scale [26]. The criterion test was the 
California Verbal Learning Test (CVLT). The CVLT consists of five 
learning trials of a 16-word target shopping list, which can be grouped into 
four semantic categories of four items. In the original version, the 
experimenter does not indicate that the items can be grouped. Moreover, 
the sequence in which the words are read by the experimenter is fixed and 
each subsequent item belongs to a category being different from the 
category to which the preceding word belongs. After each learning trial 
free recall was measured. 
In this study, we changed the format of the CVLT two times. In the 
explicit condition, the experimenter told the subjects in which semantic 
categories the items of the shopping list could be grouped, thus explicitly 
indicating in which way items could be grouped during the learning trials. 
For the rest, the procedure was identical to the original CVLT. In the 
permuted condition, the sequence of the items in each trial was different 
from the previous ones, thus preventing the subject from adhering to an 
externally imposed, fixed sequence. In accordance with the mixed condition 
and in contrast with the explicit condition, the experimenter did not 
indicate that the items were derived from four categories. 
The following relevant CVLT indices were included in this study: the 
number of words recalled per trial and across trials 1-5, and semantic and 
serial clustering ratio per trial and across trials 1-5. The semantic ratio was 
the ratio of words from the same category recalled together over semantic 
clustering expected by chance given the number of words and categories 
recalled. The serial ratio was the ratio of words recalled in the same order 
as they were presented over serial clustering expected by chance given the 
number of words recalled. For further information about tests, scoring and 
calculating we refer to the previous study [3]. 
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Statistical analysis 
Initially, we incorporated two kinds of variables in our analysis of 
covariance: one in which the parameters were computed along the lines of 
the manual [6,11], and one in which the parameters were log transformed. 
Of the covariates sex, age, IQ, attention, depression and medication, only 
sex and IQ were related to the CVLT indices. The analysis of covariance 
was done both for the testscores according to the manual and the log-
transformed testscores with the primary class variables group and 
condition, and the covariates sex and IQ. 
Results with p-values less than 0.05 (two-tailed) are considered 
significant. 
Results 
Reference variables 
In Table 1 demographical data, disease characteristics and scores of the 
reference tests are presented. 
Criterion tests 
Since the present study deals with memory performance under varying 
cueing conditions, the data of our previous study (3), which were obtained 
in the mixed condition, will be involved in the statistical analysis. The 
analyses of the manual scores and the log-transformed scores produced 
approximately the same results. Therefore, we will only present data 
obtained in the conventional way indicated in the manual, because they 
allow a comparison with other studies. In view of our previous study, we 
focused on learning across trials. Moreover, since the data per trial (i.e. 
the number of words recalled, the semantic and serial ratios) did not 
reveal any significant interaction between group and cueing condition, we 
present only the data across trials. 
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Figure 1. Recall scores of PD patients. Mean recall (± S.E.M.) of the CVLT words. 
Mixed condition: continuous line; explicit condition: interrupted line with 
S.E.M. upward; permuted condition: interrupted line with S.E.M. 
downward The number of words recalled are shown on the y-axis. 
Figure 2. Recall scores of CS. Mean recall (± S.E.M.) of the CVLT words. Mixed 
condition: continuous line; explicit condition: interrupted line with S.E.M. 
upward; permuted condition: interrupted line with S.E.M. downward. The 
number of words recalled are shown on the y-axis. 
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Number of words recalled across trials 1-5. 
There were no significant differences across trials between PD patients 
and CS in any condition. PD vs CS in the mixed condition: β =-0.10 (ns); 
in the explicit condition: β=0.01 (ns); in the permuted condition: β =-0.04 
(ns). Testing the homogeneity of the ß's indicated that there was no 
significant interaction between group and cueing condition. 
Semantic clustering ratio across trials 1-5. 
There were no significant differences across trials between PD patients 
and CS in any condition. PD vs CS in the mixed condition: β=-0.18 (ns: 
p=0.07); in the explicit condition: β=0.03 (ns); in the permuted condition: 
β =0.08 (ns). In the log transformed parameters of our previous study, the 
difference between PD and CS in the mixed condition was significant: ß=-
0.21 (p<0.05). Testing the homogeneity of the ß's revealed a significant 
interaction between group and cueing condition: ρ < 0.05. Apparently, 
learning of PD was more affected by the cueing condition than that of CS. 
Serial clustering ratio across trials 1-5. 
In the permuted condition the sequence of items was changed in each trial 
of the permuted condition, therefore the serial ratios in this condition do 
not make any sense: each of them refers to a new sequence, which makes 
any comparison within or between groups meaningless. For this reason we 
excluded them from the statistical analysis. There were no significant 
differences across trials between PD patients and CS in any condition. PD 
vs CS in the mixed condition: β =0.21 (ns: p=0.06); in the explicit 
condition: β =0.07 (ns). Testing the homogeneity of the ß's indicated that 
there was no significant interaction between group and cueing condition. 
Discussion 
The present study is a continuation of a previous study in memory 
performance which showed that PD patients relied increasingly on explicit 
cues which prompt the external strategy of serial clustering, in comparison 
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Figure 3. Semantic ratios of PD patients. Mean semantic ratios (± S.E.M.): mixed 
condition: continuous line; explicit condition: interrupted line with S.E.M. 
upward; permuted condition: interrupted line with S.E.M. downward. The 
semantic rations are shown on the y-axis. 
Figure 4. Semantic ratios of CS. Mean semantic ratios (± S.E.M.): mixed condition: 
continuous line; explicit condition: interrupted line with S.E.M. upward; 
permuted condition: interrupted line with S.E.M. downward. The semantic 
rations are shown on the y-axis. 
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Figure 5. Señal ratios of PD patients. Mean serial ratios (± S.E.M.): mixed 
condition: continuous line; explicit condition: interrupted line. The serial 
rations are shown on the y-axis. 
Figure 6. Serial ratios of CS. Mean serial ratios (± S.E.M.): mixed condition: 
continuous line; explicit condition: interrupted line. Tlie serial rations are 
shown on the y-axis. 
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to CS, who profited increasingly from implicit cues which prompt the 
internal and more effective strategy of semantic clustering. In this study, 
we investigated whether the recall of PD patients can be affected by 
adding or removing explicit cues. We changed the condition in which the 
words were presented in two ways: first, we added explicit cues by telling 
the subjects in which semantical clusters the words could be grouped (the 
explicit condition) and next, we removed explicit cues by presenting the 
words in a sequence which was changed after each trial (the permuted 
condition). Both manipulations of the original test format dealt with the 
encoding. Retrieval was not manipulated. We incorporated the data of the 
previous study in our present analysis. 
After correction for IQ and sex, only the semantical ratios across the 
trials showed a significant interaction between group and cueing condition. 
The performance of PD patients was in a significantly different way 
affected by the various cueing conditions than that of CS. In the mixed 
condition, CS clustered the items increasingly more in a semantic way than 
PD patients, but that difference is no longer significant in the explicit or 
the permuted condition. In contrast to CS, PD patients only profited 
increasingly from the presence of cues when the implicit cues were made 
explicit (explicit condition), or when the explicit cues were removed, and 
only implicit cues were left (permuted condition). 
As far as the explicit condition is concerned, our results indicate that 
PD patients and CS responded in the same way to explicit cues, which 
prompted semantic clustering, in this condition being an external strategy. 
Semantic clustering in verbal memory tasks as such is no problem for PD 
patients as long as explicit cues to do so are present, a striking difference 
with memory performance of patients with Alzheimer's disease [4]. With 
respect to the permuted condition, the semantic ratios of PD patients and 
CS showed a similar pattern across the five trials. PD patients resorted to 
semantic clustering, when explicit cues indicating external strategies were 
absent, and only implicit cues were left. The impossibility to rely on serial 
clustering in the permuted condition did not affect performance of PD 
patients in comparison with that of CS, which is not surprising in view of 
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our previous study, in which it was shown that serial clustering was 
negatively correlated with the number of words recalled (r=-0.59). Since 
PD patients and CS did not differ significantly with respect to mean 
performance of recall in the permuted condition, they showed to be able to 
generate spontaneously an effective strategy, i.e. semantic clustering. 
Seemingly, this finding is in contrast with those of the majority of studies 
on cognitive functioning in PD, in which it was shown that PD patients are 
impaired in self-generated problem solving [22,24]. As indicated elsewhere 
[6], heading for the only strategy, that is left - for example by obstruction 
of other strategies, such as serial clustering - can no longer be regarded as 
self-generated problem solving: in absence of concurrent explicit cues, the 
remaining implicit cues become virtually explicit ones, because the subject 
has to resort to an internal strategy or no strategy al all. 
Our manipulations of the test format involved only the presentation of 
the items to be recalled, not the retrieval. The differences in retrieval 
which we found, were dependent on the way in which the items were 
presented. Actually, retrieval of items to be recalled was similar in PD 
patients and CS in the explicit and the permuted condition, which suggests 
that the memory impairments of our PD patients were confined to the 
encoding, and that retrieval as such was not at risk in our group of PD 
patients. This is an interesting finding in view of the 'frontal' hypothesis, 
which presumes that cognitive impairment in PD corresponds with that in 
frontal patients, because a decrease of dopaminergic activity of 
frontostriatal connections brings about frontal dysfunction [9,16,18,21,22, 
cf. 17,25]. In a recent study, however, Gershberg and Shimamura [12] 
measured the use of organizational strategies in memory performance of 
frontal patients in a series of sophisticated experiments. Among others, 
they found that frontal patients profit from semantic cues either at study 
(i.e. encoding) or at test (i.e. retrieval). Only when semantic cues were 
provided at both study and test, the semantic clustering reached to normal 
levels. They suggest that both encoding and retrieval are impaired by 
frontal lobe damage. In the explicit condition of our study, however, the 
presentation of semantic cues at study brought the retrieval performance 
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of PD patients already to the level of CS, which might indicate a 
difference in memory impairments between PD patients and frontal 
patients. However, the present study does not provide conclusive evidence 
in this respect. Further research should focus on the effects of cueing of 
retrieval in a mixed condition memory task in order to establish whether 
memory impairments in PD are confined to encoding or affect retrieval as 
well. 
On the basis of animal experiments [1,20], Kritikos et al. [14] recently 
suggested that explicit cues enhance performance of PD patients by 
replacing defective, internally generated cues of the basal ganglia. Putting 
aside differences in terminology, this suggestion is in line with the findings 
of our study. Since our PD patients started to cluster semantically in the 
mixed condition to the same extent as CS, it is clear that implicit cues can 
prompt PD patients to generate spontaneously an internal strategy. 
However, PD patients were not able to maintain the strategy adopted at 
the beginning in the simultaneous presence of explicit cues. In contrast, 
when the same strategy was prompted externally (explicit condition), or 
when concurrent explicit cues were removed (permuted condition), PD 
patients adhered to the strategy which they adopted at the beginning, but 
which they were not able to maintain in the mixed condition. Apparently, 
explicit cues, which prompt external strategies, overrule increasingly the 
internal processing of the implicit cues in PD patients, which indicates that 
this internal processing might be too weak or too defective to stand up to 
the impact of explicit cues. Internal processing of implicit information 
prompts a - consequently - self-generated problem solving strategy. In 
many studies, it is shown that PD patients are impaired in self-generation 
of problem solving strategies. The findings of the present study clearly fit 
in with this concept. They suggest that memory impairments in PD 
originate - at least partly - in a diminished ability to generate internally 
problem solving strategies. 
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Summary 
In the present study, we investigated the association of two executive 
functions with disease characteristics in PD, especially with severity of 
motor symptoms. We operationalized two executive functions, viz. fluency 
and cognitive shifting, each in a number of tests with heterogeneous 
materials, but with an identical format. We calculated the correlations 
between test performance and disease characteristics, including the factor 
scores of the UPDRS. The results of this study show that only cognitive 
shifting was consistently associated with the severity of motor symptoms in 
PD, in particular with rigidity. None of the fluency tests had a significant 
association with severity of motor symptoms. The present study indicates 
that PD, as reflected by the severity of motor symptoms in PD, is not 
associated with a general decrease in executive function. In spite of the 
fact that both are executive functions and both require generation of items, 
fluency and cognitive shifting are differentially related to PD. 
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Introduction 
Most studies dealing with the relationship of cognitive dysfunction and 
other disease characteristics in non-demented patients with Parkinson's 
disease (PD) found a rather scattered pattern of associations between 
single test performance and motor symptoms [39,42,46]. This pattern may 
result from the fact that these studies aimed at a large variety of tests in 
order to cover a great diversity of cognitive functions and also from the 
heterogeneity of the patients under study. Some other studies [13,45] made 
a selection of tests on the basis of established differences between PD 
patients and control subjects (CS). With regard to this, the frequently 
observed impairment of so-called frontal or executive functions in PD 
should be mentioned. Executive functions are defined as functions which 
are involved in the self-regulation of problem solving strategies [36], a 
rather theoretical and non-specific definition. It is not surprising, therefore, 
that there is no unanimity about whether a particular function is executive 
or not. For example, Lezak [36] and Taylor et al. [53], unlike Litvan et al. 
[38] and Cooper et al. [14], include verbal fluency in the executive 
functions. Memory tasks are sometimes included [38,41,51], sometimes not 
[13,50]. Accordingly, the tests in which the concept of executive functions 
is operationalized, are very heterogeneous. Recently, David [16] and Stuss 
[49] pointed out that the concept of frontal or executive function lacks 
specificity and an empirical basis. Thus, even in studies in which tests 
assessing executive functions are selected, the heterogeneity of the tests 
predominates. The lack of corresponding findings in these studies may be 
due to this heterogeneity. 
In the present study, we investigated the relationship of cognitive 
functioning and disease characteristics of PD, especially the severity of 
motor symptoms. Instead of speculating whether associations between 
single test performance and motor symptoms reflect a hypothetical 
common feature, we no longer focused on the diversity, but on the commu-
nality of tests to be performed. From the cluster of executive functions, we 
selected fluency and cognitive shifting as the core variables in this study 
for two reasons. In a previous study [10], we found that PD patients were 
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impaired on fluency and cognitive shifting, the latter assessed with sorting 
tests. For the present study, we adopted a distinction of Kolb and Whishaw 
[33] between convergent and divergent thinking, which they derived from 
Guilford. According to Guilford who developed an empirically based 
model of human intelligence [25], fluency and cognitive shifting share a 
common trait, in that both are tests of divergent production. In tasks of 
convergent production, the subject has to generate an item which 
encompasses all items presented: he has to find one superordinate item, 
i.e. a class or category. Actually, all tests of abstraction and categorization 
are tests of convergent production. In tasks of divergent production, the 
subject has to generate different items within a given set: he has to find a 
series of juxtaposed items. In fluency tests, the subject has to generate 
items within a given category; in card-sorting tests, the subject has to 
generate categories which cover varying subsets of elements. Although 
each separate class in card-sorting tests is generated along the lines of 
convergent production, the shift from one class to another requires 
divergent production in addition. Fluency and cognitive shifting were each 
operationalized in a group of tests. Within each group, the materials were 
heterogeneous, i.e. representing distinct cognitive modalities (e.g. verbal, 
spatial), but the format was identical. As a matter of fact, the format of the 
fluency tests differed from that of the card-sorting tests. Thus the fluency 
tests had identical instructions, which required the subject to generate as 
many elements as possible within a number of different classes. Likewise, 
the card-sorting tests had identical instructions, being the feedback in 
terms of 'correct' and 'not correct', which enabled the subject to derive 
categories from varying sets of elements. This allowed us to investigate not 
only whether cognitive function is related to the severity of motor 
symptoms of PD, but also at which level of communality: the level of 
single, modality-related test performance, the level of a cognitive function, 
which goes beyond modalities, and finally the level of a more 
comprehensive function, which goes beyond modalities and formats (e.g. 
divergent production). In the latter case the scores of fluency, cognitive 
shifting and motor symptoms have to be interrelated despite the 
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heterogeneity of materials and instructions so that a common feature of all 
these tests, e.g. divergent production, prevails over the heterogeneity of 
materials and instructions. 
A correlational study like this requires that the patients under study 
show a varying degree of severity of symptoms. Therefore, both patients 
distinguished by a slight severity of symptoms (de novo patients) and 
patients distinguished by mild to moderate severity (patients on pharma-
cotherapy) were included in the present study. 
Materials and methods 
Subjects 
Originally, we started with a group of 60 PD patients. We had to exclude 
15 PD patients from the partial correlational analysis, merely because their 
neuropsychological data were incomplete. Accordingly, 45 PD patients 
were included in the present study: 23 males and 22 females. All gave 
informed consent. The diagnosis of idiopathic PD was based on the 
presence of at least two of the following symptoms: tremor, rigidity, 
bradykinesia and postural disturbances. The symptoms were evaluated by a 
neurologist (M. H.) a week before psychological testing. Patients with non-
PD symptoms, EEG and CT scan abnormalities, cerebrovascular disease 
and dementia according to DSM III-R criteria were excluded. In a 
previous study [55], we obtained evidence that anticholinergic therapy 
diminishes the performance of PD patients on card-sorting tests, and so we 
excluded patients on anticholinergic therapy. The group was composed of 
34 de novo patients and 11 PD patients on pharmacotherapy. Five patients 
were on levodopa plus carbidopa, three on bromocriptine and six on 
amantadine. Depression was measured by the Zung Depression Scale [58]. 
Table 1 presents some demographic and clinical data of the group. 
The sum score of the following subscales of the Unified Parkinson's 
Disease Rating Scale (UPDRS) was used as a measure of severity of PD: 
1. bradykinesia 2. rigidity 3. posture 4. arm swing 5. gait 6. tremor 7. face 8. 
speech and 9. activities of daily life. 
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Table 1. Demographic and clinical characteristics of the PD patients (n=45). 
Age (yrs) 
Onset disease (yrs) 
Duration (yrs) 
Sum UPDRS 
Zung score 
means 
57.4 
52.6 
5.8 
9.7 
47.3 
sd 
10.5 
10.7 
3.7 
3.5 
9.4 
Sum UPDRS = sum score of the principal subscales of the Unified Parkinson's 
Disease Rating Scale 
Zung score = score of the Zung Depression Rating Scale 
Given the number of patients, the number of subscales to be included in 
the factor analysis should be restricted to four. In order to establish 
whether it would be permissible to include the maximum of six subscales of 
the UPDRS in the factor analysis, we also analyzed the original group of 
60 PD patients which showed the same profile of disease characteristics 
and cognitive performance as the group of 45 PD patients. Therefore, we 
added the UPDRS scores of the 15 patients, who had to be excluded from 
the present study because of incomplete neuropsychological data, to those 
of the 45 patients. We selected bradykinesia, rigidity, gait, tremor, face and 
speech. The factor analysis of the group of 45 patients and that of the 
group of 60 patients provided the same factors and similar loadings as the 
factor analysis of the group of 45 PD patients, which legitimates the 
inclusion of six subscales in the present study. 
Tests 
Reference tests 
To assess intelligence, we selected four subtests from the WAIS-R: 
vocabulary and similarities, measuring verbal intelligence, and picture 
completion and block design, measuring visuoperceptual intelligence [15]. 
Memory was assessed by means of the Rey Auditory Verbal Learning Test 
[36]. A list of 15 semantically unrelated words was presented five times 
orally. The subject was asked to enumerate the memorized words after 
each presentation. The number of correct words after five presentations 
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was the score of memory performance. Attention was assessed with the 
Stroop Color Word Test [32]. Only Part В (speed of colour bar 
identification) and Part С (speed of colour vs word identification) were 
utilized. The score was obtained by subtracting the number of seconds that 
the subject needed to read the simple Part В from those needed to read 
the complex Part C. 
Executive functions 
We presented four fluency tests. The Semantic Fluency tests (SFT) 
required the subjects to enumerate as many animals as possible during one 
minute (SFT 1), and next, as many boys' names as possible (SFT 2). The 
Controlled Word Association tests (CWAT) [1,3] required the subjects to 
generate as many words as possible in one minute, beginning with the 
letter ρ (CWAT 1), and next, ending with the letter к (CWAT 2). Score 
was the number of different words. Next, these scores were transformed 
into z-scores. The sum of these z-scores was the total fluency score. 
We presented three card-sorting tests: the Wisconsin Card Sorting Test 
(WCST) [24] and a verbal and spatial variation, in order to enlarge the 
heterogeneity of the sorting criteria. In each test the subject began to sort 
on the basis of trial and error according to a criterion which was only 
known to the experimenter. A false response was corrected by the 
experimenter. This was the acquisition phase. To minimize the impact of 
memory, the correct (or corrected) matchings were laid down just below 
the appropriate stimulus cards. After a fixed number of correct responses 
the experimenter changed the criterion twice without informing the 
subject. These were the two shifting phases. In order to exclude biasing 
differences in speed of information processing there were no time 
constraints. The verbal variation of the WCST was the Animals Sorting 
Test (AST). This test consisted of three series of 24 cards and two stimulus 
cards. Initially, subjects had to match 'bird' versus 'mammal'. After seven 
consecutive correct responses the experimenter changed the sorting 
criterion to 'herbivore' versus 'carnivore' and finally to 'native' versus 
'exotic'. 
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Figure 1. Spatial Sorting Test: stimulus cards. 
The Spatial Sorting Test (SST) consisted of two stimulus cards and three 
series of 20 response cards, each depicting two figures in a varying spatial 
relationship (see Figure 1). 
The instructions given to the subjects were analogous to those for 
animals sorting. For detailed information, we refer to other studies [55,56]. 
With respect to the WCST, we used the original form [24] in which over 
half the cards are ambiguous, i.e. sharing more than one criterion with a 
stimulus card (e.g. the same in colour and the same in shape), and the 
instruction is restricted to feedback. Previous research [50,51] has shown 
that PD patients are impaired in the ability to generate efficient strategies 
spontaneously. In the modified form [43], all ambiguous cards are 
eliminated and the instruction tells the subject exactly what to do, which 
reduces the appeal to the spontaneous generation of efficient strategies. 
For this reason we preferred the original form to the modified one. 
Consequently, studies involving the modified form are omitted from 
consideration in the discussion. 
Since inclusion of ambiguous cards prevents a clear distinction of 
perseverative and non-perseverative responses [43,55], and perseverative 
responses in the acquisition essentially differ from those in the shifting 
phases [28], we did not analyze the card-sorting tests according to 
Executive functions and disease characteristics in PD 97 
perseverative/non-perseverative error pattern. In addition, to rule out 
chance, generation of a correct class can only be assessed conclusively after 
a number of correct trials in succession. The same holds true for 
perseveration. However, unlike, for example, the California Verbal 
Learning Test [23], the WCST manual [28] does not provide scoring 
formulae to correct perseverative and non-perseverative responses for 
chance, which is about one third. 
In most studies, the WCST is stopped when all cards (n=64) are 
presented twice. In the present study, the cards of the three card-sorting 
tests were presented once. The tests were stopped when the subject had 
sorted all cards, or had achieved the three categories of each test. In the 
present study, we presented three card-sorting tests once, so that the 
maximum number of categories to be found was nine. In our series of card-
sorting tests, the WCST was the only one with a restricted number of 
classes embedded in the cards (colour, form and number), which implies 
that there is only one class left in the second shifting phase. As indicated 
elsewhere [10,11], this enables the subject to solve the problem by heading 
for the only class that is left, instead of generating one, which is 
incompatible with the homogeneity of tests which we aimed at. Therefore, 
we continued the WCST by presenting the first class once again and 
omitted the second shifting phase from our analysis. Cognitive shifting was 
reflected in two scores: the number of categories achieved and the 
standardized sum of trials of all card-sorting tests taken together. The first 
measure is a conventional one [4,6,35,53]: the more the subject is able to 
shift to a new grouping, the more categories a subject discovers. Among 
the scores provided by the Heaton manual, the number of categories is the 
only one which reflects directly the number of shifts which the subject has 
achieved, and, consequently, may be considered as the most appropriate 
measure to reflect cognitive shifting. In a previous study these measures 
proved to be almost identical [55], but the sum of trials has a much wider 
range of measurement. Standardization was performed by transforming the 
number of trials that a subject needed, into the percentage of the 
maximum number of trials. 
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Table 2. Means and standard deviations of neuropsychological test performance of 
PDpatients (n=45) and CS (n=33). 
PD CS 
mean sd mean sd 
Verbal IQ 
Visuoperceptual IQ 
Memory (15 Words Test) 
Stroop C-B 
Semantic Fluency Test 1 
Semantic Fluency Test 2 
Controlled Word Association Test 1 
Controlled Word Association Test 2 
Sum trials Animals Sorting test 
Sum trials Spatial Sorting Test 
Sum trials WCST 
Sum categories Card Sorting Tests 
115.2 
119.0 
40.5 
44.5 
18.4 
20.8 
13.9 
11.3 
17.3 
24.6 
16.9 
7.6 
13.4 
18.1 
8.8 
26.6 
4.0 
4.7 
4.1 
6.1 
14.0 
18.0 
14.8 
1.5 
114.9 
117.8 
42.8 
47.9 
18.6 
19.5 
13.2 
12.8 
17.2 
20.6 
23.9 
7.6 
14.9 
16.8 
10.9 
27.9 
5.0 
4.7 
5.4 
5.9 
14.3 
18.5 
17.4 
1.2 
Statistics 
Factor analysis was performed in accordance with the procedures of 
principal components and varimax rotation (Statistical package: SAS). 
Correlations and partial correlations were established with the Pearson 
Product-Moment Correlation Coefficient r. In addition, differences 
between performance of the patients above and below the mean of each 
UPDRS-factor were tested using Student's test. Results with ρ values less 
than 0.05 (two-sided) were considered significant. 
Results 
Means and standard deviations of neuropsychological test performance are 
presented in Table 2. 
Since the reader might be interested in normal performance of our 
experimental tests (AST and SST), we added the scores of 33 control 
subjects (age: mean=57.4 yrs; sd=8.7) of the same intelligence, who 
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participated in a different study of ours [56]. The performance of both 
groups was fairly similar and, consequently, did not differ significantly. 
Age and onset of disease, being the age at which the first symptoms of 
PD became apparent, showed an identical pattern of correlations with the 
cognitive variables. Their extremely high intercorrelation (r=0.96, 
p<0.0001) confirms a strong collinearity and, as a result, it is statistically 
impossible to separate the possible effects of these variables. Therefore, we 
will refer only to 'age' from now on. Duration of disease, which correlated 
significantly with age (r=0.33; P<0.05), was only associated with 
performance IQ (r=-0.33; p<0.05). Depression scores did not correlate 
with any cognitive variable. For this reason we only present the 
correlations of the cognitive variables with age and severity of symptoms 
(see Table 3). The partial correlations between test performance and 
severity of symptoms, after partialling out age, are shown in Table 4. 
As far as the reference tests were concerned, the scores of 
visuoperceptual intelligence and the Stroop Color Word Test correlated 
significantly with age. Memory performance correlated significantly with 
age and severity of symptoms. 
The internal consistency of the four fluency tests was satisfactory: the 
two SFT scores correlated significantly (r=0.50, p=<0.001), as did the two 
CWAT scores (r=0.53, p<0.0005); the sum of the SFT z-scores also 
correlated significantly with the sum of CWAT z-scores (r=0.43, p<0.005), 
which allows us to transform the four fluency z-scores into one 
standardized sum score. Although not all intercorrelations of the card-
sorting tests were significant (AST vs SST: r=0.57, p<0.0001, AST vs 
WCST: r=0.14, p=0.35; SST vs WCST: r=0.30, p=<0.05), which is 
probably due to the pursued heterogeneity of the materials (see 
Introduction), each of the three card-sorting tests was similarly associated 
with the UPDRS sum score (AST vs UPDRS: r=0.32; p<0.05; SST vs 
UPDRS: r=0.30; p<0.05; WCST vs UPDRS: r=0.35; p<0.05). The 
standardized sumscores of the fluency tests neither correlated with age nor 
with severity of motor symptoms. 
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Table 3. Correlations of age/onset disease and 
performance in PD patients (n=45). 
Verbal IQ 
Visuoperceptual IQ 
Memory performance (15 Words Test) 
Stroop C-B 
Standardized Sum Fluency Tests 
Sum of categories Card Sorting Tests 
Standardized sum trials Card Sorting Tests 
severity of motor 
Age/ 
onset disease 
-0.07 
-0.44# 
-0.32* 
0.44# 
-0.18 
-0.10 
0.07 
symptoms with test 
Sum 
UPDRS 
-0.19 
-0.27 
-0.40# 
0.14 
0.02 
-0.38** 
0.42# 
(The number of categories increases, and the total number of trials decreases, as test 
performance improves.) 
* p<0.05 #p<0.005 
** p<0.01 
The sum of categories and the standardized sum of trials of the card-
sorting tests showed a very high intercorrelation (r=-0.96, p<0.0001), 
indicating that these variables are almost identical. Both measures 
correlated significantly with severity of motor symptoms, but not with age 
(see Table 3). The same holds true for the standardized sum of trials in 
the two shifting phases together. 
Although the correlation between age and severity of motor symptoms 
was not significant (r=0.13, p<0.38), we calculated the partial correlations 
between the cognitive variables and severity of motor symptoms to rule out 
any bias of age. The correlation of performance IQ and duration of disease 
was no longer significant (r=-0.22; p=0.15). Memory performance 
remained significantly correlated with severity of motor symptoms. Again 
there was no correlation between severity of motor symptoms and the 
standardized sumscores of the fluency tests. The sum of categories and the 
standardized sum of trials remained significantly correlated with severity of 
motor symptoms (see Table 4). 
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** 
Table 4. Correlations of severity of motor symptoms with test performance in PD 
patients (n=45), after partialling out age/onset of disease. 
Sum 
UPDRS 
Verbal IQ -0.18 
Visuoperceptual IQ -0.24 
Memory performance (15 Words Tests) -0.38 
Stroop C-B 0Л0 
Standardized sum Fluency Tests 0.04 
Sum of categories Card Sorting Tests -0.37** 
Standardized sum of trials Card Sorting Tests 0.41# 
(The number of categories increases, and the total number of triaL· decreases, as test 
performance improves.) 
# p<0.005 
** p<0.01 
Table 5. Factor analysis UPDRS-scores after varimax rotation. 
Fl F2 F3 
Eigenvalue 2.49 1.27 0.79 
bradykinesia 
rigidity 
gait 
tremor 
face 
speech 
0.58 
0.09 
0.71 
-0.09 
0.85 
0.84 
0.42 
0.96 
0.18 
0.07 
-0.03 
0.11 
0.33 
0.04 
-0.32 
0.95 
0.02 
-0.06 
Total variance explained: 76% 
Underlined loadings are significant at levelp<0.0001 
Factor analysis yielded three factors (see Table 5). Face, speech, gait and 
bradykinesia had the greatest loadings on the first factor, which was 
therefore identified as hypokinesia. Rigidity had by far the greatest loading 
on the second factor, and tremor on the third factor. 
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Table 6. Correlations and partial correlations of 
card-sorting tests. 
V-IQ 
Vp-IQ 
RAVLT 
Stroop C-B 
SS-FT 
SC-CS 
ST-CS 
Fl 
0.02 
-0.03 
Correlations 
F2 
-0.23 
-0.12 
-0.37** 0.05 
0.03 
0.10 
0.00 
0.03 
0.05 
-0.07 
-0.41# 
0.45@ 
F3 
-0.22 
-0.21 
-0.09 
0.01 
0.06 
-0.19 
0.14 
Table 7. Cognitive performance of patients with 
mean: 
F1>0 
(n=23) 
means 
I 
and standard deviations. 
FKO F2>0 
(n=22) (n= =22) 
UPDRS factor scores with scores of 
Partial correlations 
Fl 
0.03 
0.06 
-0.33* 
-0.06 
0.14 
0.02 
0.02 
factor scores 
F2<0 
(n=23) 
F2 
-0.24 
-0.18 
0.02 
0.10 
-0.09 
-0.42# 
0.46@ 
F3 
-0.23 
-0.27 
-0.12 
0.05 
0.05 
-0.20 
0.14 
above and below the 
F3>0 
(n=22) 
F3<0 
(n=23) 
Age 60.3(8.9) 54.3(11.2) 57.0(11.4) 57.7(9.8) 57.2(11.0) 57.5(10.1) 
V-IQ 115.8(12.9) 114.5(14.2) 112.7(16.0) 117.6(10.2) 112.2(15.7) 118.0(10.4) 
Vp-IQ 118.5(16.6) 119.4(19.9) 116.6(20.5) 121.2(15.6) 114.2(20.4) 123.5(14.7) 
RAVLT 38.4(7.3) 42.7(9.7) 41.0(9.6) 40.0(8.1) 37.8*(7.9) 43.1(9.1) 
Stroop 42.9(24.8) 46.2(28.9) 45.5(31.3) 43.6(21.9) 45.7(25.8) 43.3(27.8) 
SS-FT 64.9(15.5) 63.8(12.6) 64.6(16.2) 64.1(12.0) 67.0(13.9) 61.8(14.0) 
SC-CS 7.6(1.4) 7.5(1.7) 6.9**(1.7) 8.1(1.2) 7.3(1.5) 7.8(1.6) 
ST-CS 57.8(31.6) 60.1(39.5) 74.6#(37.7) 43.8(25.4) 64.4(34.7) 53.6(35.8) 
* p<0.05 
** p<0.0l 
Fl 
F2 
F3 
SS-FT = 
SC-CS = 
ST-CS = 
# p<0.005 
@p<0.001 
factor score hypokinesia 
factor score rigidity 
factor score tremor 
Standardized sum of fluency tests 
Sum categories Card Sorting Tests 
Standardized sum of trials Card Sorting Tests 
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As can be seen in Table 6, of all cognitive functions only memory 
performance correlated significantly with the factor hypokinesia. 
The two standardized sumscores of the card-sorting tests only correlated 
significantly with the factor rigidity. None of the cognitive scores correlated 
with any other factor. 
We compared cognitive performance of patients with scores above and 
below the mean of the three UPDRS factors, in order to assess whether a 
different way of testing provides confirmation of the correlational analyses. 
As can be seen in Table 7, the association between memory performance 
and the factor hypokinesia could not be confirmed. There was a significant 
difference in memory performance between patients with a tremor score 
above and below the mean. The association between cognitive shifting and 
rigidity proved to be firmly significant. 
Discussion 
In the present study, we investigated the association of two executive 
functions with the severity of motor symptoms in PD. We performed a 
factor analysis of six subscales of the UPDRS and operationalized two 
executive functions, viz. fluency and cognitive shifting, each in a number of 
tests with heterogeneous materials, but with an identical format. Finally, 
we compared test performance of patients with factor scores above the 
mean with those with factor scores below the mean. 
The results of this study show that only cognitive shifting was 
consistently associated with the severity of motor symptoms in PD, in 
particular with rigidity. Previous studies [13,50] also found associations 
between severity of motor symptoms and cognitive function, but these 
associations involved single and rather heterogeneous cognitive measures. 
In the present study, we found a firm relationship between an empirically 
established motor impairment and a decrease of a specific cognitive 
function, which has been assessed in three different modalities. 
None of the fluency tests had a significant association with severity of 
motor symptoms. The results of the correlational analyses were confirmed 
by the analysis of group differences between patients with factor scores 
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above and below the mean. These results indicate that fluency and 
cognitive shifting are differentially related to PD in spite of the fact that 
both are executive functions, and both require generation of items. The 
present study indicates that PD, as reflected by the severity of motor 
symptoms, is not associated with a general decrease in executive function. 
These findings suggest that the concept of executive function is too 
heterogeneous for empirical studies. 
Age and onset of disease showed an extremely high intercorrelation 
(r=0.96), indicating that in this study the two variables were nearly 
identical. This is in line with another correlational study [45], in which it 
has been found that age at onset no longer correlates with test scores after 
correction for age. For reasons of collinearity (see results), this finding 
does not imply a dichotomy of 'young' PD patients with an early onset and 
'old' patients with a late onset, which could have biased our results, 
because late onset is frequently associated with cognitive deterioration 
[2,9,19,29]. Duration of disease only correlated with performance IQ, but 
the significance of this correlation disappeared after partialling out age. 
Depression did not correlate with any cognitive score. All patients were 
outpatients in a relatively early stage of PD and without symptoms which 
prevented them to participate in everyday life. Indications of intellectual 
deterioration were absent (see Table 2). Therefore, it is not plausible that 
the results of the present study must be attributed to a heterogeneous 
composition of our group of PD patients. For reasons indicated in the 
introduction, we included a number of PD patients with pharmacotherapy. 
In our view, it is not plausible that the pharmacotherapy of our patients 
explains the significant correlations and group differences which we found, 
since the patients receiving pharmacotherapy form a minority, and patients 
on anticholinergic therapy, a medication known to affect cognitive shifting 
[55], were excluded. Moreover, the studies of Downes et al. [17], Lange et 
al. [34] and Owen et al. [44] have indicated that set-shifting may be 
ameliorated rather than deteriorated by levodopa therapy. 
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Thus, the relationship between cognitive shifting and motor symptoms was 
established in spite of the inclusion of patients on levodopa therapy. Our 
findings are discussed in more detail below. 
Reference variables 
Visuoperceptual intelligence and attention (Stroop Color Word test) 
showed a significant correlation with age. Visuoperceptual intelligence 
(Vp-IQ) was calculated from age-corrected standard scores, but 
nevertheless Vp-IQ showed a significant correlation with age (see Table 3). 
In our opinion this result was due to a decreased speed of performance in 
PD patients. Both block design and picture completion of the WAIS are 
subtests with time constraints. Besides, block design also requires manual 
dexterity. Probably, the correlation of Vp-IQ and age might no longer be 
significant, if we had measured untimed performance. The finding that 
memory performance correlated with age, is in line with the available 
literature [40]. The correlation of memory performance with severity of 
motor symptoms is in accordance with the frequently reported decrease in 
short term memory in PD [8,22,29,48,52]. In the correlational analyses, 
memory performance proved to be exclusively related to hypokinesia, but 
we were not able to confirm this finding in our analysis of group 
differences: the tremor scores were associated with a significant difference 
in memory performance, but the hypokinesia scores no longer shared this 
association. This may indicate that the relation between memory 
performance and hypokinesia is not a firm one. Anyhow, the results of the 
present study suggest that memory and cognitive shifting are differentially 
affected by PD. 
Attention, as reflected by the difference score on the Stroop Test, 
correlated with age, but not with severity of motor symptoms. In contrast 
to our findings, Hiëtanen and Teräväinen [30], who have studied a group 
of de novo patients, found significant correlations between the separate 
sections of the Stroop Color Word Test and motor symptoms. 
Unfortunately, these authors did not provide the crucial score, being the 
difference score between part С and part B, because it rules out speed of 
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performance [21,32]. In a later study, the same authors [31] found no 
difference between treated and untreated PD patients with regard to 
difference scores of the Stroop Color Word Test, which, just like our 
findings, indicates little impact of severity of motor symptoms on attention. 
Some studies included the Stroop Color Word Test in tests assessing 
executive function. In the present study, there was a poor relation of 
Stroop performance with fluency performance or with card-sorting, which 
once again indicates that the concept of executive function lacks 
homogeneity. 
Executive junctions 
The standardized sum scores of the four fluency tests were neither 
significantly correlated with age nor with severity of motor symptoms. Since 
fluency performance depends partly on the ability to speak quickly, one 
might suppose a firm correlation between the fluency scores and the scores 
of the factor hypokinesia, on which the speech-ratings of the UPDRS 
loaded heavily. However, this correlation turned out to be low (r=0.15). 
Moreover, the patients with a hypokinesia score above the mean and those 
who scored below the mean performed almost identically on the fluency 
tests. This is in accordance with the study by Gurd and Ward [26], who 
found no relation between scores of twelve fluency tasks and the rate of 
speaking in PD. Although the present study did not compare PD patients 
and CS, our results fit those of Hanley et al. [27], who found that 
differences in fluency between PD and CS disappeared when differences 
of age and verbal ability were partialled out. Just like us, they found no 
association between fluency performance and depression. 
In contrast with other types of cognitive performance in the present 
study, the performance on card sorting tests proved to be associated 
exclusively with severity of motor symptoms. This finding is not only 
supported by the scores of the overall performance, as reflected in the 
standardized sum scores, but also by the performance on the individual 
tests (see results). Our results are in partial agreement with those of 
Iichter et al. [37]; they studied a group of PD patients on 
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pharmacotherapy, who were older and more disabled than ours. They 
found negative correlations between motor disability scores and a number 
of neuropsychological test scores, among them the number of categories of 
the WCST. Apparently, the association between reduced cognitive 
functioning and motor disability increases as the PD progresses. Our 
findings differ from those of Cooper et al. [13], who found no correlation 
between motor disability scores and performance on the WCST. This may 
be due to differences between the groups of patients under study. One-
third of the patients involved in the latter study were considered to be 
cognitively impaired (score on the Blessed Dementia Scale above 3, being 
more than two standard deviations below the mean score of the CS in that 
study and firmly below their estimated premorbid IQ). Since the motor 
disability in the cognitively impaired and that of the non-impaired group 
were fairly identical, it is plausible that the prominent difference in general 
intelligence has suppressed a possible correlation between motor disability 
and a decrease of a subtle cognitive function. In contrast, the patients of 
our study showed a present IQ level one standard deviation above sample 
mean (see Table 2). Apparently, despite an above normal intelligence, our 
patients were not able to compensate for the decrease of the subtle 
cognitive function, which is associated with the severity of motor symptoms. 
Reviews of cognitive function in PD [5,20] often report a decrease in 
cognitive shifting in PD patients, but are rather reluctant to assume a 
deficit in some superordinate process, which is also responsible for other 
cognitive deficits. The results of the present study do not indicate a 
superordinate process at a level as high as self-regulation of problem 
solving strategies being the definition of executive function. On the other 
hand, it did prove possible to reveal the association between severity of 
motor symptoms and cognitive shifting with a variety of tests. The 
materials of our card-sorting tests were selected from cognitive modalities 
which are globally associated with separate cortical regions: the verbal 
modality (AST) with the left frontal cortex, the spatial modality (SST) with 
the right parietal cortex and the conceptual modality (WCST) with the 
prefrontal cortex. Nevertheless, the identical format of these tests 
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prevailed over the heterogeneity of the materials. This indicates that 
cognitive shifting does not break up into separate cognitive functions, each 
restricted to a certain modality, but is a rather comprehensive cognitive 
function, which goes beyond heterogeneous cognitive modalities. 
Card-sorting and fluency tests proved to be significantly interrelated 
(standardized sum fluency tests vs sum categories card-sorting tests: 
r=0.36; p<0.05). Despite their common variance, performance of fluency 
and card-sorting tests proved to be differentially related to the severity of 
motor symptoms; hence, it is plausible that PD does not affect what these 
tests have in common, for example the generation of items. Just like us, 
Downes et al. [18] did not find evidence for a general fluency deficit. They 
found that PD patients and CS only differed significantly in fluency tasks, 
which require the generation of items alternately from heterogeneous 
fluency domains. They suggest that this deficit is not related to a general 
attentional deficit, but to an impaired switching from one domain to 
another, more specifically, an impairment to inhibit and desinhibit 
algorithms alternately. Since both card-sorting and interdomain alternating 
fluency tasks require interdomain switching, it would be interesting to 
investigate whether the significant relation between card-sorting and 
fluency performance becomes stronger, when interdomain alternating 
fluency tasks are used, and further, whether, in contrast to single fluency 
performance, alternating fluency performance is related to the severity of 
motor symptoms in the same way as card-sorting. 
From previous research it may be concluded that the principal deficit in 
PD is an inability to generate plans for task achievement internally 
[6,7,10,11,12,48,50,54]. Fluency tasks are mainly predicated upon the access 
to stored information and performance of single fluency tasks is not 
improved by clustering words, being a self-generated problem solving 
strategy [18]. Such a self-generated problem solving is not required in 
fluency tasks, which are predicated upon access to stored information [50]. 
However, in card-sorting tests, the instruction does not indicate how to 
solve the problem, but is restricted to feedback in terms of 'correct' or 'not 
correct' and, what is more, the feedback in consecutive phases is 
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incompatible with the preceding feedback. Thus, the subject has to rely 
solely on his own problem solving abilities. The difference between fluency 
and card-sorting in terms of externally or internally generated problem 
solving fits the results of the present study fairly well. 
Factor analysis provided three factors which explained 76% of the 
variance. Other studies sometimes revealed different factors, depending on 
the items and patients involved. Zetusky et al. [57] found factors which 
globally correspond to ours. In their study, bradykinesia also loaded on two 
factors: rigidity and postural instability. Recently, Richards et al. [47] found 
three factors: balance/instability, rigidity and tremor. The loadings of 
UPDRS-items are comparable. In their group of patients, who were on 
average much older than ours, they found that cognitive changes in non-
demented Parkinsonians were specifically associated with motor symptoms, 
especially with the factor rigidity. In the present study, both the 
correlational analyses and the analysis of group differences indicate an 
exclusive and consistent association of cognitive shifting and rigidity. Since 
patients with a high factor score on rigidity, being the only factor which 
discriminates in card-sorting, and with a poor performance on card-sorting 
have approximately the same age as patients with a low factor score on 
rigidity and a normal performance on card sorting (M=57.0, sd=11.4 vs 
M=57.7, sd=9.8), this finding is not resulting from a dichotomy between 
'young' patients with an early onset and 'old' patients with a late onset 
[2,8,19,29]. Our finding differs from that of Pillon et al. [45], who analyzed 
neuropsychological performance of PD patients in relation to motor 
symptoms as a function of their response to levodopa therapy. They found 
that cognitive impairment correlates poorly with levodopa-responsive 
symptoms such as rigidity. However, Pillon et al. [45] used the simplified 
version of the WCST [43]. As already mentioned (see Materials and 
Methods), this simplification transforms the WCST into a test in which the 
appeal to the spontaneous generation of efficient strategies is drastically 
reduced. In other words, the present study does not contradict the study of 
Pillon et al. [45]. This emphasizes the necessity to specify test and scoring 
procedures. 
по 
Chapter 4 
То summarize, the present study shows that executive function is a concept 
which is too heterogeneous to assess the association of cognitive 
functioning and severity of motor symptoms in PD. On the other hand, it 
proved possible to go beyond the level of single, modality-related cognitive 
functions. We found a firm relationship between cognitive shifting and 
severity of motor symptoms, especially rigidity. This relationship prevailed 
over the heterogeneous cognitive modalities, viz. verbal, spatial and 
conceptual, which are globally associated with separate cortical regions, 
indicating that PD affects superordinate cognitive processes, but at a lower 
level than the assumed level of executive functions. Our finding that 
fluency and cognitive shifting are differentially associated with severity of 
motor symptoms fits the notion of an impaired self-generated problem 
solving in PD. 
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Summary 
In this study we established that cognitive shifting, an ability that is known 
to be affected in Parkinson's disease (PD), is more impaired in PD 
patients, treated with anticholinergics, than in de novo patients. Eleven PD 
patients on anticholinergic monotherapy were compared with 30 de novo 
patients. The groups did not differ with respect to age, duration and 
severity of PD, and depression, nor with respect to general intelligence or 
attention. We assessed cognitive shifting with three different card-sorting 
tests. The patients on anticholinergics showed a poorer performance on all 
card-sorting tests than the de novo patients did. The patients on 
anticholinergics needed significantly more trials in two card-sorting tests 
and discovered significantly less categories in total. There was also a 
significant difference in memory performance, but memory performance 
did not correlate with any score on the card-sorting tests. This indicates 
that the performance of card-sorting tests and the memory performance 
were independent. 
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Introduction 
Although nowadays levodopa is the most powerful and widely used drug in 
the pharmacotherapy of PD, anticholinergics are still prescribed, especially 
in the early stage of the disease, mainly in order to delay the onset of 
levodopa therapy. There is a discussion whether or not levodopa therapy is 
a risk factor for the emergence of fluctuations and dyskinesia [4,12,18]. 
Thus the question arises whether the advantages of postponing possible 
levodopa problems outweigh the risk of inducing anticholinergic cognitive 
deficits. In order to answer this question one must be aware of the cogniti-
ve side effects of anticholinergic therapy in PD. 
The influence of anticholinergics on cognitive functioning of PD patients 
is still controversial, since the results of most studies diverge. This may be 
due to differences in design (e.g. cross-sectional versus longitudinal), to the 
selection of cognitive functions and of patients. Since cholinergic deficits 
are commonly associated with the cognitive decline in Alzheimer's disease 
(AD) [8], most studies deal with functions that are impaired in AD [20,21], 
such as memory [9,10,13,15,17,22], and only a few focus on the cognitive 
impairments that are frequently established in PD. Moreover, it is 
remarkable that, as far as we know, there are no neuropsychological 
studies in which patients on anticholinergic monotherapy have been 
compared with de novo patients. The patients under study mostly used 
other drugs, like levodopa and amantadine, in addition to anticholinergics, 
and so pharmacological interaction [5,16] cannot not be ruled out. 
As already indicated, anticholinergics nowadays are often prescribed in 
the early stages of PD. If anticholinergics impair cognitive functioning in 
early PD, they may well exert this deleterious effect by enhancing cognitive 
problems, that are characteristic of PD. One of these problems has been 
described as an impaired 'ability to maintain and to shift set'[2], or 'shifting 
conceptual sets' [14]. 'Shifting aptitude' [6] also refers to cognitive shifting, 
but is restricted to cognitive shifting that is not prompted or guided by 
external cues. 
The present study is a part of a longitudinal study in PD. The group of 
patients in this study included eleven patients on anticholinergic monothe-
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тару. We composed a group of de novo patients with the same clinical 
status. These two groups enabled us to compare the effect of anticholiner­
gics on a number of cognitive functions, especially on cognitive shifting, 
being a function that is often reported as being impaired in PD. In order 
to avoid test-specific artefacts, that may be present when a cognitive 
function is measured only by one test, we assessed cognitive shifting by 
means of three tests of shifting sorting-criteria. We selected the Wisconsin 
Card Sorting Test (WCST) and developed a verbal and a spatial variation 
of this test. If anticholinergics bring about a poor performance of these 
three different shifting tests, this will firmly favour the conclusion, that 
anticholinergics impair cognitive shifting, a finding, that may caution 
against their prescription in PD. 
Materials and methods 
Subjects 
Forty-one patients (23 male and 18 female) diagnosed as suffering from 
idiopathic Parkinson's disease participated in this study: 11 patients on 
anticholinergic monotherapy (PD-AC; mean age 61.5 ± 7.2) and 30 de 
novo patients (PD-DN; mean age 58.1 ± 11.0). Patients with non-PD 
symptoms, EEG and CT scan abnormalities, cerebrovascular disease and 
dementia according to DSM III-R criteria had been excluded. Among PD-
AC ten patients were taking orphenadrine (daily dose 150 mg for 9 
patients and 225 mg for one patient) and one trihexyphenidyl (daily dose 6 
mg). From a group of 46 de novo patients we excluded 16 patients with a 
total Websterscore Ü8. The 30 remaining PD-DN and PD-AC showed a 
nearly identical Websterscore. For PD-AC the mean severity of PD, as 
reflected by the Webster score, was 12.6 ± 3.4 and duration of PD in years 
6.3 ± 1.7, for PD-DN 11.1 ± 2.2, respectively 5.8 ± 3.6. The two groups 
did not differ with respect to depression as reflected by the Zung Depres-
sion Scale [24]: mean score of PD-AC was 48.5 ±9 .1 and that of PD-DN 
was 46.7 ± 9.6. 
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Tests 
In order to control for intelligence, memory and attention we included a 
range of standardized reference tests in our battery. We selected four 
subtests from the Dutch adaptation of the WAIS-R to control for intelli­
gence and to exclude general mental deterioration: vocabulary and similari­
ties, measuring verbal intelligence, and picture completion and block 
design, measuring visuoperceptual intelligence. The subtest similarities also 
covers concept formation, an ability, which along with cognitive shifting is 
supposed to be unimpaired in normal performance of card sorting tests. 
Attention (maintaining response set) and memory were assessed by means 
of the Stroop Color-Word Test and the 15 Words Test. Efficiency of 
performing the Stroop Color-Word Test is reflected by dividing the score 
of the difficult Part С by the simple Part В [23]. The 15 Words Test is a 
Dutch adaptation of the Rey Auditory Verbal Learning Test. The number 
of correct words after five presentations is the score of memory performan­
ce. 
'Cognitive shifting' was measured by three card-sorting tests: the Wiscon­
sin Card Sorting Test (WCST), and a verbal and spatial variation, respecti­
vely the Animals Sorting Test (AST) and the Spatial Sorting Test (SST). 
While developing both variations of the WCST we adopted the traditional 
dichotomy of verbal and visuoperceptual intelligence in order to enlarge 
the heterogeneity of the sorting criteria. In each test the subject begins to 
sort on the basis of trial and error according to a criterion that is only 
known to the experimenter. A false response was corrected by the experi­
menter. After a fixed number of correct responses the experimenter 
changes the criterion two (AST and SST) or three times (WCST) without 
informing the subject. In order to exclude biasing differences in speed of 
information processing [23] there were no time constraints. 
The verbal variation of the WCST was the Animals Sorting Test (AST). 
This test consisted of three series of 24 cards. On each card the name of 
an animal species was printed. Each card had to be assigned to one of two 
stimulus cards 'deer' or 'vulture'. Initially, subjects had to match 'bird vs 
mammal'. After seven correct responses the experimenter changed the 
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sorting criterion to 'herbivore versus carnivore' and finally to 'native versus 
exotic'. The response cards had been selected in a way that each card 
might be sorted according to the three sorting criteria. When a subject still 
failed to make a correct assignment after 17 trials, the experimenter 
proceeded with the next series of cards. The spatial sorting test (SST) 
consisted of two stimulus cards and three series of 20 response cards, each 
depicting two figures that are assembled from a line and a triangle in a 
varying spatial relationship. Three patterns out of all conceivable spatial 
relationships were selected as criteria in assigning the cards to one of the 
two stimulus cards. 
Considering the WCST, in many studies the modified form of Nelson 
[19] is used, because it is simpler for the subject. In this form all ambigu-
ous cards from the original form [11] - these are the cards which share 
more than one criterion with a stimulus card (e.g. the same in colour and 
the same in shape) - have been removed. However, irrespective of the fact 
that it proved impossible to develop a verbal and visuospatial variation on 
WCST without any ambiguous cards, ambiguous cards appeal more to 
cognitive shifting than unambiguous cards do, because the feedback of the 
experimenter does not guide the problem solving unequivocally. For this 
reason we preferred the original form to the modified one. 
We did not analyse the card-sorting tests according to perseverative-
nonperseverative error pattern. The classification in perseverative and 
nonperseverative errors is formally correct, but actually rather interpreta-
tive, since it is not allowed to ask the subject why he has decided to this 
particular assignment. Actually, in a study of the original authors of the 
WCST [1] only a minority of the normal subjects was able to give a correct 
verbal report of what he was doing during the test. In addition, the two 
versions of the WCST use quite different definitions of perseverative 
errors, a fact that is neglected in many studies. Correct formation or 
shifting set can only be assessed conclusively after a number of correct 
trials in succession. The same holds true for perseveration. Moreover, the 
presence of a lot of ambiguous response cards prevents an unequivocal 
distinction between perseverative and nonperseverative errors. 
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Table 1. Means and sd of reference test measures; level of significance L· associated 
with t values. 
PD-DN PD-AC Significance 
(n=30) (n=ll) oft 
M sd M sd t Ρ 
WAIS voc 
WAIS sim 
WAIS bd 
WAIS pic 
Stroop С/В 
15 Words test 
31.0 
15.5 
12.7 
10.3 
1.7 
39.0 
9.9 
4.6 
6.4 
4.1 
0.5 
8.5 
27.9 
14.4 
11.5 
9.2 
2.0 
31.5 
13.5 
4.3 
7.6 
3.4 
0.5 
9.1 
-0.79 
-0.71 
-0.48 
-0.81 
1.21 
-2.47 
ns 
ns 
ns 
ns 
ns 
<0.05 
voc = vocabulary bd = block design 
sim = similarities pic = picture completion 
Consequently, analysis of types of error will not be involved in this study. 
Performance of the card-sorting tests was measured in two ways: the sum 
of all trials - correct or incorrect - that a subject needed before he per­
forms the fixed number of correct sortings, and the total number of 
categories that a subject is able to discover. The last measure is a conven­
tional one [2,3,14,23]: the more the subject is able to shift to a new grou­
ping, the more categories a subject discovers. In most studies the cards of 
the WCST were presented two times so that the total number of categories 
came to six. In this study we presented three card-sorting tests once, so 
that the total number of new categories came to ten (AST:3, SST:3 and 
WCST:4). 
Results 
The scores on the reference tests are shown in Table 1. The groups do not 
differ in general intelligence or attention (maintaining response set), but 
they differ in memory performance (15 Words Test). As to cognitive 
shifting, the scores are shown in Table 2. 
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Table 2. Means and sd of criterion test measures; level of significance L· associated 
with t values. 
AST 
SST 
WCST 
TSC 
PD-DN 
(n= 
M 
16.0 
21.1 
25.4 
5.1 
=30) 
sd 
10.8 
15.4 
19.4 
1.7 
PD-AC 
(n= 
M 
22.7 
37.4 
48.9 
3.5 
= 11) 
sd 
9.1 
18.1 
32.4 
2.2 
t 
1.84 
2.86 
2.25 
-2.31 
Significance 
oft 
Ρ 
ns (=0.07) 
<0.01 
<0.05 
<0.05 
AST = Sum trials Animal Sorting Test 
SST = Sum trials Spatial Sorting Test 
WCST = Sum trials Wisconsin Card Sorting Test 
TSC = Total sum categories 
PD-AC needed more trials than PD-DN on all card-sorting tests. The 
difference between the groups is significant in SST and WCST and not 
significant on AST (p=0.07). With regard to number of categories a 
summary score was computed. The internal consistency appeared to be 
satisfactory: the intercorrelations were checked by Pearson г and proved to 
be significant (AST vs SST: r=0.32, p<0.05; AST vs WCST: r=0.35, 
p<0.05; SST vs WCST: r=0.42, p<0.01). PD-AC discovered significant less 
categories in total than PD-DN. The correlations between the number of 
trials and the number of categories per test turned out to be extremely 
high (AST: r=-0.94, p<0.0001; SST and WCST: r=-0.93, p<0.0001). The 
negative correlations are quite correct: the more categories and the less 
trials, the better performance), which indicates that the number of trials 
and the number of categories are fairly identical measures. 
Finally, we inspected the Pearson correlations between memory and 
shifting performance. Not one measure of shifting performance proved to 
correlate significantly with the scores on the 15 Words Test. 
Discussion 
In this study we compared PD patients on anticholinergic monotherapy 
Impaired cognitive shifting in PD patients on anticholinergics 125 
and de novo patients on three tests measuring cognitive shifting. The 
clinical status did not differ between the groups. We included some 
reference tests to assess intelligence, attention (maintaining response set) 
and memory. In accordance with several authors (see Introduction), we 
found that - in comparison with de novo patients - patients on anticholi-
nergics had an impaired memory, whereas the two groups did not differ in 
general intelligence and attention. 
The PD patients on anticholinergics showed a poorer performance on all 
tests measuring cognitive shifting than the de novo patients did. Although 
we are aware of the various ways in which performance of card sorting 
tests can be analysed [3,7], we selected the sum of trials and that of 
categories as measures to assess performance of the card-sorting tests, for 
a number of reasons indicated in the section materials and methods. These 
two measures showed extremely high correlations, indicating that they are 
fairly identical. However, the number of trials shows a much larger range 
of measurement than the number of categories, which makes it more 
convenient for future research. 
In this study PD-AC showed a lower performance on all shifting tasks 
than PD-DN. PD-AC needed significantly more trials in two sorting tests 
and discovered significantly less categories in total. Since the patients were 
selected in a way that the clinical status of the two groups was almost 
identical, this difference cannot be attributed to factors which underlied 
the prescription of anticholinergics. Our findings correspond to those of 
Dubois et al. [10], who established that anticholinergics impaired the 
performance on the modified form of WCST. 
As indicated in the Introduction most evidence for cognitive impairment 
by anticholinergics concerns memory. In this study memory scores were 
lower in PD-AC. However, in neither group memory performance correla-
ted with any measure of shifting performance. This suggests that these two 
cognitive functions are independent. 
As a final remark, the primary aim of the present study was to establish 
whether or not de novo patients and patients on anticholinergic monothe-
rapy differ in certain aspects of the cognitive domain. PD patients on anti-
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cholinergic therapy have an impaired cognitive shifting, which is signifi­
cantly more impaired than that in de novo patients. The present data 
suggest, that anticholinergics worsen an already decreased cognitive 
shifting in these patients. This may be added to the evidence that anticho­
linergics also impair memory performance. An additional within subject's 
design will be necessary to provide conclusive evidence in favor of this 
suggestion. Anyhow, the cognitive domain vulnerable to impairment by 
anticholinergic therapy in PD appears to be larger than supposed hitherto, 
a fact that once again cautions against the prescription of anticholinergics 
i n P D . 
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Summary 
Most studies revealing intellectual deficits in myotonic dystrophy (MyD) 
involved heterogeneous groups of patients with respect to intelligence and 
onset of disease. The present study was undertaken to investigate whether 
patients with early adult and adult MyD show subtle cognitive deficits 
despite a normal intelligence. 
We compared 26 MyD patients of normal intelligence with mild 
symptoms and early adult and adult onset to 25 matched control subjects 
(CS) on a range of neuropsychological tests and a number of motor tasks 
of increasing complexity, which required increasing cognitive control. 
The groups did not differ as far as the neuropsychological tests were 
concerned, with the exception of the Stroop Color Word Test. With 
respect to motor performance, the MyD patients were poorer scorers on 
simple and automatic motor tasks than CS, but the difference disappeared 
as the complexity of the tasks increased and required correspondingly 
more cognitive control. 
We found hardly any evidence of cognitive dysfunction in our group of 
MyD patients with early adult and adult onset. 
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Introduction 
Myotonic dystrophy (MyD) is an autosomal dominant multisystem disease 
with a variable clinical expression. The primary genetic defect is an 
increased number of cytosine-thymidine-guanine (CTG) trinucleotide 
repeats in the 3' untranslated sequence of a gene, located at the ql3.3 
band of chromosome 19 [2,11,25]. Expansion of the CTG repeat correlates 
with early onset and severity of MyD [8,11]. The principal symptoms are 
myotonia, slowly progressive weakness and atrophy [26], but, since MyD is 
a multisystem disease and the genetic deficit is present in every cell, symp-
toms and signs arise in several tissues and organs [38]. Cognitive impair-
ment is common in MyD and is often the most disabling component of the 
disease. Most studies in MyD showed mild to severe intellectual deficits 
[6,14,15,34,40,42,43,53,54], but some did not [10,21]. The diversity of these 
findings depends largely on the composition of the group of patients under 
study [28,49], but also on the way in which cognitive functioning was 
assessed. Accordingly, if one intends to investigate cognitive functioning in 
MyD, it is necessary to study homogeneous groups. Furthermore, some 
studies only assess global intelligence, some studies also measure more 
subtle cognitive functions of which impairment may occur in absence of 
diffuse intellectual deterioration. Despite a normal IQ profile, Chang et al., 
[15] did not find any completely normal SPECT in a homogeneous sub-
group of MyD patients with parental inheritance and with early adult and 
adult onset. Thus, it is not at all excluded, that these patients might have 
shown discrete cognitive dysfunctions in a more detailed neuropsychologi-
cal assessment. As far as we know, the study of Franzese et al. [21] is the 
only one which investigated a homogeneous group of patients, but with a 
very restricted test battery, and there are no studies, which investigated 
cognitive functioning in a homogeneous group of MyD patients as well as 
with a broad spectrum of neuropsychological tests. 
The aim of the present study was to investigate whether normal intelli-
gent MyD patients with early adult and adult onset show subtle cognitive 
dysfunction. We compared a homogeneous group of mildly disabled 
patients without mental retardation and with early adult and adult onset 
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MyD and a group of matched control subjects (CS) on a range of neuro-
psychological tests, sensitive to cortical and subcortical dysfunction, and 
motor tasks of increasing complexity, which required correspondingly more 
cognitive control. With respect to the motor tasks: if MyD impairs cogniti-
ve control of motor performance, patients suffering from MyD will show a 
greater drop in performance from simple to complex motor tasks than CS. 
We added a task of shifting motor sequences, which enabled us to diffe-
rentiate between output-specific motor programming and non output-
specific response planning. If performance of MyD patients is significantly 
poorer than that of CS in the shifting condition in comparison with that in 
the two prior conditions, then it seems plausible that there is an additional 
impairment on the level of response planning, being the highest level of 
cognitive control of motor performance. 
If performance of the MyD patients on the neuropsychological tests and 
on the complex and/or shifting motor tasks equals that of CS, there is no 
evidence of subtle cognitive dysfunction in spite of an ubiquitous genetic 
deficit. 
Material and methods 
Subjects 
The patients included in this study are members of kindreds with classical 
myotonic dystrophy according to the diagnostic criteria of Griggs and 
Wood [24]. All patients had an early adult and adult onset, that is an onset 
between the ages of eleven and forty-five years in terms of the criteria of 
Koch et al. [31]. None of the patients had a history of sleep apnoea [9]. 
Patients with non-MyD symptoms, or using drugs, that might interfere with 
test performance, were excluded. Patients with an IQs80, impaired vision 
or hearing and a Karnofsky disability-score <70 [30] were also excluded 
from this study. We used two rating scales to assess muscular disability: the 
Muscular Disability Rating Scale (MDRS) [35] and the scale of the 
Medical Research Council (MRC) [36]. Eventually, twenty-six patients 
participated in this study. All gave informed consent 
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Table 1. Demographic and clinical characteristics of patients suffering from myotonic 
dystrophy (MyD) and control subjects. 
Number 
Ratio male/female 
Age 
Educational level (yrs) 
WAIS-IQ 
Age at onset 
Duration (months) 
Maternal inheritance 
Paternal inheritance 
Inheritance unknown 
Kamofsky score 
MRC sum score 
MDRS 
Dysarthria 
MyD 
26 
13/13 
35.6 (10.3) 
10.2 (3.8) 
107.6 (18.3) 
24.8 (8.9) 
121.1 (102.5) 
7 (26%) 
14 (54%) 
5 (19%) 
83.8 (9.4) 
51 (5.2) 
2.9 (0.6) 
18 (70%) 
MRC : Medical Research Council Scale 
MDRS : Muscular Duability Rating Scale 
CS 
24 
9/15 
38.3 (10.3) 
9.5 (3.4) 
110.9 (15.1) 
Seven patients had maternal, and fourteen had paternal inheritance. In 
five patients inheritance was unknown. All patients scored below the cut-
off score of the Zung depression scale [55]. A sample of 24 healthy control 
subjects (CS), matched for age, IQ and educational level, was obtained 
from relatives and hospital employees. Neurological screening of the CS 
did not reveal any indication of neurological disease or trauma. None of 
the CS was taking drugs. Table 1 summarizes some demographic and 
clinical data. 
Methods 
We selected neuropsychological tests which assess a broad spectrum of 
cognitive functions, such as memory, maintaining set, visuospatial scanning, 
fluency and executive function, besides global intelligence. Impaired 
executive functions are extensively documented in frontal lobe dysfunction, 
but also in diseases with subcortical degeneration [1], such as Parkinson's 
disease [16,17,50], Huntington's disease [3,13,48], supranuclear palsy [37] 
138 Chapter 6 
and multiple system atrophy [45]. 
To assess intelligence we made a valid and reliable selection of four 
subtests from the revised Wechsler Adult Intelligence Scale [18]: vocabula­
ry and similarities, measuring verbal intelligence, and picture completion 
and block design, measuring visuoperceptual intelligence. Memory was 
assessed by means of the California Verbal Learning Test [19]. We selec­
ted the CVLT, because this test provides not only a measure of the 
amount of information that a subject is able to remember, but also a multi-
factor framework for quantifying his learning strategies. Test protocols 
were scored using the IBM-PC California Verbal Learning Test scoring 
program [22]. Score was the total number of words recalled over the five 
trials. The semantic and serial cluster ratio reflected the semantic and 
serial clustering tendency respectively, both being learning strategies. It 
was obtained by dividing the observed cluster score (i.e. the total number 
of semantically clustered words) by the cluster score expected by chance. A 
decrease of semantic clustering [12,51] and an increase of serial clustering 
[12] are established in Parkinson's disease, and might therefore be linked 
with subcortical dysfunction. We included a variety of tests measuring 
executive functions [32]. The Stroop Color Word Test involves the ability 
to inhibit a well-rehearsed response in favour of a counter-intuitive one 
[29]. Score was the time in seconds needed by a subject for each card. The 
score of interference was calculated by subtracting the score of card В 
from that of card C, thus extracting speed of performance. The Trail 
Making Test (TMT) assesses alternation of set [44]. The score was the 
time difference between Section A and В (B-Α). This removed the effect 
of motor speed from performance. The Verbal Fluency test (VFT) requi­
red the subjects to enumerate as many animals as possible during one 
minute. The score was the number of items generated. The Wisconsin 
Card Sorting Test [5] is a categorization test. In this test the subject began 
to sort on the basis of trial and error according to a criterion that was only 
known to the experimenter. A false response was corrected by the experi­
menter. After a fixed number of correct responses the experimenter 
changed the criterion twice without informing the subject. In order to 
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exclude biasing differences in speed of information processing there were 
no time constraints. Performance was reflected in the number of categories 
the subject discovered [7] and the total number of trials he needed [52]. 
We presented a range of motor tasks to be performed by each hand 
separately [16,41]. For these tests, keyboards were constructed with four 
push-buttons. Measurement of pushes was computerized. Before starting 
the motor tasks the patients were asked to clench their hands as often as 
they needed to get rid of stiffness. Motor ability was assessed in a number 
of tasks of increasing complexity. The first was classical diadochokinesis of 
each hand separately. The other tasks were finger tapping tasks of increa-
sing complexity. In the first three tasks, the subjects had to press one push-
button with the index finger as fast as possible for a period of 5 s. Then 
they had to press all push-buttons with the index finger. Next, they had to 
place the four fingers on the buttons and to push the buttons in a random 
sequence for 10 s. In the following series complexity with respect to 
response planning and motor programming increased [39,46,47]. The sub-
jects had to press the push-buttons in a fixed sequence of increasing 
complexity, firstly, index finger - middle finger - ring finger - little finger; 
next, index finger - ring finger - middle finger - little finger; and finally, 
they had to shift from the first and simple sequence to the second and 
more complex one. The following scores were computed: the total number 
of pushes in each task; the total number of correct successive pushes in the 
shifting task (a push was counted as correct when it was preceded or 
followed by the correct push as defined in the sequence). 
Results 
Table 2 summarizes means, standard deviations and t tests of the neuro-
psychological test scores. The groups of patients and CS were matched for 
intelligence. 
Globally, the MyD patients did perform as well as the CS on all tests. 
With respect to the CVLT we also tested whether the learning perfor-
mance of the MyD patients and that of CS differed over the five trials. 
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Table 2. Means and standard deviations of neuropsychological test scores: 
level of significance L· associated with t values. 
CVLT 
first shopping list: 
immediate recall 
semantic ratio 
second shopping list: 
immediate recall 
first shopping list: 
short term free recall 
short term cued recall 
long term free recall 
long term cued recall 
Stroop A 
Stroop В 
Stroop С 
Stroop С-В 
Т М Т А 
ТМТВ 
ТМТВ-А 
Verbal fluency 
WCST sum categories 
WCST sum trials 
MyD 
(n=26) 
Mean 
57.64 
1.95 
8.14 
11.90 
13.27 
13.18 
13.45 
49.48 
64.64 
115.48 
50.80 
38.92 
93.50 
54.00 
19.54 
3.73 
22.00 
sd 
10.52 
0.74 
2.60 
3.10 
2.91 
2.86 
2.63 
10.03 
11.56 
21.48 
13.40 
17.18 
37.60 
22.61 
4.63 
0.45 
13.93 
CS 
(n= 
Mean 
60.06 
2.18 
7.61 
12.98 
13.94 
13.78 
14.06 
42.88 
54.79 
90.58 
35.79 
32.86 
77.43 
44.57 
22.13 
3.79 
21.21 
24) 
sd 
8.68 
0.72 
2.30 
2.27 
1.77 
2.07 
1.77 
8.13 
10.08 
19.70 
12.63 
14.91 
35.90 
26.08 
5.47 
5.47 
13.61 
significance 
oft 
Ρ 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
<0.05 
< 0.005 
< 0.0001 
< 0.0005 
ns 
ns 
ns 
ns 
ns 
ns 
A MANOVA test revealed that there was no group χ trial interaction: 
F=1.33 (ns). There were no significant differences between the groups 
with respect to the semantic and serial cluster ratios. Thus, we did not find 
any indication of cognitive impairment, with the exception of the Stroop 
Color Word Test. Even after correction for speed of performance by 
subtracting time of performance of the simple Card В from that of the 
complex card C, the scores of the MyD patients remained significantly 
higher than those of CS. Table 3 summarizes means, standard deviations 
and t tests of the motor scores. 
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Table 3. Means and standard deviations of motor scores: 
level of significance L· associated with t values. 
diadochokinesis DH 
diadochokinesis NDH 
Tapping tasks: 
index one button DH 
index one button NDH 
index four buttons DH 
index four buttons NDH 
free sequence DH 
free sequence NDH 
1-2-3-4 DH 
1-2-3-4 NDH 
1-3-2-4 DH 
1-3-2-4 NDH 
Shifting tasks: 
1-2-3-4 DH total 
1-2-3-4 NDH total 
1-2-3-4 DH correct 
1-2-3-4 NDH correct 
1-3-2-4 DH total 
1-3-2-4 NDH total 
1-3-2-4 DH correct 
1-3-2-4 NDH correct 
DH: dominant hand 
NDH: non-dominant hand 
MyD 
(n=26) 
Mean 
11.8 
10.9 
21.9 
19.8 
9.1 
8.7 
24.6 
23.2 
21.9 
21.3 
17.5 
17.8 
20.6 
21.5 
18.8 
19.3 
17.6 
16.6 
14.6 
12.8 
sd 
4.6 
4.8 
6.3 
5.6 
3.5 
3.8 
9.1 
7.9 
7.9 
8.0 
6.7 
8.4 
7.7 
7.3 
8.6 
6.3 
7.9 
7.9 
7.1 
7.9 
CS 
(n= 
Mean 
16.7 
16.0 
25.5 
23.9 
12.6 
12.4 
37.5 
29.7 
29.3 
27.1 
19.4 
18.5 
27.0 
26.1 
20.7 
19.8 
19.5 
18.5 
15.3 
13.0 
total: total number 
correct: number of 
=24) 
sd 
2.7 
3.1 
4.0 
3.4 
6.0 
5.0 
20.1 
10.2 
9.7 
8.6 
7.9 
8.2 
8.2 
8.3 
9.2 
9.1 
7.6 
9.0 
6.5 
9.0 
of pushes 
significance 
oft 
Ρ 
< 0.0005 
<0.0005 
<0.05 
<0.01 
<0.05 
<0.01 
<0.05 
<0.05 
<0.01 
<0.05 
ns 
ns 
<0.05 
ns 
ns 
ns 
ns 
ns 
ns 
ns 
correct pushes 
MyD patients showed a significantly poorer performance on simple motor 
tasks. However, the difference between the groups decreased on more 
complex tasks, which required increasingly cognitive control. In the most 
complex task, i.e. the shifting task, the difference between MyD patients 
and CS has disappeared. 
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Discussion 
The purpose of the present study was to investigate whether a group of 
patients with early adult and adult onset MyD show subtle cognitive dys-
function despite a normal intelligence. We compared the neuropsycholo-
gical performance of these patients with that of matched CS. The MyD 
patients and CS did not differ in performance on these tests, with the 
exception of the Stroop Color Word Test. Our results with respect to 
global intelligence are not in accordance with studies, which did not 
exclude patients with infantile and juvenile MyD [6,14,28,34,40,42,43,53,54], 
but are fully in agreement with the study of Franzese et al. [21], as far as 
we know the only study that involved only early adult and adult onset 
patients. In the latter study, fully normal IQ-scores are reported. Many 
studies [6,14,15,31,42] revealed more cognitive impairment in patients with 
maternal inheritance than in patients with paternal inheritance. In the 
present study, patients with maternal inheritance (n=7) showed a poorer 
performance overall than the patients with paternal inheritance (n=14), 
but the difference was only significant in the immediate recall of the 
second shopping list of the CVLT. The lack of significance might be due to 
sample sizes. 
Although we did not include a separate test to assess visuospatial 
abilities, we have no indication that our Myd patients are disabled in this 
respect, because the block design scores (WAIS-R) did not differentiate 
between MyD patients (mean=14.2; sd=5.9) and CS (mean=16.4; sd=6.6). 
Some authors [10,34,] found visuospatial and constructional disabilities, 
suggesting greater right hemisphere dysfunction in MyD, but this hypothe-
sis is not supported by the finding in the same studies and in ours, that 
there are no significant differences in motor performance between the 
right and left hand. Thus, in the motor domain there is no corresponding 
finding, which indicates right hemisphere dysfunction in MyD. In a hetero-
geneous group of 22 MyD patients, Chang et al. [15] found significant 
correlations between right hemisphere perfusion and visuospatial skills 
(Hooper Test, Visual Reproduction), but also between left temporo-
parietal perfusion and Performance-IQ, a measure which also reflects 
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visuospatial skills. Thus, an exclusive relationship between right hemisphe­
re dysfunction and visuospatial or constructional impairments in MyD is 
uncertain. An overall reduction of speed itself might also account for 
poorer performance of MyD patients in visuospatial tasks. 
With regard to the Stroop Color Word Test, MyD patients had signifi­
cantly poorer scores on all cards. Nevertheless, they scored better than the 
patients in the study of Broughton [9]. Our patients also scored better than 
the MyD patients and CS in the study of Stuss et al. [49], but the CS in 
that study, who were matched with MyD patients for intelligence, showed a 
dull normal mean IQ (WAIS-R)=87.1. However, the subgroup of late 
onset MyD patients in that study produced only slightly poorer scores than 
our patients. Apparently, the distinct findings are due to the composition 
of the groups under study. The results of the present study emphasize the 
necessity to have homogeneous groups. The selective poor performance of 
MyD patients with respect to the Stroop Color Word Test is not easy to 
interpret. This test is based on a conflicting response paradigm [20]: the 
first and most automatic response is reading words (Card A), the second 
response is simple, but less automated: naming colours (card B). Finally, in 
Card С the subject is required to suppress the automatic response (reading 
words) in favour of the less automated response (naming colours). Since 
our MyD patients produced poorer scores on all cards, a retardation of 
information processing is plausible. Our MyD patients were also slower 
than CS in the TMT, but this difference did not reach significance. Since 
the correlation of the Stroop scores and the TMT scores of the MyD 
patients was not significant (r=0.34), performance of these tests seems to 
be independent and does not indicate fronto-subcortical dysfunction [17]. 
Since the Stroop performance of our MyD patients worsened, as the 
complexity of the task increased, they appear to be sensitive to response 
interference. However, our data also allow a different interpretation. In 
the majority of our MyD patients (see Table 1), dysarthria was already 
clinically established during normal speaking. Because of this - MyD 
coupled - dysarthria [26], speaking aloud and as fast as possible, is a more 
effort demanding task for MyD patients than for CS, which is reflected in 
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the significant lower scores on cards A and B. Therefore, it seems plausi­
ble, that in the case of MyD patients, simultaneously speaking fast and 
reading the difficult card С required a dual task performance. Previous 
research has shown that performance of the Stroop Color Word Test 
significantly affects the performance of a concurrent motor task, viz. 
control of balance after lower limb amputation in normal subjects [23]. 
Further research will be needed, involving a test of the Stroop paradigm, 
but without an appeal to fluently speaking. Anyhow, in our view the lower 
performance of the Stroop Color Word Test does not necessarily imply a 
central cognitive deficit, but may also be due to a peripheral defect. 
We also presented a number of motor tasks of increasing complexity, 
which required correspondingly more cognitive control. The scores of all 
motor tasks showed very low correlations with any disease variable or 
rating scale. This last finding is not surprising, since both the MRC-scale 
and MDRS assess muscular weakness, a disease characteristic, which 
played a minor part in our motor tasks. The MyD patients produced sig­
nificantly poorer scores than the CS on simple tasks. The difference bet­
ween the groups reached the highest significance in diadochokinesis, being 
the most automatic one in our series. The difference between the groups 
disappeared in tasks in which performance depends less on speed of motor 
execution, but more on response planning and motor programming, i.e. 
cognitive control. Since we did not find any significant correlation between 
simple motor performance and the Stroop scores, the significant group 
differences in simple motor tasks cannot be attributed to the significant 
differences in Stroop performance between the groups. Simple nor 
complex motor performance showed any significant correlation with the 
dysarthria scores which we obtained from 15 of our MyD patients within 
the scope of another study of ours [33]. Complex motor sequence perfor­
mance is known to deteriorate in diseases with central programming 
deficits, such as Parkinson's disease [4,16,27]. Our results indicate that the 
cognitive control of motor performance is not impaired in MyD. Our fin­
dings lead us to conclude that MyD patients with mild symptoms, normal 
intelligence, and early adult and adult onset show no cognitive dysfunction. 
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In tum, this indicates that in this group of patients there is no evidence of 
brain dysfunction, such in spite of an ubiquitous genetic deficit 
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SELF-GENERATED PROBLEM SOLVING 
IN PATIENTS WITH MYOTONIC DYSTROPHY: 
A COMPARISON WITH PATIENTS WITH PARKINSON'S DISEASE 
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Introduction 
In many studies, it has been shown that PD patients are impaired in self-
generated problem solving. Among tests which assess self-generated 
problem solving, card-sorting tests, especially the Wisconsin Card Sorting 
Test (WCST) [4,11,24,37] are prominent, but it is unclear whether an 
impaired performance on card-sorting is specific to PD. Although the 
WCST was originally developed to assess mental flexibility in normal 
subjects [18], it gained later the reputation to detect frontal lobe 
dysfunction [29,30]. Accordingly, poor performance of PD patients on the 
WCST was interpreted in terms of frontal lobe dysfunction [37]. However, 
Anderson et al. [2] found that the WCST lacks specificity as a measure of 
frontal lobe damage. Pillon et al. [34] were not able to establish specific 
features of WCST performance in cortical and subcortical diseases, such as 
Alzheimer's, Huntington's, Parkinson's disease, and progressive supra-
nuclear palsy. There is more evidence for lack of specificity. Heinrichs [21] 
found poor WCST performance in the majority of patients with cerebral 
diseases in general (i.e. with or without frontal involvement), with 
schizophrenia and with mood disorders. He also established a deteriorating 
effect of hospitalization on WCST performance. Braff et al. [5] and 
Goldman et al. [17] also established poor WCST performance in 
schizophrenia, and Sullivan et al. [36] in schizophrenia and chronic 
alcoholism. Ozonoff et al. [31] found that autistic children and adolescents 
were highly deficient on the WCST relative to controls. Apparently, an 
impairment on the WCST is widespread and not at all specific to PD. In 
our opinion, this lack of specificity may be due to the fact that the current 
scores of the WCST are overall scores [20], although the test is constructed 
in distinct phases. In a recent study [40], we established that the overall 
test performance of a mildly disabled group of PD patients on card-sorting 
tests did not differ from that of CS, but that impaired performance of PD 
patients proved to be restricted to the first shifting phase after correction 
for performance in the acquisition phase. In the acquisition phase and in 
the second shifting phase, PD patients and CS did not differ. 
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In the present study, we analysed the performance of patients with early 
adult and adult onset myotonic dystrophy (MyD) in order to compare the 
outcome with that of a similar analysis in PD patients. MyD is an 
interesting disease to compare with PD. The clinical picture of MyD shows 
several traits, which are usually summarized under the heading 'subcortical 
dementia' [1,12], such as slowed motor speed, slowed cognitive processing 
time [19,32], dysarthria [19,26,27], and depression [6,32]. More in detail, 
several studies in MyD patients [6,8,32,41] found poor performance of the 
WCST, a frequently established finding in subcortical dementia. Huber et 
al. [22] explicitly stated that the pattern of their findings in MyD patients 
was reminiscent of that associated with subcortical dementia. However, 
MyD is a disease of which the pathogenesis is quite different from that of 
PD. Although studies involving magnetic resonance imaging [9,14,16], 
evoked potentials [33,35], single photon emission computed tomography [9] 
or positron emission tomography [28] indicated a high incidence of 
cerebral involvement, they did not show the anatomical or fysiological 
deficits of striatal areas, which are characteristic for PD. 
The MyD patients and PD patients, involved in the present thesis 
showed an average or above average global intelligence [39,40]. If self-
generated problem solving is specific for PD, MyD patients will not show 
the impaired performance of first shifting phase after correction of the 
acquisition. Previously [39], we had already found that MyD patients do 
not show the pattern of an impaired self-generated problem solving in the 
California Verbal Learning Test (CVLT) [15], which we had found to 
occur in PD patients [7]. 
Material and methods 
Subjects 
The group of MyD patients was matched with a group of control subjects 
(CS) for age and IQ; the same holds true for the group of PD patients. 
For demographical and clinical data of the four groups (MyD vs CS; PD vs 
CS) we refer to the original publications [39,40]. Both groups of patients 
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did not differ with respect to overall performance on the three card-sorting 
tests involved in this study. Since phase-wise shifting performance can only 
be assessed correctly in subjects who are able to achieve the acquisition 
phase [11,40], all subjects who were unable to achieve the acquisition 
phase of any card sorting test were excluded. From the pool of MyD 
patients 3 patients were excluded, and no one from the corresponding CS. 
From the pool of 71 PD patients, 6 patients were excluded, and 8 subjects 
from the corresponding group of 32 CS. Since we have found evidence that 
anticholinergic therapy deteriorates performance of PD patients on card 
sorting tests [38], PD patients on anticholinergic therapy (n=14) were also 
excluded. 
Tests 
In order to assess intelligence, memory and attention we included a series 
of reference tests in our battery. We selected four subtests from the Dutch 
adaptation of the WAIS-R to exclude biasing differences in intelligence 
between both groups, and to exclude general mental deterioration: 
vocabulary and similarities, measuring verbal intelligence, picture 
completion and block design, measuring visuoperceptual intelligence [13]. 
In MyD patients, memory was assessed by means of the California Verbal 
Learning Test [15], a test which provides not only a measure of the amount 
of information that a subject is able to remember, but also a multi-factor 
framework for quantifying his learning strategies. In the group of PD 
patients, of which the performance of the card-sorting tests was analysed 
phase-wise, memory was assessed by means of the Dutch adaptation of the 
Rey Auditory Verbal Learning Test [25]. Attention was assessed with the 
Stroop Color-Word Test [23]. 
We presented the WCST and two card sorting tasks of the WCST 
format: the Animals Sorting Test and the Spatial Sorting Test. After the 
acquisition phase, in which basis concept formation was assessed, there 
were two unannounced shifts to a category, which had been irrelevant in 
the preceding phase. Material and scoring procedures of these tests are 
extensively described elsewhere [39,40]. 
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Table 1. Test results. 
SS acquisition 
SS first shift 
SS second shift 
CSS first shift 
CSS second shift 
MyD patients 
(n-24) 
mean sd 
14.2 (12.8) 
33.2 (22.9) 
36.7 (20.9) 
19.9 (28.5) 
23.4 (22.3) 
CS 
(n=23) 
mean 
15.2 
27.5 
39.0 
12.9 
24.4 
sd 
(14.1) 
(16.9) 
(25.2) 
(21.5) 
(28.1) 
PD patients 
(n=51) 
mean sd 
5.2 (5.4) 
31.7 (23.6) 
38.8 (23.9) 
26.5 (23.0) 
33.7 (23.5) 
CS 
(n-24) 
mean sd 
6.0 (6.8) 
21.6 (18.1)* 
36.6 (26.6) 
15.6 (17.6)# 
29.6 (28.6) 
SS = standardized sum of trials transformed into percentage of the 
maximum number of trials 
CSS first shift = SS first shift corrected for acquisition performance 
CSS second shift = SS second shift corrected for acquisition performance 
* :p<0.10 
# :p<0.05 
Results 
Both the MyD patients and the PD patients did not differ from their 
respective CS as far as intelligence and memory are concerned. MyD 
patients were impaired on the Stroop Color Word Test, PD patients not. 
Table 1 summarizes means, standard deviations and t tests (two-tailed) 
of the standardized sum scores of the acquisition phase, the first and 
second phase, and the difference scores between the first shifting phase 
and the acquistion, and between the second phase and the acquisition. 
After correction for the acquisition, MyD patients and CS did not differ 
in the first shifting phase, in contrast to PD patients which differed from 
their CS in this respect. 
Discussion 
The aim of the present study was to answer the question whether or not 
the pattern of phase-wise performance of PD patients is also present in 
patients with early adult and adult MyD. The results indicate that MyD 
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patients did not show a decrease in performance on the acquisition 
corrected first shifting phase. In contrast, the PD patients showed an 
impaired performance in this respect, viz. a finding confirming our 
previous findings [10]. This difference between PD and MyD patients can 
not be attributed to differences in performance of tests, assessing 
intelligence, memory or attention, because the only significant difference 
on these tests, being the poor performance of MyD patients on the Stroop 
Color word Test in MyD, did not result in a poor performance on card-
sorting tests. 
As indicated in the Heaton manual [20], young and old subjects score in 
approximately the same way on the WCST, and also in the acquisition 
phase in particular. The fact that the standardized sum scores of the older 
subjects on the acquisition are lower than those of the younger subjects in 
the present study is only seemingly in contrast with this finding. The 
Heaton manual does not provide a rule for breaking off the test. In our 
study, more older than younger subjects had to be excluded because they 
were not able to achieve the acquisition. However, before this exclusion, 
the scores of the original sample groups did not differ significantly. 
In view of our previous studies in MyD and in PD [7,10,40], which allow 
a broader comparison of cognitive function in PD and MyD than the 
present one, it becomes clear that the cognitive profiles of PD and MyD 
are different, especially with respect to functions involved in self-directed 
task planning, which are at risk in PD, such as cognitive shifting, semantic 
organization in memory tasks and sequential motor performance. 
In Table 2 similarities and differences between PD patients and CS, and 
between MyD patients and CS are summarized. 
The present findings show that an impaired self-generated problem 
solving, as reflected in a decreased performance of the first shifting phase 
after correction for the performance in the acquisition phase, is not a 
common characteristic of diseases, of which the clinical picture is 
frequently described in terms of the subcortical dementia syndrome: MyD 
patients did not show the pattern of phase-wise card-sorting performance 
which we established in PD. 
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Table 2. Differential patterns of test 
Stroop 
C-B 
PDvsCS 
MyD vs CS 
CVLT CVLT SS 
sem ser Acq 
ratio ratio 
+ 
CCS 
first 
shift 
_ 
performance. 
CCS 
second 
shift 
= 
Simple 
motor 
perf 
-
Seq 
motor 
perf 
_ 
CVLT = California Verbal Learning Test 
sem ratio = semantical ratio 
ser ratio = serial ratio 
SS = standardized sum of trials transformed into percentage of the maximum 
number of triaL· 
Acq = acqubition performance card-sorting tests 
CSS first shift = SS first shift corrected for acquisition performance 
CSS second shift = SS second shift corrected for acquisition performance 
Seq motor performance = sequential motor performance 
One might wonder whether or not this difference reflects the involvement 
of striatal areas, which is present in PD and absent in MyD. We have a 
strong indication that this involvement is crucial: in a previous study [3], 
we found that patients suffering from spasmodic torticollis, being a disease 
without evidence of striatal involvement, just like MyD patients, did not 
show a decreased card-sorting performance in the first shifting phase. 
However, after administration of haloperidol, a drug known to diminish the 
dopaminergic activity in the striatal areas, we were able to provoke the 
impaired self-generated problem solving under discussion. These data 
taken together provide support in favor of the hypothesis that the noted 
impairment has a relatively high degree of specificity for striatal disorders. 
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Summary 
Although striking and pervasive failure of social understanding is common-
ly viewed as a major defining characteristic of people with autism, few 
follow-up reports were published that have focused on improvement of 
social intelligence. In this prospective study in which 17 high-functioning 
adolescents with autism were involved, cognitive shifting as measured by 
card sorting tests, unlike overall intelligence, was shown to be the only 
significant factor in predicting progress in social understanding as assessed 
by social comprehension tests. A pretest-posttest design was used. During 
the 2-year follow-up all the subjects were in residential care and enrolled 
in educational curricula focusing on the development of social intelligence, 
living and vocational skills. 
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Introduction 
Of the various cognitive deficits associated with autism, impaired social 
intelligence, as assessed by social comprehension tests, is a consistently 
reported finding. Even high-functioning autistic subjects show dramatically 
reduced scores in a variety of measures of their understanding of social 
situations [11,20,23,28,30,31]. In a stepwise discriminant analysis Rumsey 
and Hamburger [30] selected the Binet Problem Situations score as the 
best variable for discriminating autistic subjects and age- and education-
matched controls; in Sattler's classification scheme [33] this powerful 
discriminator is presented as a test reflecting social intelligence. In contras-
ting the Wechsler profiles of autistic, dyslexic and control subjects the 
same authors [30,31] showed seriously deficient performance in the autistic 
group, especially, on the Comprehension and Picture Arrangement sub-
tests. It was exactly the combination of these two subtests that was classi-
fied by Kaufman [16] as a measure of social judgement or common sense. 
Baron-Cohen, Leslie and Frith [1] have found that the social cognition 
ability of retarded autistic children to infer the mental states of others is 
deficient, whereas most mentally retarded and normal controls of lower 
mental age were able to do so with facility [18]. Similarly, Ozonoff, Pen-
nington and Rogers [26] reported that their nonretarded autistic group 
performed significantly less well than the matched controls in the domain 
of social cognition as described by Baron-Cohen and colleagues. 
Striking and pervasive deficits in social intelligence are characteristic of 
autism. However, to our knowledge there are few follow-up reports 
concerning autism that have focused on improvement of social intelligence 
as a treatment outcome. In the field of cognition, verbal and visuopercep-
tual intelligence as well as linguistic abilities have been used in order to 
assess the effect of treatment on autism. And these variables have, indeed, 
repeatedly been shown to be stable with time. In spite of well developed, 
highly structured, educational programs, verbal and visuoperceptual IQ 
scores rarely increase with age in autistic individuals [9,10,29]. In accordan-
ce with these findings, we established in our follow-up study on 25 high-
level adolescents with autism, that only 4 subjects had achieved significant 
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improvement in verbal intelligence after over 3 years of specialized resi-
dential training [2]. However, by applying social comprehension tests, no 
less than 15 treated subjects obtained significant gain scores. 
Our attempts at that time to identify predictive indicators were rather 
less successful. It was surprising that only a negligible part of the variance 
in outcome was accounted for by markers such as symptom severity, social 
class, and intellectual functioning. All we could refer to as a prognostic 
variable was whether or not the subjects had been treated: the group who 
underwent treatment (n=25) had considerably better progress in social 
understanding than the group without treatment (n=12, consisting of age-
and intelligence-matched autistic subjects on a waiting list; none of these 
12 subjects obtained significant gain scores). Any treatment whatsoever is 
positively correlated with outcome [43]. Generally, IQ and language level 
are considered important prognostic markers in the outcome of autistic 
children. However, at higher levels of functioning there is no clear-cut 
relationship between these variables and later achievements [12]. In autism 
the relationship between IQ and progress in social understanding is appa-
rently not linear: although normal or high IQ is not a sufficient condition 
for better outcome, it is a necessary condition. 
The present study addresses the question whether or not cognitive 
shifting may be considered as an indicator of prognosis. The follow-up 
literature on high-level autism suggests that, almost invariably, autistic 
subjects are left with serious social impairments [34]. During remedial 
efforts focused on the development of social awareness, autistic persons 
may acquire considerable social knowledge. Unfortunately, such informati-
on usually remains rather academic and appears to be overridden by rigid 
mental sets. Despite treatment, many autistic persons persistently fail to 
develop strategies for adapting to continually changing social contingen-
cies. Their rigidity makes it hard for them to adjust to new circumstances. 
They become distressed over trivial changes in the environment. They are 
inclined to be overrestrictive in their use of available cues. Their perseve-
rance with the wrong response is striking; they do not shift away from 
ineffective problem-solving strategies [27,32]. Accordingly, they function 
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most appropriately in steady and highly structured situations [21,40]. The 
adverse effects that this overselectivity has on the generalization of learned 
behaviours are well known. Individuals with autism often seem to lack the 
ability to rearrange learned behaviour into self-generated behaviour. These 
findings raise the possibility that cognitive shifting may be a relevant factor 
in predicting progress in social intelligence. 
Impaired cognitive shifting is a familiar notion in the literature concer-
ning deterioration due to either lesions in cortical areas projecting to the 
basal ganglia or lesions in the basal ganglia themselves. These cerebral 
areas are thought to be part of a system that is involved in planning and 
modulating ongoing activity in the absence of external guidance. Patients 
suffering from lesions in this system consistently show a failure in shifting 
problem solving strategies when they have to rely on internal control 
[4,5,17,19]. Since Maurer and Damasio [24] indicated that the behavioural 
manifestations of autism correlate best with those of cortico-striatal dys-
function, the construct cognitive shifting appears more and more in the 
field of autism research. Several recent investigations have documented 
cognitive shifting deficits in autism and have suggested that these deficits 
may be mediated by cortico-striatal dysfunctioning [13,26,27,29-31]. Howe-
ver, with regard to cognitive shifting as a potential predictive marker, our 
search in the literature yielded few available data. Only Szatmari et al. [34] 
reported that performance on a cognitive shifting task was among the most 
sensitive predictors of outcome in a group of high-functioning autistic 
children. Their study, however, was not a prospective one: correlations 
were performed using simultaneous scores on predictor and outcome 
measures. 
The objective of this prospective study is (a) to measure the progress in 
social understanding - as assessed by social comprehension tests used in a 
pretest-posttest design - of high-functioning, residentially treated subjects 
with autism; and (b) to evaluate the role of IQ and cognitive shifting in 
predicting that progress. 
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Method 
Subjects 
Seventeen high-functioning subjects with autism were recruited from the 
"Dr. Leo Kanner Huis", the only residential unit in the Netherlands serving 
autistic patients exclusively. The age range of the 14 males and 3 females 
was 16 to 25 years; mean age was 18.9 (sd=2.2). 
All of the individuals were separately diagnosed by a clinical 
psychologist and a psychiatrist according to the full diagnostic criteria for 
autistic disorder, described in DSM III-R. Information upon which the 
diagnosis was based included a review of medical records, face-to-face 
interviews, and interviews with parents. For inclusion in this study, both 
diagnosticians had to agree on the diagnosis of autism. 
Only autistic subjects with normal or near-normal scores on IQ 
measures were included in the design: first, to exclude the subjects who 
might not understand the test instructions; second, to provide a better 
opportunity to delineate impairments that are specific to autism rather 
than mental retardation. The mean verbal IQ, prorated from Vocabulary 
and Similarities of the WAIS-R, was 97.6 (sd=18.5); the mean visuoper-
ceptual IQ, prorated from Block Design of the WAIS-R and Form Board 
of the GIT - a Dutch test similar to Visualization 1 in the manual for kit of 
factor-referenced cognitive tests [7] - was 117.9 (sd=16.1). As a minimum 
condition the subject had to have an IQ score over 85 based on these four 
measures. 
None of the subjects had any known infectious, metabolic or neurolo-
gical disease or sensory impairments that might affect test performance, 
nor were any of them currently taking medication. 
All the subjects were in residential care due to their striking deficits in 
social intelligence and their extremely inadequate living and working skills. 
They could not or could hardly take care of their daily needs, could not 
cope with time or money, had not mastered any trade, and could not fill 
their leisure time in a conventional way. They hardly ever asked about 
treatment and projected a disconcertingly naive image of themselves and 
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others. A striking case in point was the following answer to the question 
about how subject's life will be in the future: "I am going to live by myself 
in a form of housing in the shape of a sphere ... I will manage because I 
can already prepare macaroni and Mexican pancakes". 
Apart from the low incidence of autism, the criteria for inclusion of 
high-level autistic adolescents limited the number of subjects to be inves-
tigated in this study which per se does not deviate from the average 
number of patients included in comparable studies [23,31,34]. 
All subjects and their parents gave informed consent. 
Measures 
A neuropsychological test battery was administered to these 17 autistic 
subjects individually, in three sessions according to a fixed order. Included 
were tests of verbal, visuoperceptual, and social intelligence (each function 
represented by two variables), cognitive shifting (three variables) and the 
ability to attend selectively (one variable). These measures are, for the 
most part, commonly used clinical tests with standard procedures for 
administration and scoring. 
All of the testing was done by a clinical psychologist (P. W. J. M. Lam-
mers) who was experienced in the administration of the tests. This psycho-
logist was blind to the purpose of the study. All of the protocols were 
separately examined for accuracy by two individuals. The tests were carried 
out in a quiet, well-illuminated room. The duration of the testing session 
never exceeded 1 hour. 
There was a 1-week interval between the first and second sessions, these 
constituting the pretest, and a 2-year interval between the pretest and the 
third session, the posttest. 
In the first session the following five measures were administered: 
- WAIS Vocabulary, representing verbal intelligence; 
- Stroop Color-Word Test: this test has been developed to assess the 
ability to maintain one mode of response against a competing alternati-
ve mode, that is the equivalent of selective attention or maintaining sets 
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[15,37]; 
- WAIS Block Design, representing visuoperceptual intelligence; 
- WAIS Picture Arrangement. Wechsler suggests that this test shows the 
subject's ability to comprehend and size up a total situation and that, as 
all the stories concern human activities, it may be a measure of social 
intelligence [42]. Picture Arrangement is reputed to be a WAIS subtest 
that has little in common with the prominent WAIS factors verbal and 
visuoperceptual intelligence [19]. To further assess the construct validity 
of the WAIS subtests in a sample of 33 high functioning autistic 
children and adolescents, a principal component analysis with a varimax 
rotation was performed by Lincoln et al. [20]. In their analysis Picture 
Arrangement loaded most heavily on the factor referred to as 
comprehension of social and context-relevant information. Accordingly, 
we included this test for measuring social intelligence. 
- Spatial Card Sorting, representing cognitive shifting [3]. By analogy with 
the Wisconsin Card Sorting Test, three series of 20 response cards were 
designed, depicting circle/square figures that differed in some spatial 
dimensions: (identical vs. reversal, side by side vs. one below the other, 
circle and square separated vs. contiguous). Subjects had to assign the 
response cards to one of two stimulus cards depicting figures which 
differed from each other in these three dimensions. Stimulus card 1 
showed two identical, columned figures in which circle and square were 
separated. Stimulus card 2 showed two reversal figures placed side by 
side in which circle and square were contiguous. See Figure 1. First, 
subjects had to match "identical vs. reversal", the acquisition phase; then 
- always after seven correct answers and without warning by the exami-
ner - "side by side vs. one below the other"; and finally "separated vs. 
contiguous", thus there were two shift phases. The instructions given to 
the subjects were as follows: "I am going to show you several figures one 
at a time. Each of them matches one of these two figures (indicating the 
stimulus cards). I want you to sort these cards (indicating the response 
cards) by placing them below the figure you think they fit best. I shall 
tell you whether your choice is right or wrong". 
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Figure 1. Spatial Sorting Test 
To minimize the impact of memory, the correct (or corrected) matchings 
were placed in order under the appropriate stimulus cards. The score 
was the total number of trials preceding seven correct answers to the 
consecutive criteria in the acquisition and shift phases. The greater the 
number of trials, the lower the level of performance. The score was 
expressed in percentages: number of required trials divided by the 
maximum number of trials. 
As argued in a previous report on cognitive shifting [3], we did not add an 
analysis of card sorting performance in terms of perseverative and nonper-
severative error pattern. The classification in perseverative and nonper-
severative errors is formally correct, but actually rather interpretative, since 
it is not allowed to ask the subject why he has decided on this particular 
assignment. So correct shifting can only be assessed conclusively after a 
number of correct trials in succession. The same holds true for persevera-
tion. Moreover, the presence of ambiguous response cards prevents an 
unequivocal distinction between perseverative and nonperseverative errors. 
In our opinion this ambiguity is crucial: the subject is asked to process the 
same stimulus in different ways without any help of external cues. 
~0 
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Cognitive shifting is considered to be properly reflected by card sorting 
tests [6,17,19,25]. To avoid test-specific artefacts, that may be present when 
a cognitive function is measured by only one test (e.g. poor discrimination 
of the differences between the specific stimuli) we assessed cognitive 
shifting by means of three tests of shifting sorting criteria: Spatial Card 
Sorting, Number Card Sorting, and Figurai Card Sorting. 
In the second session the subsequent five measures were administered: 
- WAIS Similarities, representing verbal intelligence; 
- Number Card Sorting, representing cognitive shifting. By analogy with 
the Wisconsin Card Sorting Test, three series of 15 response cards were 
designed, depicting three-figure numbers which differed in three dimen-
sions (even vs. odd, upward vs. downward, two-point vs. four-point 
interval). Subjects had to assign the response cards to one of two 
stimulus cards depicting figures which differed from each other in these 
three dimensions. Stimulus card 1 showed odd numbers, an upward 
trend and a two-point interval: 1-3-5. Stimulus card 2 showed even 
numbers, a downward tendency and a four-point interval: 12-8-4. First, 
subjects had to match "even vs. odd", this being the acquisition phase. 
Then - always after seven correct answers and without warning by the 
examiner - "upward vs. downward" and finally "two-point vs. four-point 
interval"; again, there were two shift phases. The instructions and 
scoring were similar to those in Spatial Sorting. 
- GIT Form Board, a Dutch test [22] similar to Visualization 1 in the 
manual for kit of factor-referenced cognitive tests [7], representing 
visuoperceptual intelligence; the norms were made in 1976. 
- SIT (Social Interpretation Test), a Dutch adaptation of Terman's 
"Response to Pictures" [38]. The test consists of a picture, depicting a 
snapshot of daily life: a slight collision without people being wounded, 
people discussing it, and people apparently not at all bothered about it. 
The instruction consists of a standard number of open questions, such 
as: 'Tell me something about it".; "Do you think there is something stri-
king or strange in the picture?"; "What have these people got to do with 
it?". A results table has been developed for the purpose of numeric 
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scoring. By means of an iterative cluster analysis a cluster was identified 
consisting of 24 categorical statements. The SIT scores range from none 
of the statements were mentioned (0) to all the statements were mentioned 
(24). In "Documentation of Tests and Testresearch in the Netherlands" - the 
Dutch counterpart of Mental Measurements Yearbook - the SIT-
literature has been critically evaluated: the SIT has proved its reliability 
and factorial and construct validity as a measure of social intelligence 
[39]. In various regression analyses the SIT, along with social com-
petence scales, appeared to show a similar pattern of separation from 
verbal and visuoperceptual factorscores. 
- Figurai Card Sorting, in the form of the Wisconsin Card Sorting Test, 
representing cognitive shifting. The material for this test was the same 
as that used in the original test. Four stimulus cards were presented, 
each of which is unique in terms of its color (red, green, blue, or 
yellow), shape (triangle, star, cross, or circle), and number of items (one, 
two, three, or four). The response cards comprised three sets of 24 
cards depicting figures with all possible combinations of color, shape, 
and number. First, subjects had to match for color, this being the 
acquisition phase; next - always after 10 correct responses and without 
warning by the examiner - for shape and finally for the number of items. 
The instructions and scoring were similar to those in Spatial Sorting and 
Number Sorting. 
After a two-year interval the third testing session (the posttest) was 
performed, consisting of the readministration of both social intelligence 
tests - WAIS Picture Arrangement and SIT. Pretest and posttest were 
conducted by the same examiner to ensure consistency throughout the 
study. 
During the two-year follow-up all the subjects were in residential care 
and lived in two Dr. Leo Kanner Huis units each of which accommodated 
about 8 residents. These units were located in close proximity in order to 
promote flexible staffing and to improve the administration's ability to 
supervise the programs. Staff-to-client ratio averaged 1 to 2. 
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The Dr. Leo Kanner Huis considers autism to be a developmental 
disability. Deficits in social understanding are regarded as belonging to the 
core symptoms of autism. Accordingly, in the establishment special 
education programs designed to improve cognitive functioning are used 
and behaviour management is emphasized as opposed to psychotherapy. 
The residential programs are highly structured, behaviourally based 
curricula. They focus on the development of social understanding, and 
living and vocational skills. Moreover, expectations are that the forced 
confinement of living with others in a small, well-organized setting will 
have a beneficial effect on the subjects' social awareness. 
Statistical procedures 
On the basis of their content domains, scores derived from the sue intel-
ligence tests were grouped into three summary variables: verbal intel-
ligence (the sum of WAIS Vocabulary and WAIS Similarities), 
visuoperceptual intelligence (the sum of WAIS Block Design and GIT 
Form Board), and social intelligence (the sum of WAIS Picture Arrange-
ment and SIT). Equal weight was assigned to the variables in question. 
The scores were expressed in IQ equivalents. Internal consistency and 
discriminant validity of the constructs were checked by Pearson corre-
lations and Hotelling's t tests. Attention was expressed in the standard 
Stroop phenomenon "interference": subjects had to name stimuli according 
to the color of the ink when there was a competing word meaning; inter-
ference was recorded in seconds. Cognitive shifting was quantified by 
adding the equally weighted scores on Spatial, Number and Figurai Card 
Sorting; again, the intercorrelations were performed. The score was 
expressed in percentages: number of required trials divided by the 
maximum number of trials. 
To assess progress in social understanding, pretest-posttest performance 
changes in social comprehension were measured by means of gain scores. 
Subjects were divided into two groups: Group 1 (progress) included 
subjects who achieved social IQ gain scores >15, corresponding to at least 
1 sd; Group 2 (no progress) included subjects who attained social IQ gain 
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Table 1. Mean demographic and test measures. 
Group 1: 
progress 
(n=7) 
Group 2: 
no progress 
(n=10) 
Measure M sd M sd T(15) 
Gain score: posttest-pretest 
Social IQ 19.3 4.5 -1.0 3.2 10.9@ 
- Picture Arrangement 6.0 3.4 -0.2 1.5 5.2@ 
(raw scores) 
- SIT (raw scores) 5.0 2.0 -0.3 1.8 5.7@ 
Age (years) 18.7 1.9 19.1 2.2 -1.5 
Verbal IQ 98.0 20.9 97.0 17.7 0.1 
Visuoperceptual IQ 126.4 18.9 112.0 11.4 1.9 
Social IQ (at pretest) 83.6 14.4 91.0 13.5 -1.0 
- Picture Arrangement 9.7 4.3 11.4 4.4 -0.8 
(raw scores) 
- SIT (raw scores) 8.1 3.3 11.7 2.2 -2.5* 
Social IQ (at posttest) 102.9 12.2 90.0 14.1 1.9 
- Picture Arrangement 15.7 2.9 11.2 4.4 2.4* 
(raw scores) 
- SIT (raw scores) 13.1 2.3 11.4 2.8 1.3 
Attention (seconds) 44.9 20.7 33.5 13.0 1.3 
Cognitive shifting (% trials) 26.4 11.7 47.6 17.2 -2.8** 
All variances were equal 
* p<0.05 
** p=0.01 
@ p<0.0001 
scores <15. Given that the social intelligence score is composed of only 
two variables, it was thought to be useful as a validation to check whether 
the results held true if Picture Arrangement and SIT were analyzed 
separately. Differences between the groups with respect to age, intelli-
gence, attention, and cognitive shifting were evaluated by means of analysis 
of variance and, if necessary, by means of ANCOVA (Statistical Analysis 
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System; procedure: General Linear Models). No nonautistic control group 
was used; the autistic subjects act as their own control in relation to 
pretest measurements, the progressors and non-progressors as control for 
each other. In addition, multiple regression analyses were applied to select 
the best predictor of outcome (Statistical Analysis System; procedure: 
Stepwise Regression). All tests were two-tailed. 
Results 
The means and standard deviations for demographic and neuropsycho­
logical measures obtained by the two groups are presented in Table 1 in 
conjunction with results of the analysis of variance by groups expressed in 
levels of significance associated with Τ values. 
Seven of the 17 subjects met the criteria for progress, judging not only 
by the combined gain scores on Picture Arrangement and SIT, but also by 
the difference-scores on the individual tests. Indeed, both individual gain 
scores appeared to correlate substantially: r=0.61, p<0.01. 
With regard to verbal and visuoperceptual intelligence, the grouping 
into summary IQ equivalents was fully allowed as appears from the pattern 
of intercorrelations between the individual tests, as shown in Table 2. The 
correlation between the tests grouped together was highly significant and 
nearly all correlations within the constructs were significantly greater than 
those with the measures in other constructs, excepting the difference 
between г=0.83 (between the two visuoperceptual measures) and г=0.60 
(between Form Board and the verbal intelligence test Similarities): Hotel-
ling's t=1.67 was not significant. Concerning the summary domain of social 
intelligence the internal consistency appeared to be satisfactory (r=0.66, 
ρ < 0.005), but the discriminant validity is less certain. The correlations with 
tests in other domains were smaller, but not always significantly so. In 
particular, three difference scores with verbal measures were not sig­
nificant: with Hotelling's test the differences between r=0.66 on the one 
hand and r=0.46, r=0.51 and r=0.56 on the other hand failed to reach a 
significant level. 
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Table 2. Matrix of Pearson intercorrelations among the six Intelligence Tests at 
pretest. 
Test 
1. Vocabulary 
2. Similarities 
3. Block Design 
4. Form Board 
5. Picture Arrangement 
6. SIT 
* p<0.05 
** p<0.01 
@ p<0.005 
2 
0.84@ 
-
3 
0.30 
0.48* 
-
4 
0.29 
0.60** 
0.83@ 
-
5 
0.15 
0.46 
0.1 
0.32 
-
6 
0.51* 
0.56* 
0.21 
0.31 
0.66@ 
-
Hence, to further validate the social measures it was thought to be 
worthwhile to analyse the summary scores and the individual scores as 
well. As shown in Table 1, the effects remained when Picture Arrangement 
and SIT were considered separately. With respect to age, attention and 
intelligence, the two groups were equivalent. As to visuoperceptual intel-
ligence the mean performance in Group 1 would appears to exceed that in 
Group 2; however, the difference did not reach statistical significance 
(p=0.07). Both groups showed rather equal performance excluding on the 
subtest SIT; here, the results seem to violate common sense: greater 
progress in the least well-functioning group. 
The difference between the groups in cognitive shifting performance 
was striking. Both the composite cognitive shifting score, as well as the 
performance on two of the 3 constituent Sorting Tests, namely Number 
and Figurai Sorting, could differentiate the two groups significantly. With 
regard to Spatial Sorting, Number Sorting, and Figurai Sorting the level of 
significance appeared to be p=0.18, p=0.04 and p=0.02 respectively. Com-
pared to the progress group, the no-progress group performed worse on 
each of the measures representing cognitive shifting. The subjects in 
question needed far more trials to complete the categories in the shift 
phases. In the acquisition phases the two groups obtained similar scores 
(p=0.51). 
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Table 3. Correlations between predictors and criterion. 
Social IQ Gain score: 
posttest-pretest 
Age 
Verbal IQ 
Visuoperceptual IQ 
Social IQ 
Attention 
Cognitive Shifting 
Pearson г 
-0.37 
-0.03 
0.36 
-0.34 
0.40 
-0.54 
ns 
ns 
ns 
ns 
ns 
0.03 
Table 4. Stepwbe regression procedure for dependant variable Social IQ Gain Score. 
Step Variable Partial R2 F ρ 
1 Cognitive Shifting 0.29 6.2 0.03 
2 Social IQ at pretest 0.17 4.4 ns 
No other variables met the 0.05 significance level for entry into the model 
The substantial intercorrelations between the three sorting tests provided 
documentation of the homogeneity of the summary variable cognitive 
shifting: Spatial and Number Sorting: r=0.53 (p=0.03); Spatial and Figurai 
Sorting: r=0.46 (p=0.06); Number and Figurai Sorting: r=0.49 (p=0.05). 
The relationship between intelligence and cognitive shifting was slightly 
positive; two of the coefficients reached statistical significance. The values 
given below are negative due to the scoring system used in cognitive 
shifting. The greater the number of trials, the lower the level of perfor­
mance: Verbal IQ and Cognitive Shifting: r=-0.25 (p=0.33); Visuopercep­
tual IQ and Cognitive Shifting: r=-0.54 (p=0.03); Social IQ (pre-treat­
ment) and Cognitive Shifting: r=-0.20 (p=0.45). Social IQ (post-treatment) 
and Cognitive Shifting: r=-0.54 (p=0.03). 
The relation between attention and cognitive shifting was negligible: 
Stroop and Cognitive Shifting: r=-0.14 (p=0.60). 
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Table 5. Stepwise regression procedure for dependent variable Social IQ at posttest 
Step Variable Partial R2 F ρ 
1 Cognitive Shifting 0.39 9.1 0.01 
2 Social IQ at pretest 0.47 14.9 <0.01 
No other variables met the 0.05 significance level for entry into the model. 
To appreciate the relative contributions of the independent variables (age, 
intelligence, attention, and cognitive shifting) in predicting the criterion 
(improvement in social intelligence) uni- and multivariate correlational 
analyses were carried out. The univariate correlation coefficients between 
predictors and criterion are presented in Table 3. 
Also in the multiple regression analysis, cognitive shifting was shown to 
be the sole significant predictor (see Table 4). 
Because of the small number of subjects and the concern that there 
might have been idiosyncratic effects at either pretest or posttest that 
might have contributed to gain scores, a multiple regression analysis was 
carried out in which social intelligence at posttest (and not social gain) was 
the dependent variable. Only cognitive shifting predicted social intelligence 
at posttest after removing the effect of social intelligence at pretest (see 
Table 5). 
Discussion 
The performance of high-functioning autistic subjects on intelligence tests 
is characterized by uneven functioning: marked social and, frequently, 
verbal deficits versus intact and, on occasion, excellent visuoperceptual 
intelligence [20,31]. Our 17 subjects convincingly displayed that feature: 
the mean distance between their social and visuoperceptual IQ equalled as 
much as 2 sd. 
Again, significant improvement in social intelligence has been es­
tablished in a considerable proportion of treated subjects (i.e. over 40%). 
In a previous report [2], an analogous progression was revealed in 60% of 
the subjects. With respect to age and level, the autistic individuals partici-
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pating in both studies were equivalent and, to assess progression, the same 
social comprehension tests were applied. However, it should be pointed 
out that the intervals between pre- and posttest were unequal. In the 
present design the period of treatment took only two years, whereas in the 
previous report treatment extended beyond three years. 
In autistic persons of near-normal intelligence the relationship between 
IQ and social progress is alleged to be quite poor [12]. Our findings, which 
showed negligible correlations between intelligence and progress in social 
understanding, are fully consistent with this claim. 
The most robust result obtained in this prospective study about high-
functioning autistic residents is the relevance of cognitive shifting to 
progress in social understanding over a 2-year time span. Of various 
cognitive measures, sorting tests have proved to be the most powerful 
discriminant between good outcome and poor outcome cases. The highly 
significant correlation between the gain scores on the separate measures 
Picture Arrangement and SIT (r=0.61, p<0.01) is considered to be in 
favor of the validity of the measurement of social outcome. 
These results, however, should be interpreted with caution. Especially, 
the impact of the small number of subjects on the results should be 
pointed out. Although social intelligence gain score was significantly 
correlated with cognitive shifting only (r=-0.54, p=0.03), there were also 
nonsignificant trends (Table 3). Progress was apparently seen in younger 
subjects with higher visuoperceptual intelligence and attention, as well as a 
lower initial social IQ. Any of these different elements might have 
contributed to the gain achieved in social intelligence. Particularly, the 
contribution of visuoperceptual intelligence should be addressed. The 
progress group had higher visual perceptual scores than the no-progress 
group, though this difference did not reach statistical significance. From 
the data, it is possible that a slightly larger sample might have yielded a 
statistical difference. This is important because the correlation between 
cognitive shifting and visuoperceptual intelligence was statistically sig-
nificant (r=-0.54, p=0.03). However, the contribution of visuoperceptual 
intelligence to progress appeared to be by no means a crucial one. 
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Table 6. Analysis of covariance. 
0.6 
2.3 
7.2 
0.1 
0.005 
ns 
0.01 
ns 
Dependent variable: Cognitive Shifting, prorated from Spatial, Number 
and Figurai Card Sorting. 
Source F ρ 
Group 
Social IQ 
Group 
Attention 
Group 3.3 ns(0.09) 
Visuoperceptual IQ 5.0 0.04 
Dependent Variable: Cognitive Shifting, prorated from Number and 
Figurai Card Sorting. 
Source F ρ 
Group 6.6 0.02 
Visuoperceptual IQ 0.2 ns 
Of the three shifting tests it was exactly the measure with the lowest corre­
lation with visuoperceptual intelligence that showed the highest correlation 
with progress: Figurai Card Sorting (correlation with visuoperceptual intel­
ligence: r=-0.19 and correlation with progress: r=-0.53). 
Given the trend toward a lower initial social IQ, a higher visuopercep­
tual IQ, and higher attention in the improved group, analyses of covariance 
were also applied to test the independence of the significant difference on 
cognitive shifting between the groups. As shown in Table 6, when social IQ 
and attention were taken as a covariate, the difference on cognitive 
shifting remained highly significant. When visuoperceptual IQ was used as 
a covariate, the difference on cognitive shifting remained significant on 
condition that the shifting ability subtest Spatial Card Sorting was removed 
from the composite shifting score. Of the three shifting tests it was only 
the Spatial Card Sorting task which showed a significant correlation with 
visuoperceptual intelligence. 
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The fact that there is greater progress in the group with the lowest SIT 
score is hard to interpret. It is most unlikely that the initially lower scoring 
group has a built-in advantage thanks to ceiling effects. The range of SIT 
scores is from 0 to 24 points. Age-matched control subjects show a mean 
performance of 15.0 with sd=3.3. Accordingly, within both autistic groups 
the SIT scores were dramatically reduced. One subject in the progress 
group brought about some bias: at pretest his SIT score was exceptionally 
low (4) and at posttest about the average (13). In our previous study [2] 
the sign of the correlation between SIT gain score and SIT pretest score 
turned out to be in the opposite direction: the autistic subjects with 
nonsignificant higher pretest scores tended to have larger gains than the 
subjects with lower pretest scores. 
It has been speculated by several researchers that autism may involve 
difficulties in the acquisition and formation of semantic concepts [8,27]. In 
fact, sorting tests have been designed to measure both concept formation 
and the ability to shift set. Consequently, our interpretation, that it is 
precisely a failure in shifting ability that was critical in differentiating 
between the progress and the no progress group, may be inaccurate. Yet 
we consider we have good arguments for standing by our interpretation, 
since neither the WAIS concept-formation task, Similarities, nor any of the 
acquisition phases of the three sorting tests has been found to separate the 
two groups (p values ranging from .41 to .95). Moreover, in our autistic 
sample the mean IQ score on Similarities comes to nearly 100. Hence we 
argue, in accordance with experimenters like Tager-Flusberg [35] and 
Ungerer and Sigman [36], that it is not typical of autistic individuals to 
have particular difficulty in acquiring superordinate concepts. 
In this study cognitive shifting and progress in social understanding 
proved to be related: the progress group showed significantly better pre-
treatment shifting ability than the no-progress group (T=-2.8; p=0.01). In 
our cognitive shifting tasks, the subjects were not told that the rule to 
match the response cards would change without any warning. Nor was 
information regarding the nature of categories supplied. Thus the subjects 
had to develop self-initiated strategies for adapting to changing environ-
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mental contingencies. One of the essential deficits in autism is the im-
paired ability to rearrange learned behaviour into self-directed behaviour. 
It is exactly this self-initiated flexibility that can hardly be taught explicitly 
by means of highly structured educational programs. Obviously, this 
therapeutic paradox holds preeminently for autistic patients with impaired 
shifting ability. 
Both failure of social understanding and failure of social competence 
are commonly viewed as major defining characteristics of people with 
autism. However, this does not necessarily imply that the level of social 
understanding is similar to the level of social competence. The relationship 
between these cognitive and behavioural parameters is thought to be not a 
linear one: well-developed cognition is a necessary but not a sufficient 
condition for competent social adaptive behaviour. In their sample of 53 
autistic patients Freeman et al. [9] established a significant positive relati-
onship among cognitive (IQ) and Vineland Adaptive Behaviors Scale 
scores. In a Dutch validation study with 25 autistic adolescents, the 
correlation appeared to be significant between improvement in social 
inteligence, as assessed by Picture Arrangement and SIT, and progress in 
social competence, as measured by an experimental behaviour rating scale 
consisting of items from Doll's Vineland Social Maturity Scale and Wing's 
Children's Handicaps, Behavior and Skills Schedule [14]. However, even 
autistic persons with high cognitive level show persistent social impairment 
and maladaptive behaviours [9,29]. The outcome measure in this study is in 
the experimental task, not a measure of social functioning in the real 
world. To further monitor the relation between cognitive shifting and 
progress in social competence, the next step in our study will be the 
administation of the recent revision of the Vineland, as recommended by 
Volkmar et al. [41]. 
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Summary 
In this study haloperidol appeared to affect the performance on 
a selected category of cognitive tasks considered to represent shifting 
aptitude. A pretest-post-test design was used with two groups of subjects: 
17 patients suffering from idiopathic spasmodic torticollis, and 17 controls 
who were matched for age and intelligence. The results are discussed in 
relation to previous findings on haloperidol and cognition, shifting disorder 
in Parkinson's disease and changes in behavioural organization found in 
animals with an experimentally induced dopaminergic hypoactivity. 
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Introduction 
One kind of behavioural dysfunction repeatedly observed in recent neuro-
psychological studies concerning patients suffering from Parkinson's 
disease (PD) has been described as a failure in cognitive flexibility in the 
execution of a plan when external cues are not available. PD patients 
appear to have an impairment in the ability to generate spontaneously 
efficient strategies when relying on self directed task-specific planning. The 
nature of this cognitive impairment is described as a deficit in "executive 
functions", in "shifting sets", or in "shifting aptitude" [1,8-10,12,17,22,32,57]. 
These findings draw renewed attention to the almost forgotten idea of 
Barbeau that PD patients, if not prompted or guided, have a diminished 
ability to shift to a new grouping [2]. 
Disorders in shifting aptitude appear to coincide rather selectively with 
basal ganglia and frontal cortical lesions in both men and animals 
[12,24,26,29,32,36,57,58]. In view of the intimate relationships between the 
basal ganglia and the frontal cortex [15], it is not surprising that PD 
patients show a decreased performance on shifting aptitude tests conventi-
onally ascribed to frontal lobe dysfunction, such as the Wisconsin Card 
Sorting Test, the Trail Making Test and Word Fluency Tests [19,42,55,61]. 
In PD, the most prominent neuropathological changes are found in the 
basal ganglia. Hence, it is not yet fully elucidated whether these tests can 
be regarded exclusively as marker tests for frontal lobe function. It is not 
necessarily true that frontal type cognitive deficits are the result of intrin-
sic frontal disease. They may reflect the impact of pathology in the basal 
ganglia on normal frontal physiology [62]. An accurate comparison of the 
findings in both animal and human studies concerning the cognitive 
consequences of damage to the basal ganglia and the frontal areas that 
project to the basal ganglia led to Stern's decision to argue that these 
areas work in series rather than in parallel, each component having a 
differential impact [53]. Further research is needed to understand the 
precise nature of the functional significance of both areas in shifting 
aptitude. 
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A deficiency of the neurotransmitter dopamine in the basal ganglia is 
assumed to represent the major neurochemical change in PD [27]. Can a 
shifting aptitude disorder be conceived as a neuropsychological correlate of 
a depletion of dopamine? Is this cognitive dysfunction in PD patients 
influenced by treatment with levodopa, the precursor of dopamine? 
Levodopa treatment alleviates the PD symptoms to a considerable 
extent. Unfortunately the beneficial effects of levodopa on motor functions 
are known to decline during the course of PD [38]. Taylor et al. [58] argue 
that approximately 60% of levodopa-treated PD patients lose between 30 
and 40% of their initial improvement within 3-4 year. Apparently the same 
effect of dopa is observed in the performance on intelligence tests. 
Whereas the initial response to treatment with levodopa is promising 
[3,16,25,35,40,47], long-term treatment has been reported to be associated 
with a subsequent return of intellectual functions to baseline scores and 
with mental deterioration [6,21,46,48,56]. As to shifting performance in 
function of levodopa treatment, our search in the literature hardly yielded 
relevant data. It was found that levodopa-treated PD patients are able to 
produce more correct responses on the Wisconsin Card Sorting Test than 
an untreated PD group [7]. However, these findings result from cross-
sectional and not from longitudinal research. The same holds true for the 
study of Taylor et al. [58] in which PD patient groups classified according 
to response to levodopa and/or dopamine agonists are compared with 
respect to the performance on (among other tests) the Wisconsin Card 
Sorting Test, a verbal fluency test and the Trail Making Test. 
Research reports in which dopamine receptor blocking drugs are 
studied for their effects on shifting aptitude are also scarce. Phillipson and 
Harris [44] reported that there is a tendency for chlorpromazine (which 
has well-known dopamine receptor blocking properties) to lower the 
reversal rate in perceptual experiments with reversible pictures. 
The present study was carried out in order to test our hypothesis that a 
hypofunctioning dopaminergic system is associated with shifting deficiency. 
This paper reports on changes in performance on tests of shifting aptitude 
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after reducing the dopaminergic neurotransmission by haloperidol. A 
pretest-post-test design is used with a matched control group. 
Methods 
Subjects 
In our experimental design, haloperidol was selected to decrease the 
activity in the dopaminergic transmission. Haloperidol has been described 
as an occasionally effective drug in patients suffering from idiopathic 
spasmodic torticollis (ST) [13,30]. For that reason our experimental group 
consisted of idiopathic ST patients; n=17. Patients with torticollis sympto-
matic for Wilson's disease, inflammatory disorders, post-traumatic atrophic 
processes, tumor cerebri, bony anomalies, carbon monoxide intoxication or 
neuroleptic treatment were excluded. 
The 17 ST patients, who participated in this study with informed 
consent, were referred to the outpatient Department of Neurology at 
Nijmegen University. They were all in a clinically stable state. There were 
asked to stop taking medication 3 months prior to the investigation. 
However, four patients noted an exacerbation of ST, and so they continued 
their drug treatment: two patients were on oxazepam medication (daily 
dose: 10 mg), one patient took paracetamol and caffeine (daily doses: 500 
and 50 mg respectively) and the fourth patient took nitrazepam, lorazepam 
and oxazepam (daily doses: 5, 2.5 and 50 mg respectively). For additional 
details concerning duration and severity of ST the reader is referred to 
Van Hoof et al. [23]. There appeared to be no handicaps to such an extent 
as to prevent the patients to perform the tests in a normal way. 
The control group (CS) consisted of 17 healthy subjects matched with 
respect to age and intelligence who did not take any drug. Whenever 
possible the partners of ST patients were invited to participate. 
The mean age of the ST group was 47.7 ± 7.3 year, and of the CS 
group 47.4 ± 8.9 year. The sex ratio was identical in both groups: 4 men 
and 13 women. 
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An IQ equivalent >85, based on Vocabulary, Similarities and Block Design 
(Wechsler Scale) was used as inclusion criterion in order to prevent the 
subjects being unable to understand the test instructions. 
Psychodiagnostic tests 
Shifting aptitude was measured by using several criterion tests. If possible, 
existing tests were chosen. One test (Wisconsin Card Sorting Test) has to 
be adapted because of its relatively long duration. In addition, appropriate 
parallel forms of existing tests were developed. To assess specifically the 
influence of haloperidol on shifting aptitude we had to control for the 
variation resulting from alternative independent variables. Test failure may 
be due to a wide range of factors. So we used reference tests to rule out 
obviously alternative explanations for group differences in the criterion 
tests. We controlled for verbal and visuo-perceptual intelligence, recent 
memory for factual information, ability to attend selectively, motor perfor-
mance and depression on account of the well-known impact of these 
factors on test performance. 
The tests were carried out in a quiet well-illuminated room. The durati-
on of the testing session never exceeded 2 hours. 
Reference test 
As generally accepted marker tests for verbal intelligence, we used the 
Vocabulary subtest of the Wechsler Adult Intelligence Scale (WAIS) (all 
WAIS subtests were scored according to standard procedures) [54], and 
Similarities subtest WAIS. 
As generally accepted marker tests for visuoperceptual intelligence, we 
included the Block Design subtest WAIS and Picture Completion subtest 
WAIS. 
As marker tests for recent memory for factual information, we used the 
Digit Span subtest WAIS and 15 Words Test, an equivalent test to the Rey 
Auditory-Verbal Learning Test [34]. This test consists of a list of 15 
unrelated words which were read to the subjects in 25 seconds for immedi-
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ate recall over five trials. The score was the total number of words correct-
ly recalled. 
For assessing attention, we included the Stroop Color-Word Test [28]. 
In the first subtest, subjects had to read aloud 100 items as quickly as 
possible: the words blue, red, green and yellow, randomly printed in black 
letters. In the second subtest, subjects had to name the colours -blue, red, 
green en yellow- of 100 coloured rectangles printed in random order; again 
the experiment insisted on speed. In the third subtest subjects had to name 
the four colours in which the items were printed although the colour was 
different from the one it designated; once again: 100 randomized items 
and again the instructions stresses speed. Reading times in seconds were 
recorded. The test score was obtainted by subtracting the reading time of 
subtest 2 from that of subtest 3. 
The Stroop Color Word Test has been developed to assess the ability to 
maintain one mode of response against a competing alternative mode, that 
is the equivalent of attention [28]. As noted elsewhere [52], this test is 
designed for measuring "maintaining sets" but not for "shifting sets" [22,57]. 
The Stroop Test may control for the ability to attend selectively, while in 
Digit Span and 15 Words Test recent memory and attention in the sense 
of vigilance is tested. 
As index of motor performance, we used Finger Tapping. Two 
keyboards with four push-buttons were constructed to fit the relative 
lengths of the left- and righthand fingers, analogous to the apparatus for 
the repetitive finger movements task used by Perret et al. [12,43]. Subjects 
were asked to press the buttons as fast as possible with the writing hand, 
using a free sequence of their four fingers. They were not allowed to press 
two or more buttons simultaneously. The total number of presses within 15 
seconds was recorded (Tf). 
For rating depression we included the Depression Adjective Checklist 
[33,49]. The list, named Vropsom, consisted of 22 adjectives expressing a 
dysphoric feeling and 12 adjectives expressing euphoric feeling. Subjects 
had to indicate those adjectives which expressed how they felt. Score: 12 
plus the number of marked dysphoric items and minus the number of 
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marked euphoric items. The Vropsom Depression Checklist is one of the 
best standardized Dutch depression rating scales. 
Criterion tests 
In the literature card sorting and word fluency tasks appear to be fre-
quently reported shifting tests [12,32,39,57], both aiming at a specific 
aspect of cognition conventionally ascribed to the function of frontal 
association cortex. Word fluency is considered as a retrieval task and owing 
to its time limited character as a shifting task [20]. The test is known to 
reflect the access to stored information without the help of external cues. 
Both in card sorting and in word fluency the ability is assessed to generate 
and shift efficient strategies when relying on self directed task-specific 
planning [39,57]. For that reason we included card sorting and word 
fluency, and in addition we used a shifting task in a motor modality. 
- Card Sorting I. Three series of 24 response cards were designed, depic-
ting figures which differed in three dimensions: shape (angular vs not 
angular), outline (thick vs thin) and orientation (vertical vs horizontal). 
Subjects had to assign the response cards to one of two stimulus cards 
depicting figures which differed from each other in these three dimen-
sions (thick ellipse in vertical orientation and thin rectangle in horizon-
tal orientation, see Figure 1). Firstly, subjects had to match for shape, 
i.e. the acquisition phase, then - always after seven correct assignments, 
and without warning by the experimenter- for outline, next for orientation 
and, finally, again for shape; hence there were three shift phases. The 
instructions given to the subjects were as follows: "I am going to show 
you several figures one at a time. Each of them matches one of these 
two figures (indicating the stimulus cards). I want you to sort these 
cards (indicating the response cards) by placing them below the figure 
you think they fit best. I shall tell you whether your choice is right or 
wrong". The score was the total number of trials preceding seven correct 
assignments to the consecutive criteria in the three shift phases: outline, 
orientation and shape. The acquisition phase (non-shift phase) 
represented baseline performance. 
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I 
Figure 1. Card Sorting I: stimulus cards. 
- Card Sorting Π. Wisconsin Card Sorting Test [41] in abbreviated form. 
The material for this test was the same as that used in the original test. 
Four stimulus cards were presented, each of which is unique in terms of 
its colour (red, green, blue or yellow), shape (triangle, star, cross or 
circle) and number of items (one, two, three or four). The response 
cards comprised three sets of 64 cards depicting figures with all possible 
combinations of colour, shape and number. Firstly, subjects had to 
match for colour, i.e. the acquisition phase, next - always after 10 
correct responses, and without warning by the experimenter- for shape, 
then for the number of items and, finally, again for colour. The instruc­
tions were similar to those in Card Sorting I. The score was the total 
number of trials preceding 10 correct assignments to the consecutive 
criteria in the three shift phases: shape, number of items and colour. 
The acquisition phase represented baseline performance. The Wisconsin 
Card Sorting Test was originally devised to assess concept formation by 
adding the scores of all trials. As we were interested in changing con­
cepts, we made a distinction between the first trial being the acquisition 
phase and next trials being the shift phases. We did not analyze Card 
Sorting according to perseverative-nonperseverative error pattern. The 
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classification in perseverative and nonperseverative errors is formally 
correct, but actually rather interpretative, since it is not allowed to ask 
the subject why he has decided to this particular assignment. So correct 
shifting can only be assessed conclusively after a number of correct 
trials in succession. The same holds true for perseveration. Moreover, 
the presence of a lot of multivalent response cards prevents an unequi­
vocal distinction between perseverative and nonperseverative errors. 
- Word Fluency I [4]. Subjects were asked to produce in 1 minute as 
many different words as they could think of beginning with the letter Ρ 
and, next, to produce as many different words as they could think of 
ending in the letter K. Peoples' names and proper nouns were not 
permitted. The score was the total number of different items mentioned 
in both trials. 
- Word Fluency II. The instructions and scoring were identical to those 
for Word Fluency I, but the letters presented were different: words 
beginning with the letter S and next, words ending with the letter P. 
- Motor sequences. Keyboards for Finger Tapping were used. The test 
consisted of two trials. Subjects were instructed to press each push­
button with the dominant hand as frequently as possible in the following 
sequence: ring finger - middle finger - little finger - index finger, i.e. the 
acquisition phase. After receiving a sign from the experimenter, they 
had to change the sequence to: middle finger - little finger - index 
finger - ring finger, i.e. the shift phase. A time limit of 15 sec was used 
to both trials. The total number of presses (T) in each trial was 
recorded as well as the correct successive presses (C) in each trial (a 
press was recorded as correct when it was preceded and followed by the 
press as defined in the sequence). The ratio CT:Tf was computed in 
order to obtain a measure indicating the quality of sequential perfor­
mance, taking into account individual differences in basic motor capaci­
ties [12]. 
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Procedure 
ST patients and CS were tested twice, the order of tests being identical: 
Depression Checklist, Vocabulary, Word Fluency, Block Design, Card 
Sorting, Stroop, Picture Completion, Digit Span, Similarities, 15 Words 
Test, Finger Tapping and Motor Sequences. Between Card Sorting and 
Stroop there was a break of 20 min. To minimize test-retest effects on the 
criterion tests, Card Sorting II and Word Fluency Π were administered at 
the post-test as alternate forms of Card Sorting I and Word Fluency I at 
the pretest; test-alternate test reliability was computed with Pearson г. A 
fixed order of the two alternate forms of Card Sorting and Word Fluency 
has been designed as our groups are too small for balancing. There was a 
3-week interval between pretest and post-test. 
Three days before the post-test, ST patients were treated with 60 mg 
haloperidol decanoate i.m. 60 mg haloperidol decanoate approximately 
corresponds to the oral treatment of ST usual (low) dose of haloperidol: 3 
mg daily (personal communication: С Niemegeers, Janssen Farmaceutica). 
The plasma levels of haloperidol were assessed by radioimmunoassay just 
before the post-test (A. J. M. Loonen and J. F. W. Tertoolen, Laboratory 
of Nuclear Medicine, Vught). 
Differences between the ST and CS group with respect to pretest scores 
and post-test scores, and with respect to differences between post- and 
pretest scores in both groups were evaluated by means of analysis of 
variance (Statistical Analysis System; procedure: General Linear Models). 
Results 
The means and sd of the scores obtained by the two groups on the refe­
rence tests at pre- and post-test are presented in Table 1 in conjunction 
with results of the analysis of variance by groups expressed in levels of 
significance associated with F ratios. With the exception of Picture 
Completion and Depression at pretest, no significant differences in any 
reference test were observed in groups means, either at pre- or at post-
test. 
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Table 2. Level of significance of mean performance between torticollL· (n=17) and 
control group (n=17) on the reference functions at pretest and post-test, and 
at post-test after eliminating variance due to the pretest. 
Post-test after eliminating 
Pretest Post-test variance due to the pretest 
Function Ρ Ρ Ρ 
Verbal Intelligence 0.61 0.52 0.54 
Visuoperceptual Intelligence 0.58 0.44 0.57 
Recent Memory 0.50 0.43 0.68 
Attention 0.82 0.84 0.96 
Motor Performance 0.86 0.67 0.68 
Depression 0.01* 0.21 034 
In extensive testing of intelligence, recent memory, attention and motor 
performance the torticollis (ST) and control group (CS) proved to be well 
matched. 
Table 2 shows the level of significance in mean performances on verbal 
intelligence (i.e. standardized sum scores on Vocabulary and Similarities), 
visuoperceptual intelligence (i.e. standardized sum scores on Digit Span 
and 15 Words Test), attention, motor performance and depression between 
ST and CS at pretest and post-test, and at post-test after eliminating 
variance due to the pretest (by means of a regression analysis). 
Apparently, haloperidol did not affect the performance on any reference 
function in a differential way, with the exception of the visuoperceptual 
subtest Picture Completion. 
To assess the plasma level of haloperidol, blood samples were taken just 
before the post-test: the mean was 1.39 ng/ml and sd=0.22. Four ST 
patients commented to experience side effects at post-test: trismus (1), dry 
mouth (1), trembly and stiff feelings in arms and legs (2). Non of the ST 
patients reported sedative effects. 
The mean performance of both groups on the criterion tests for shifting 
aptitude is summarized in Table 3. As indicated earlier, alternate testforms 
of Card Sorting and Word Fluency were designed in order to prevent test-
retest effects. 
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The correlation coefficients between Card Sorting I and Card Sorting Π as 
well as the one between Word Fluency I and Word Fluency II, subdivided 
into the initial and the final letter form, were r=0.48 (p<0.05), r=0.69 
(p<0.01) and r=0.73 (p<0.01) respectively. 
Haloperidol treatment interfered with the performance on the Card 
Sorting Test. While CS and ST showed a similar, nearly perfect perfor­
mance in the acquisition phase, CS performed significantly better than ST 
in the shift phase. 
The influence of haloperidol on fluency performance was found to be 
striking. In spite of the instructions that stressed speed, ST patients 
produced fewer words than CS at post-test, both in the initial- and in the 
final letter test form of Word Fluency. 
In the Motor Sequences task, however, there was no evidence of a 
differential haloperidol effect, either in the acquisition or in the shift 
phase. 
Discussion 
According to the results of the present study, reduction of the dopaminer­
gic neurotransmission by haloperidol affected the performance on a selecti­
ve class of cognitive tasks considered to represent shifting aptitude. In 
contrast, no deficits were found at the level of shifting sets in a motor task. 
It might be argued that these deficits can be attributed to a general 
sedative effect of haloperidol. However, we did not find indications in our 
study that such an effect was present. Firstly, none of the haloperidol-
treated ST patients reported feelings of drowsiness. Secondly, there was a 
lack of clear effects on the marker tests for recent memory for factual 
information and attention, as could be expected in case of sedation. There­
fore we judged the introduction of another experimental group of CS 
treated with a nondopaminergic sedative drug unnecessary. 
Whereas the aetiology of ST is still unknown, most neurologists today 
[18] consider ST to be a focal dystonia in accordance with the view of 
Marsden [37]. Furthermore, with respect to the therapy of ST it has been 
reported that both dopaminergic antagonists as well as agonists may be 
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effective in treating ST symptoms [13,31,51]. Given the limited knowledge 
about the nature of deficient substrates underlying ST, one cannot exclude 
the possibility that this speculative neurological disease provokes neuro-
psychological dysfunction. However, in this study the test performances of 
ST were largely equivalent to those of CS. 
Apart from the exceptions mentioned below, the torticollis (ST) and the 
control group (CS) appeared to be well-matched: as to cognitive and basic 
motor functioning no gross intergroup differences were discovered at 
pretest. In a sample section of the Dutch population mean and sd of the 
Vropsom Depression Checklist turned out to be 9.5 and 5.1, respectively. 
And so the depression scores of ST at pre- and post-test appeared to be 
within the normal range just like those of CS at post-test. However, the 
depression scores of CS at pretest were strikingly low. This finding may 
reflect a bias caused by social desirability. Initially, our healthy volunteers 
may experience the personality checklist as being too intrusive. At post-test 
they have become much more familiar with examiner and test methods, 
and as a consequence their bias has disappeared. In any case, applying the 
pretest scores on depression as a covariate did not result in significant 
differences between the two groups in depression scores at post-test (Table 
2). The reason why there was a significant difference in both groups on 
Picture Completion at pretest is unclear, but this seems to be of minor 
importance. Firstly, those tests of visual organization, in which the subject 
fills in a missing part, such as Picture Completion, are least vulnerable to 
the effects of brain damage, probably because their content is usually so 
well-structured and readily identifiable [34]. Secondly, both Block Design 
and Picture Completion were used as marker tests for visuoperceptual 
intelligence. In order to assess visuoperceptual intelligence the standardi-
zed sum scores on Block Design and Picture Completion were computed, 
the result being that the difference in question disappeared (Table 2). 
The present data show that treatment by haloperidol (at least in the low 
dose used in our patient group) did not induce an impairment in verbal 
and visuoperceptual intelligence, attention or recent memory for factual 
information. Only scattered reports on haloperidol deal with cognitive 
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effects. Most of these reports included sample populations which are quite 
different from ours, such as hospitalized schizophrenic patients [50,60], and 
children with highly explosive and aggressive behaviour [14,45,63,64]. The 
findings reported in these studies confirmed the usefulness of haloperidol 
in the treatment of various states of agitation. Wahba et al. [60], for 
instance, showed a reduction in the level of arousal and as a consequence 
a decrease in schizophrenic thought disturbances following haloperidol 
administration. In non-psychotic groups, however, the treatment with 
haloperidol necessary to reduce conduct disorders hardly appeared to 
interfere with cognition. Most investigators found the performance on 
intelligence, memory and attention tests to be completely unaffected by 
haloperidol [45,50,64], viz. a phenomenon confirmed in the pretest study. 
Table 3 shows that the post-test scores of haloperidol treated ST 
significantly differed from those of the untreated CS in three of the four 
criterion tests, especially after eliminating variance due to pretest scores. 
Table 3 also shows that the post-test scores of CS in the shift phase of the 
Card Sorting Test are much better than the corresponding pretest scores, 
suggesting at first sight that CS improved their performance at post-test. 
However, this suggestion has to be rejected in view of the fact that such a 
comparison is not allowed: the pretest and post-test card sorting tasks are 
not at all identical, but alternate forms of each other, viz. a prerequisite 
for excluding test-retest effects. Given these considerations, the present 
data show that the haloperidol treatment induced an impaired shifting 
aptitude as revealed by a diminished performance of ST in card sorting 
and word fluency tasks. After correction for pretest performance, card 
sorting, initial letter as well as final letter wordfluency turned out to be 
significantly reduced in ST compared to CS. As indicated in the Intro-
duction, we do not know any research report in which haloperidol is 
studied for its effects on shifting aptitude. Piatt et al. [45] included a 
concept attainment task in their cognitive battery, that resembles our Card 
Sorting Test. But, unfortunately, the behaviour disordered children in their 
study were primarily of a low intellectual level: mean WISC-R full-scale IQ 
score was 84 with a range from 56 to 101. It is our firm belief that at such 
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a dull level, a concept attainment task is very unlikely to act as a marker 
test for something other than "general intelligence". For this reason, we set 
up a WAIS IQ score >85 as criterion for inclusion in our study. Piatt et al. 
[45] themselves pointed out that the generalization of their findings to 
other types of population should not be assumed. 
Only indirectly connected with our study is the investigation of Phillip-
son and Harris [44]. They studied the effect of chlorpromazine (which has 
well known dopamine receptor blocking properties) on the perception of 
ambiguous visual figures. There appeared to be a tendency for chlorpro-
mazine to lower the reversal rate in the perception of reversible pictures. 
In line with our findings this drug effect might be attributed to an experi-
mentally induced dysfunction in shifting sets. 
In a previous study on Parkinson's disease [12], the authors were able to 
show that a deficient shifting aptitude can manifest itself at both the 
cognitive and the motor level, the latter being measured by means of a 
sequential motor task. In the present study it was found that a low dosage 
of haloperidol induced a shifting aptitude disorder that manifested itself 
only at the cognitive level. Animal studies have provided evidence that 
altering the dopaminergic, striatal activity gives rise to analogous shifting 
disorders in rats, cats and monkeys [5,11,26,59]. Moreover, it has been 
found that pathological changes in motor behaviour require a stronger 
suppression of dopaminergic striatal activity than do analogous effects in 
non-motor behaviour [11,59]. In view of these data, the present results may 
imply that the dosage of haloperidol used in our ST patients induced a 
minor change in the dopaminergic, striatal activity just sufficient to bring 
about a shifting disorder at the most complex level of behavioural or-
ganization, i.e. cognition. The finding that the pretest performance of ST 
was largely equivalent to that of CS makes it likely that the noted effect in 
ST patients resulted from a haloperidol induced reduction of the 
dopaminergic neurotransmission. To which degree the neurological 
substrate of ST played an additional role cannot yet be answered. For that 
reason we decide as yet not to discuss the actual target site of haloperidol. 
The present study, together with our findings in Parkinson patients [12] as 
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well as in animals with specific basal ganglia deficits [26], strongly suggest 
that the dopamine process in the caudate nucleus is a relevant candidate 
in this respect. 
It remains to be investigated whether higher doses of haloperidol are 
also able to provoke analogous disorders at subsequently less complex 
levels of behavioural organization, such as motor behaviour. 
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GENERAL DISCUSSION 
The subject of the present thesis originates in animal experiments. In those 
studies it was found that disruption of striatal functioning brought about 
alterations in behavior, which went beyond the motor level. The results of 
these studies indicated that the striatal areas also play a crucial role in the 
programming of behavior. Dysfunction of these areas brings about an 
impairment of shifting behavior programmes not guided by currently 
available information [6]. The question arose whether or not it was possi-
ble to find evidence of similar impairments in human subjects with striatal 
dysfunction, such as Parkinson's disease (PD). Transposing the results of 
the animal studies to human subjects, Cools et al. [7] were able to trace 
analogous deficits in PD patients, not only at the level of programming 
motor behavior, but also at the level of programming cognitive processes. 
What is more, the motor and cognitive deficits proved to be linked [27]. A 
crucial element of these deficits, which was sometimes overlooked [17], is 
that they are restricted to arbitrary behavior. The studies presented in this 
thesis elaborated this topic in terms of external guidance versus internally 
generated problem solving. Our findings corresponded globally with those 
of the animal studies mentioned above, which indicates that animal studies 
can provide testable models of human cognitive function. 
Once cognitive impairments in PD had been identified, the question 
arose whether or not these impairments showed a common feature. 
Depending on the orientation - anatomical versus functional - many studies 
clustered these impairments respectively in terms of a frontal lobe 
syndrome or executive dysfunction [4]. Since executive functions are 
generally ascribed to the frontal lobe, both orientations converged. 
However, this approach raises some problems, which we have tried to 
overcome: 
1. The clusters are often constructed post hoc and lack empirical evidence. 
In many studies, a common denominator was derived from tests which 
proved to be performed poorly by PD patients. One should keep in 
mind that such a common denominator is hypothetical. Hitherto, 
empirical evidence for the construct executive functions is lacking. 
In contrast, this thesis started from a hypothesis, based on animal 
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experiments, which stated that patients with striatal dysfunction are 
impaired in the internal generation of problem solving strategies. Next, 
we operationalized self-generated problem solving in a number of tests 
and selected also tests which did not require self-generated problem 
solving from the cluster of executive functions. In accordance with the 
hypothesis, only the tests requiring self-generated problem solving 
differentiated between PD patients and CS. 
2. The clusters are derived from single test scores. In many studies, a wide 
range of heterogeneous tests - the more, the better - have been presen-
ted to PD and control subjects (CS), at the risk of basing conclusions on 
unique variance of single tests. Among these tests, the Wisconsin Card 
Sorting Test assesses cognitive shifting, a prominent executive function, 
but only in the conceptual domain. However, executive functions, being 
defined as functions which are involved in the self-regulation of 
problem solving strategies [16], are essentially not domain-bound. They 
go beyond single intradomain performance and refer to supradomain 
performance [16]. Accordingly, we presented three card-sorting tests 
with an identical format, each assessing cognitive shifting in a different 
domain: conceptual, verbal and spatial. This enabled us to draw conclu-
sions about cognitive shifting at supradomain level. Despite differences 
in domains, the interrelations of the tests of cognitive shifting proved to 
be acceptable, and the tests showed the same pattern of associations 
with other variables under study. As far as the assessment of memory is 
concerned, the length of the investigation did not allow multiple 
measurement of memory performance. As we will argue in the next 
paragraph, the lack of multiple memory measurement is not likely to 
invalidate our conclusions with respect to memory performance in PD. 
3. The clusters are derived from product scores rather than from process 
scores. Most studies provide sum scores of the tests presented, but no 
comparative subscores which reflect cognitive processing. This is rather 
peculiar, because executive functions are essentially processing functi-
ons, as is evident from the definition mentioned above. In this thesis we 
explicitly focused on the processing aspects. We based the majority of 
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our conclusions on comparative subscores: the number of trials per 
phase in the tests of cognitive shifting and the number of items recalled, 
the semantic and the serial ratio per trial. These scores allowed us to 
develop models of the processes underlying performance. Since our 
interest in memory performance concerned the processing aspect rather 
than the eventual product, i.e. total memory performance, it is plausible 
that the lack of multiple memory measurement did not invalidate our 
conclusions in this respect. 
In this thesis we only found a specific impairment in self-generated 
problem solving in absence of other impairments. In many studies relatively 
more cognitive impairments have been found in PD. One should keep in 
mind that the majority of the PD patients who participated in our studies 
were relatively young, mildly disabled, and showed an above normal 
intelligence. Many of them were de novo patients. Therefore, it is plausible 
that self-generated problem solving is the first cognitive function at risk in 
PD. It is interesting to notice that our PD patients still scored in the 
normal range as far as self-regulation of behaviour is concerned. Self-
regulation is assessed in tasks in which complex or multiple problem 
solving strategies are required, which are explicitly presented by the 
experimenter and, accordingly, have not to be generated. Tasks, such as 
alternation of set [23], alternating fluency [9], maintaining set [15], se-
quential and simultaneous (motor) tasks [1,11,14], tasks with multiple 
instructions [5,8], are tasks of self-regulation. In contrast to tasks which 
only require execution, tasks of self-regulation require selecting, tuning and 
running more than one problem solving strategy. Self-regulation is likely to 
be the next function at risk, as PD progresses. 
The present study suggests several topics for future research. 
1. We have shown that the concept of learned irrelevance does not clarify 
the performance of PD patients on card-sorting tests, as hypothezised 
by Owen et al. [21] on the basis of their experiment on extra- and intra-
dimensional shift performance. The question arises whether or not 
learned irrelevance is the correct interpretation of the results in that 
experiment. In line with our study of Chapter 1, the experiment of 
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Owen et al. has to be repeated, but this time with three instead of two 
dimensions. Only if the difference between PD patients and CS, found 
in the second phase of the experiment, is also present in the third 
phase, in which the third, added dimension becomes the relevant one, 
their hypothesis is correct. If not, it is plausible that the same processes 
underly the performance of PD patients in this respect as in our card-
sorting tests. 
2. In PD we found an impaired self-generated problem solving in tasks of 
cognitive shifting and memory. The next issue is whether or not the 
crucial scores of self-generated problem solving in cognitive shifting, i.e. 
the number of trials of the first shifting phase after correction of the 
acquisition phase, are associated with the crucial scores of self-
generated problem solving in memory performance, i.e. decreasing 
semantic ratios and increasing serial ratios in the mixed version of the 
California Verbal Learning Test (CVLT). 
3. In the present study, we manipulated the format of the CVLT at the 
level of encoding. The next step is to investigate whether or not the 
same phenomena are seen when the format of the CVLT is manipulated 
at the level of retrieval. 
4. Hitherto, studies in the specificity of cognitive impairments in PD are 
rather disappointing. This holds true for studies aiming at the differen-
ces between cortical and subcortical disorders [3,13,19,22,24], as well as 
for studies aiming at similarities between PD and other subcortical 
syndromes [10,13,22,26]. In this study it was shown that the differential 
performance of PD patients does not show up in the conventional 
global sum scores. We presented alternative scoring methods which 
proved already useful in early PD with mild disabilities. Comparative 
studies with these scoring methods might show to what extent cognitive 
performance in PD differs from that in other disorders. In view of our 
remarks about an impaired self-regulation of problem solving strategies 
in the subsequent stage of disease, we suggest to start such comparative 
studies with patients in an early stage of the disease. 
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5. Many studies suggest that the cognitive impairments in PD reflect 
frontal dysfunction [20,24]. However, in the study of Owen et al. [21], a 
closer look at performance of PD patients and frontal patients revealed 
differences, especially with respect to the way in which frontal and PD 
patients differentially cope with external stimuli. Since our study also 
deals with the internal-external paradigm, comparison of PD patients 
with frontal patients using our scoring methods is a topic of high inte­
rest. So far, the Wisconsin Card Sorting Test (WCST), also one of our 
instruments, has the reputation to detect frontal lobe dysfunction [18], 
but phase-wise data are usually not provided. However, the current 
manual reports [12] that frontal patients needed three times the number 
of trials to achieve the acquisition than CS, whereas our data show that 
PD patients scored even slightly better than CS. A phase-wise analysis 
of the performance of frontal patients is needed to establish which are 
the similarities and the differences of performance in these groups. Such 
an analysis may also indicate which are the processes, which underly 
such differences in performance. 
The ultimate goal is to construct a neuropsychological instrument for early 
detection of PD [2]. For this purpose, it has to be established whether or 
not a combination of tests, which have been shown to be sensitive to PD, 
has enough discrminative power. Besides the tests of cognitive shifting 
presented in this thesis, the CVLT, some subtests of The Cambridge 
Neuropsychological Test Automated Battery [20], viz. attentional set-
shifting, spatial working memory and the 'Tower of London', have to be 
involved in such a research program. 
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SUMMARY 
The subject of this thesis is self-generated problem solving in Parkinson's 
disease (PD). Previous studies have indicated that PD patients are impai-
red in the internal generation of problem solving strategies, but that they 
perform as well as control subjects (CS) when external information is 
provided as to how a problem can be solved. The distinction between 
external guidance and internal generation of problem solving strategies in 
PD is the central issue of the studies presented. The thesis consists of two 
parts. 
The first part deals with self-generated problem solving in shifting and 
memory performance of PD patients. In Chapter 1 we investigated whether 
or not an impaired self-generated problem solving in PD patients is 
reflected in the phase-wise performance of card-sorting tests, being tests of 
cognitive shifting. Card-sorting tests are constructed in different phases. 
The first phase, being the acquisition phase, only requires correct sorting 
oh the basis of the feedback of the experimenter. In this phase, PD 
patients performed even slightly better than CS. In the first shifting phase, 
the experimenter changes the sorting category without telling so. Conse-
quently, external guidance is failing, and the subject himself has to 
generate a problem solving strategy. After correction for the base-line 
performance in the acquisition phase, the performance of PD patients in 
the first shifting phase was significantly poorer than that of CS, i.e. they 
needed more trials to generate an adequate problem solving strategy. In 
the second shifting phase, however, the performance of PD patients and 
CS did not differ: apparently, PD patients have learned during the first 
shifting phase how to cope with incompatible feedback. This last finding 
contradicts the hypothesis of Owen et al., who suggested that the poor 
card-sorting performance of PD patients is due to learned irrelevance. 
Learned irrelevance would implicate that card-sorting performance of PD 
patients would also be poor in the second shifting phase. 
Chapter 2 and 3 bear upon memory performance, which is known to be 
affected in PD. We investigated whether or not poor memory performance 
in PD reflects an impaired self-generated problem solving. We selected the 
Califoria Verbal Learning Test (CVLT), because this test provides 
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measures of distinct memory strategies. It was found that PD patients 
gradually adhered more to the externally imposed serial sequence, in 
contrast to CS, who appeared to rely increasingly on the internally 
generated semantic organization (Chapter 2). The question arised whether 
or not PD would use the semantic organization of the material to be 
recalled when it was externally presented, or when the externally imposed 
serial sequence was removed. For this purpose, we manipulated the format 
of the CVLT in such a way that - including the original one - three 
versions emerged, which differentially appealed to external guidance and 
internal generation of problem solving strategies. It was found that sig-
nificant differences in learning performance between PD patients and CS 
were restricted to the original version in which the more effective perfor-
mance was dependent on the internal processing of the information of the 
test items, i. e. on self-generated problem solving. In the manipulated 
versions of the CVLT, in which self-generated problem solving was made 
redundant, no significant differences in performance between PD patients 
and CS were found, indicating that poor memory performance in PD 
originates at least partly in an impaired self-generated problem solving 
(Chapter 3). 
Chapter 4 adresses the question to what extent an impaired self-
generated problem solving is associated with disease characteristics of PD. 
Many studies suggest that PD patients show a decreased performance on 
tests of executive functions, which are assumed to be dependent on the 
integrity of the frontal lobe. The cluster of executive function includes a 
great variety of heterogeneous functions. For our study, we selected 
cognitive shifting and fluency for the following reasons: both are executive 
functions, and what is more, both have divergent production in common. 
However, in contrast to fluency, which requires access to stored informati-
on, cognitive shifting requires that the subject himself generates problem 
solving strategies. Only cognitive shifting performance showed a firm and 
consistent relationship with the severity of motor symptoms in PD, in 
particular with rigidity, indicating that an impaired self-generated problem 
solving is coupled to the core symptoms of PD. 
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In Chapter 5 a pharmacotherapeutical study is reported. Among the many 
pharmacotherapies in PD, only anticholinergic therapy is known to 
produce negative side-effects on cognitive performance, which are 
restricted to memory performance. We examined whether or not cognitive 
shifting is also at risk in anticholinergic therapy. After correction for 
differences in memory performance, PD patients on anticholinergic 
monotherapy still performed poorer on our tests of cognitive shifting than 
de novo PD patients. Moreover, a reanalysis of these data along the lines 
described in Chapter 1 revealed that anticholinergics have a deteriorating 
effect on concept formation as well as on cognitive shifting. 
These results indicate that the negative side-effects of anticholinergic 
therapy in PD are more pervasive than generally assumed. 
The second part of this thesis deals with the question whether or not an 
impaired self-generated problem solving is specific to PD. For this purpose, 
we investigated three groups of patients of which the disorder or the 
pharmacotherapeutical regime is associated with different levels of striatal 
involvement, being a pathognomic characteristic of PD. 
First, we selected a group of patients with early adult or adult onset 
myotonic dystrophy (MyD), being a disorder without evidence of striatal 
dysfunction, despite a clinical picture, which is reminiscent of the subcor-
tical dementia syndrome. In Chapter 6 and the subsequent addendum, it is 
shown that the MyD patients did not show a poor performance on tests, 
which proved to be sensitive to PD in the first part of this thesis. 
Next, we selected a group of high-functioning adolescents suffering 
from autism, a disorder in which striatal involvement is sometimes es-
tasblished, sometimes not. This study is reported in Chapter 7. In line with 
these divergent findings, we found that an impaired self-generated problem 
solving fits the clinical picture of only a part of these patients, and that 
poor performance in tasks of self-generated problem solving is a predictor 
of poor progress in social understanding, being one of the most pervasive 
symptoms of this disorder. 
Finally, we investigated whether or not disrupting of striatal function is 
associated with an impaired self-generated problem solving. In Chapter 8, 
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we compared patients before and after administration of haloperidol, a 
dopamine antagonist. These patients were suffering from torticollis spas-
modieus, a disorder without evidence of striatal involvement. It was found 
that a low dose of haloperidol produces poor performance on tests, which 
require self-generated problem solving, in absence of parkinsonian motor 
symptoms. 
SAMENVATTING 
Onderwerp van dit proefschrift is zelf-gegenereerd probleemoplossen bij 
de ziekte van Parkinson. Eerdere studies wezen erop dat Parkinson-
patienten verminderd in staat zijn tot intern genereren van 
oplosstrategieën, maar dat zij even goed presteren als controle-subjecten 
(CS) wanneer externe informatie wordt verstrekt omtrent de wijze waarop 
een probleem opgelost kan worden. Het onderscheid tussen externe sturing 
en intern genereren van oplosstrategieën is het centrale thema van de 
onderhavige studies. 
Het proefschrift bestaat uit twee delen. 
Het eerste deel betreft het zelf-gegenereerd probleemoplossen in shifiing-
en geheugenprestaties van Parkinson-patiënten. In hoofdstuk 1 onderzoch-
ten wij of een stoornis in het zelf-gegenereerd probleemoplossen bij 
Parkinson-patiënten wordt weerspiegeld in de fasegewijze verrichting van 
kaartsorteertests, zijnde tests die cognitive shifting meten. Kaartsorteertests 
zijn opgebouwd in verschillende fases. De eerste fase - de acquisitie-fase -
vereist louter correct sorteren op geleide van de feedback van de 
proefleider. In deze fase presteerden de Parkinson-patiënten zelfs eniger-
mate beter dan CS. In de eerste shift-iase verandert de proefleider de 
sorteercategorie zonder dat er bij te vertellen. Bijgevolg hapert de externe 
sturing en moet de proefpersoon zelf een oplosstrategie genereren. Na 
correctie voor de uitgangsprestatie in de acquisitie-fase was de prestatie 
van de Parkinson-patiënten in de eerste shift-ïasc significant lager dan die 
van CS, dat wil zeggen, zij hadden meer pogingen nodig om een adequate 
oplosstrategie te genereren. In de tweede shift-fase echter verschilden de 
prestaties van de Parkinson-patiënten en CS niet: klaarblijkelijk hebben de 
Parkinson-patiënten tijdens de eerste shift-fase geleerd hoe tegenstrijdige 
feedback te pareren. Deze laatste bevinding weerspreekt de hypothese van 
Owen et al. die opperden dat de zwakke prestatie van Parkinson-patiënten 
bij kaartsorteren te wijten is aan aangeleerde irrelevantie. Aangeleerde 
irrelevantie zou immers inhouden dat de prestatie van Parkinson-patiënten 
bij kaartsorteren ook zwak zou moeten zijn in de tweede shift-fase. 
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Hoofdstuk 2 en 3 gaan over geheugenprestaties die naar bekend zijn 
aangedaan bij de ziekte van Parkinson. Wij onderzochten of de zwakke 
geheugenprestaties van Parkinson-patiënten een stoornis van het zelf-
gegenereerd probleemoplossen weerspiegelt. Daartoe selecteerden we de 
California Verbal Learning Test (CVLT), omdat deze test maten levert 
voor onderscheiden geheugenstrategieën. Parkinson-patiënten bleken zich 
gaandeweg aan de extern opgelegde seriële volgorde vast te klampen, in 
tegenstelling tot CS die in toenemende mate bleken af te gaan op de 
intern gegenereerde semantische organisatie (Hoofdstuk 2). De vraag rees 
of Parkinson-patiënten de semantische organisatie van het te herinneren 
materiaal zouden benutten, als die extern werd aangeboden of als de 
extern opgelegde seriële volgorde werd weggenomen. Daartoe manipuleer-
den wij het format van de CVLT zodanig dat er - inclusief de 
oorspronkelijke - drie versies te voorschijn kwamen die elk op 
onderscheiden wijze beroep deden op externe sturing en interne generatie 
van oplosstrategieën. Wij vonden dat significante verschillen in leerpres-
taties tussen Parkinson-patiënten en CS beperkt bleven tot de 
oorspronkelijke versie waarin de effectievere prestatie afhing van de 
interne verwerking van de testitems, dat wil zeggen van het zelf-
gegenereerd probleemoplossen. In de gemanipuleerde versies van de 
CVLT, waarin zelf-gegenereerd probleemoplossen redundant was gemaakt, 
werden geen significante verschillen tussen Parkinson-patiënten en CS 
gevonden, hetgeen er op wijst dat de zwakke geheugenprestaties bij de 
ziekte van Parkinson tenminste voor een deel voortkomen uit een stoornis 
in het zelf-gegenereerd probleemoplossen (Hoofdstuk 3). 
Hoofdstuk 4 betreft de vraag in hoeverre een afname in het zelf-
gegenereerd probleemoplossen verbonden is met ziektekenmerken van de 
morbus Parkinson. Veel studies geven aan dat Parkinson-patiënten een 
verminderde prestatie te zien geven op tests voor executieve functies die 
een intacte frontaal kwab vooronderstellen. Het cluster executieve functies 
omvat een grote variëteit aan heterogene functies. Voor ons onderzoek 
kozen we cognitive shifting en fluency uit en wel om de volgende redenen: 
beide worden gerekend tot executieve functies, en beide hebben daaren-
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boven divergente produktie gemeen. Echter, in tegenstelling tot fluency die 
toegang tot opgeslagen informatie vereist, komt het er bij cognitive shifiing 
op aan dat het subject zelf een oplosstrategie genereert. Alleen cognitive 
shifting bleek hecht en consistent gerelateerd aan de emst van de 
motorische symptomen, in het bijzonder aan rigiditeit, hetgeen er op duidt 
dat een afname van zelf-gegenereerd probleemoplossen gekoppeld is aan 
de kernsymptomen van de ziekte van Parkinson. 
In hoofdstuk 5 wordt een farmacotherapeutisch onderzoek verslagen. 
Van de vele farmacotherapieën bij de ziekte van Parkinson zijn alleen van 
anticholinerge therapie negatieve bijwerkingen op cognitieve prestaties 
bekend, die overigens beperkt zijn tot geheugenprestaties. Wij onderzoch-
ten of ook cognitive shifiing wordt aangedaan bij anticholinerge therapie. 
Na correctie voor verschillen op geheugentaken presteerden Parkinson-
patienten met anticholinerge monotherapie nog steeds zwakker op onze 
tests voor cognitive shifting dan de novo patiënten. Bovendien bracht een 
aanvullende analyse van deze data volgens de richtlijnen die beschreven 
zijn in hoofdstuk 1 aan het licht dat anticholinergica zowel op concept-
formatie als op cognitive shifiing verslechterend uitwerken. Deze resultaten 
duiden erop dat de negatieve bijwerkingen van anticholinerge therapie 
uitgebreider zijn dan gewoonlijk wordt aangenomen. 
Het tweede deel van dit proefschrift betreft de vraag of een verslechtering 
van het zelf-gegenereerd probleemoplossen specifiek is voor de ziekte van 
Parkinson. Met dit oogmerk onderzochten wij drie groepen patiënten 
waarvan de stoornis dan wel het farmacotherapeutisch regime gekoppeld is 
aan verschillende niveaus van striatale betrokkenheid, zijnde een pathog-
nomisch kenmerk van de ziekte van Parkinson. 
Allereerst kozen wij een groep patiënten uit met dystrofische myotonie 
(MyD) met een vroeg-volwassen of volwassen debuut van de ziekte. MyD 
is een stoornis zonder aangetoonde striatale dysfunctie, in weerwil van het 
klinisch beeld dat doet denken aan het subcorticale dementiesyndroom. In 
hoofdstuk 6 en het erop volgend addendum wordt aangetoond dat de 
MyD-patiënten geen zwakke prestaties laten zien op tests die in het eerste 
deel van dit proefschrift gevoelig bleken te zijn voor de ziekte van Parkin-
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son. Vervolgens kozen we een groep uit van goed functionerende adoles-
centen met autisme, een stoornis waarin striatale betrokkenheid nu eens 
wel, dan weer niet wordt vastgesteld. Dit onderzoek wordt weergegeven in 
hoofdstuk 7. Overeenkomstig deze uiteenlopende bevindingen vonden we 
dat een verstoord zelf-gegenereerd probleemoplossen bij het klinisch beeld 
van slechts een deel dezer patiënten past en tevens dat een zwakke 
prestatie op taken van zelf-gegenereerd probleemoplossen een voorspeller 
is van geringe vooruitgang in sociaal inzicht dat immers een van de meest 
indringende symptomen van deze stoornis is. 
Ten slotte gingen wij na of verstoring van de functie van het striatum 
verbonden is met een verslechterd zelf-gegenereerd probleemoplossen. In 
hoofdstuk 8 vergeleken wij patiënten voor en na toediening van haloperi-
dol, een dopamine agonist. Deze patiënten leden aan torticollis spas-
modieus, een stoornis zonder aangetoonde striatale betrokkenheid. We 
vonden dat een lage dosis haloperidol een zwakke prestatie teweegbrengt 
op tests die zelf-gegenereerd probleemoplossen vereisen terwijl er geen 
Parkinson-achtige motorische symptomen optreden. 
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STELLINGEN 
behorende bij het proefschrift 
SELF-GENERATED PROBLEM SOLVING 
IN PARKINSON'S DISEASE 
a neuropsychological study 
in het openbaar te verdedigen 
op 29 april 1996 
des namiddags om 3.30 uur 
door KJP.M. van Spaendonck 
I Bij patiënten met de ziekte van Parkinson neemt het vermogen om zelf een 
oplosstrategie te genereren af. - dit proefschrift 
Π Het verminderd vermogen van Parkinson-patiënten om zelf oplosstrategieën te 
genereren is gerelateerd aan de emst van de motorische symptomen, met name 
aan rigiditeit. - dit proefschrift 
III De geheugenstoornissen van Parkinson-patiënten zijn tenminste voor een deel 
te herleiden tot het verminderd vermogen om zelf oplosstrategieën te genereren. 
- dit proefschrift 
Г Patiënten met een vroeg-volwassen of volwassen debuut van dystrofische 
myotonie laten geen cognitieve stoornissen zien. - dit proefschrift 
V Er is onvoldoende empirische evidentie voor het construct executieve functies. -
dit proefschrift 
VI Het ontbreekt de diagnose 'subcorticale dementie' aan voldoende conver-
gerende en discriminerende validiteit. - Brown RG & Marsden CD, Neurosa. 
25, 363-387,1988. 
VII Functionele klachten vereisen een directieve aanpak. - Van Spaendonck KPM, et 
al. Functionele klachten in de medische praktijk, 1996. 
VIII Medische televisieprogramma's brengen forse kostenverhogingen in de 
gezondheidszorg met zich mee. Deze programma's dienen op sluikreclame 
getoetst te worden. 
IX Het toenemend aantal allochtone geneeskundestudenten met andere culturele 
opvattingen en onvoldoende beheersing van de Nederlandse taal stelt het 
medisch onderwijs voor een onmogelijke opgave als ook zij geacht worden 
uiteindelijk onverkort te voldoen aan de eindtermen van de opleiding. 
X Zolang co-assistenten zich nog tot de patiënt richten met 'ik' en opleiders met 
'wij', wordt in de medische opleiding afgeleerd gedrag voor eigen rekening te 
nemen. 
XI Eenmaal begonnen met een specialistische opleiding gaat de basisarts weldra 
teloor. 
XII Ten opzichte van non- en paraverbale kenmerken worden retorische kenmerken 
in trainingen gespreksvaardigheid onderbelicht. 
XIII Het geweldsmonopolie van de overheid impliceert dat beoordeling en 
tenuitvoerlegging van actieve euthanasie uitsluitend aan haar mogen toevallen. 
XIV De moeilijkste differentiaal-diagnose is die tussen de klinische blik en een lui 
oog. 



